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The simple diatom radical nitric oxide (NO) has numerous roles in biology.  In 
organisms, healthy nanomolar NO levels are highly regulated.  Deficiencies in NO can 
lead to atherosclerosis, diabetes, glaucoma, and many other conditions.  Yet organisms 
also purposefully increase NO concentrations to micromolar levels in combatting 
pathogens.  However, these high levels can backfire and damage cells and tissues, as 
found for Parkinson’s disease and ischemia, among others. 
Fluorescent NO probes enable live cell, tissue, and sometimes whole-animal 
imaging with minimal perturbation of their biological environment.  2-aminobiphenyl-
based probe NO550 brought about a novel mechanism of detection in which NO-surrogate 
nitrosonium cation is assimilated into the nascent cinnoline fluorophore, resulting in low 
background and increased sensitivity.  A family of second-generation 2-aminobiphenyl 
based probes were designed, producing four top performers in abiotic conditions.  
 ix 
Chapter 1 describes the synthesis of these top candidates and their evaluation in cells.  
Two emerged as promising options for NO researchers. 
Chapter 2 describes the design and synthesis of sequence-defined non-natural 
oligomers that are sequenceable.  Biological polymers peptides and DNA/RNA’s 
exquisitely complex properties are dictated by their sequence; changing the sequence 
sufficiently may have detrimental effects on their performance.  Both their synthesis and 
sequencing continue being optimized; a human genome that once required thirteen years 
to sequence now takes one day.   
Not as developed but growing rapidly is the field of non-natural sequence-defined 
polymers.  Without the constraints of biology, limitless options exist for backbone 
structures and sidechains.  Such diversity discourages the focused development of 
sequencing technologies on par with those for biological polymers.  Consequently, 
tandem MS is the favored form of analysis. 
We sought to change the approach to polymer design by factoring in the 
sequencing of the polymer in addition to its synthesis.  Oligourethanes based on β-
aminoalcohols were designed so that the terminal unit could be derivatized to sequence 
by cyclizing upon itself and thereby releasing the remainder of the oligomer.  Several 
derivatizations were investigated, to find that the oligomer sequenced itself without any 
terminal unit transformation, rather by self-immolation under conditions that slowed the 
“unzipping” of the polymer sufficiently to be able to detect the intermediate sequences.  
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Chapter 1:  Synthesis and Cell Studies on 3’-(N,N-dialkylamino)-2-
aminobiphenyl Fluorescent Dosimeter for Nitric Oxide Surrogate N2O31 
1.1 INTRODUCTION 
The uncharged diatomic radical gasotransmitter nitric oxide (NO) participates in a 
variety of biological processes, an effector molecule for the cardiovascular, immune, and 
nervous systems.  Research from 1972 to 1989 determined this hydrophobic gas, 
commonly known as a noxious pollutant in vehicle and factory emissions, to be the 
Endothelium-Derived Relaxing Factor (EDRF) – the chemical that initiates the process of 
dilation of blood vessels.  That such an inconspicuous molecule could play a prominent 
role in signaling in the cardiovascular system resulted in its being named Molecule of the 
Year in 1992, and then the Nobel Prize was awarded in 1998 to Furchghott, Ingarro, and 
Murad for their research establishing NO as the EDRF.  Over time, scientists have 
revealed the pleiotropic roles of NO in physiology and pathology, either through indirect 
methods, such as quantification of NO-producing enzymes, or through direct detection of 
NO or its reaction by-products.  Electro-paramagnetic resonance (EPR), electrochemistry, 
chemiluminescence, and fluorescence comprise most of the direct measurement methods.  
The multitude of fluorescent probes fall into five main approaches to detection.  Among 
these are the probes based on the 2-amino-4´-dialkylamino-biphenyl core, with NO550 as 
the progenitor.  Seeking to improve upon NO550’s poor hydrophilicity and reactivity, a 
second generation of probes was developed and compared to NO550 abiotically.  We 
 
1 Most of the content from pages 58 to 84 was published in Escamilla, P. R.; Shen, Y.; Zhang, Q.; 
Hernandez, D. S.; Howard, C. J.; Qian, X.; Filonov, D. Y.; Kinev, A. V.; Shear, J. B.; Anslyn, E. V.; Yang, 
Y., 2-Amino-3′-dialkylaminobiphenyl-based fluorescent intracellular probes for nitric oxide surrogate 
N2O3. Chemical Science 2020, 11 (5), 1394-1403.  Shen, Zhang, Qian, and Yang synthesized probes 1 to 
15 and determined their fluorescence properties in the absence and presence of NO in abiotic media.  I 
wrote the article and performed the cell studies to produce cell images and quantification of cellular 
fluorescence intensity. 
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evaluated the top two performers in cells versus NO550 and versus DAF-FM, the most 
published, “gold standard” fluorescence NO probe. 
1.1.1 Chemical Properties and Reactivity of Nitric Oxide 
Nitric oxide is a neutral radical that exists as a gas at biologically relevant 
temperatures.  The molecule has a bond order of 2.5, with a 115 pm bond length.  Its lack 
of charge and low polarity (0.159 D dipole moment, ten times less than water)1 results in 
greater solubility in hydrophobic than hydrophilic environments.  In fact, a solution in 
water saturates at 1.9 mM,2 whereas organic solvents retain five to ten times the 
concentration.3  With a diffusion rate of 3300 µm2/sec in water at 37 °C (1.4 times that of 
O2
4 - corresponding to approximately one length of a cell per 25 milliseconds),5 NO 
diffuses across cells readily, and its lipophilicity obviates the need for membrane 
receptors.  Due to the larger electronegativity of oxygen over nitrogen, the radical, 
located in an anti-bonding pi orbital, has a greater orbital contribution at the nitrogen 
atom, and molecular orbital theory correctly predicts that most reactions with NO form 
bonds at the nitrogen.  The reduction and oxidation potentials of NO, calculated at -0.76 
V6-7 and -1.2 V8-9 (1M in H2O vs. NHE), respectively, testify to NO’s weakness as an 
oxidizing or reducing agent and consequently to its inertness towards diamagnetic 
species. As such, nitric oxide predominantly reacts with paramagnetic species. 
●NO + 1 e- → 3NO- (-0.76 V/-0.56 V pH 7)   ●NO → NO+ + 1 e-  (-1.2 V) 
1.1.2 Sources of NO 
1.1.2.1 Nitric Oxide Synthases 
The oxidation of L-arginine to L-citrulline by nitric oxide synthases (NOSs) is the 
main source of nitric oxide in organisms.  In mammals, the two constitutively-expressed 
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synthases, endothelial (eNOS, or NOS 3)10 and neuronal (nNOS, or NOS 1),11 produce 
nanomolar levels of NO of seconds to minutes in duration.12  In contrast, the inducible 
synthases (iNOSs, or NOS 2),13-14 whose increased expression is activated in immune 
response, for example by cytokines or by lipophilic polysaccharides (LPS) in bacterial 
cell walls, output micromolar levels of NO over hours – until the synthases are 
degraded.15-17  Endothelial, epithelial, cardiac myocyte, platelets, erythrocyte,18-19 
fibroblasts, skeletal muscle, bone, motor neuron, and astroglia20 cells are known to 
contain eNOS, and the Ca2+/calmodulin-dependent NO they produce promotes 
vasodilation to regulate blood pressure.  NO from nNOSs, localized in neurons, 
astrocytes, and neuronal stem cells, reinforces glutamatergic synapses for learning and 
memory and for synaptic plasticity.  The higher levels of NO from iNOS in macrophages, 
hepatocytes, smooth muscle cells, chondrocytes, glial cells, astrocytes, neurons, and 
myocytes channel into pathogenic functions necessary for immune response.21 
 The enzymatic conversion of L-arginine to nitric oxide proceeds through 
reduction of molecular oxygen to first produce ω-N-hydroxy arginine (NOHA) and, in a 
second cycle, NO and L-citrulline (Scheme 1.01). 
Scheme 1.01:  Enzymatic conversion of L-arginine to L-citrulline and NO 
 
This intricate process requires substrate nicotine adenine dinucleotide phosphate hydride 
(NADPH) and cofactors flavin adenine dinucleotide (FAD), flavin mononucleotide 
(FMN), heme B, and (6R)-5,6,7,8-tetrahydro-L-biopterin (H4B).  Cytochrome P450, 
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which also reduces oxygen to then oxidize a wide variety of compounds, has most of 
these cofactors and substrates in common. 
1.1.2.1.1 NOS Structure 
The three isoforms of NOS, though encoded by different genes,22-23 share many 
similarities in structure, with iNOS the most divergent.  All three have a reductase 
domain at the C-terminus and an oxidase domain at the N-terminus, separated by an 
alpha-helix region in which the small Ca2+-binding protein calmodulin (CaM) docks.24-25  
NADPH, FAD, and FMN bind in the reductase domain, where the electron transport to 
the oxidase domain originates.  In the oxidase domain, cysteine-thiol-ligated heme B 
accepts these electrons and exchanges electrons with the neighboring H4B.  Both nNOS 
and eNOS have an autoinhibitory loop26-28 in the FMN subdomain of the reductase region 
as well as an electron-transfer-repressing C-terminal extension,29-31 necessary to regulate 
their nanomolar output of NO as constitutive enzymes.  The autoinhibitory loop is absent 
in iNOS, whose greater output depends upon the extent of induction to express a large 
population of the enzyme.  Unique to nNOS is an N-terminal extension known as the 
PDZ domain, which localizes the enzyme near the cell membrane, at the cytoskeleton, 
and at post-synaptic receptor locations.32-33 
 Although NOSs may exist as monomers or heterodimers with regulating proteins, 
only the homodimers bind L-arginine and H4B and catalyze NO synthesis (Figure 1.01).
34  
Within the same monomer subunit of the homodimer, NADPH substrate transfers a 
hydride to FAD, which reduces FMN, located a mere 5 Å away in nNOS, one electron at 
a time, first to the semiquinone and then to the hydroquinone.35-36  This FMN 
hydroquinone, sufficiently activated for a one-electron reduction of ferric heme,37 can do 
so efficiently only to the more proximal ferric heme residing in the oxidase domain of the 
partner subunit of the homodimer.38-40  Neither the monomer alone nor any heterodimers 
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efficiently transfer electrons to heme, as the greater degree of conformational change in 
the protein required for FMN hydroquinone to reach the ferric heme on the same 
monomer proves insurmountable.  Furthermore, the two H4B cofactors in the enzyme, 
which hydrogen bond to the proprionate arms of the heme, also reside in proximity (13 
Å) to each other, with a tryptophan aromatic residue in between.  This proximity enables 
electron exchange, possibly also channeled through the tryptophan residue, to an H4B 
radical in one monomer from H4B in the other monomer.
41   Essential to homodimer 
formation and cooperative in H4B binding is a tetrahedral zinc-ion bridge with four 
cysteine residues, two from each monomer, as ligands.42-43 
Figure 1.01: NOS homodimerization is necessary for the production of NO  
  
A) Depiction of eNOS non-associated monomers.  Without heme present, reductase domain activity is 
limited to the low-capacity reduction of oxygen to superoxide.  B) Heme binding promotes the 
formation of NOS homodimers, stabilized by Zn2+ binding by thiol fingers, which also stabilizes BH4 
cofactor binding. Calmodulin protein binding promotes NADPH/FAD/FMN electron transport 
chain.  FMN on one monomer transfers electrons not to the heme bound to it but rather to the heme 
bound to its dimer pair, firing up the catalytic production of NO.  Figure used with permission 
from44 
Equally vital to NO synthesis is calmodulin (CAM), a small protein which binds 
to a thirty-amino-acid residue between the FMN subdomain and the oxidase domain.25 
For the constitutive NOSs,  raised intracellular Ca2+ levels activate eNOS and nNOS (200 
to 400 nM for half-maximum activation).45  CAM binds four calcium ions in a penta-
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coordinate manner in each of four EF loops (the EF name derives from the last two of six 
helix regions A-F in the first crystal structure describing this substructure),46 provoking a 
change of conformation that increases exposure of hydrophobic side chains.  This greater 
hydrophobic surface enhances quaternary interactions with eNOS and nNOS, although it 
is not necessary for iNOS, whose more complementary sequence binds CAM regardless 
of resting Ca2+ levels (40 nM half-maximum activation).45, 47  The C-terminal domain and 
the autoinhibitory loop in the reductase region of eNOS and nNOS interfere with CAM 
binding, proven by selective mutation of residues in these constructs.33  They therefore 
require the more optimal, Ca2+-induced, hydrophobic CAM conformation.   
Although CAM binding affects several processes in NOS homodimers, such as 
enhancing reduction rates of the reductase flavins, it crucially increases the rate of one-
electron reduction of heme by FMN hydroquinone, the overall rate-limiting step for NO 
synthesis.48-49    FMN gets reduced by FAD in the reductase domain, distant from the 
heme in the oxidase domain.  A flexible hinge region enables a change in conformation 
through which FMN swings closer to heme, away from FAD.  The hinging occurs more 
readily in the open, rather than closed, conformation induced by CAM binding.50 
1.1.2.1.2 NOS NO Production Mechanism 
The mechanism for NO production from L-arginine has not been fully elucidated, 
although there is agreement on parts of the synthesis.  A large consensus describes the 
first cycle oxidation of arginine to NOHA as analogous to the Cytochrome P450 radical-
rebound mechanism (Scheme 1.02).51 Arginine and molecular oxygen substrates localize 
in the binding pocket above the ferric heme.  The NADPH to FAD to FMN electron 
transport chain reduces the ferric heme to ferrous, thus enabling complexation of oxygen.  
The incipient peroxo anion in this complex,52 due to π-back-bonding from the electron 
rich iron to the anti-bonding orbitals of oxygen, is stabilized by electrostatic interactions 
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with arginine and by hydrogen bonding to both a guanidinium proton of the arginine 
substrate and an active-site water molecule.53  Another electron, this time from H4B,
54-55 
the pterin cofactor hydrogen-bound to the proprionate arms of the heme, reduces the 
complex to the ferric-peroxy intermediate that then dehydrates to Compound I, the oxo-
Fe (IV) heme cationic radical.51  The ferryl oxygen abstracts a hydrogen radical from 
arginine substrate, forming the guanidinyl radical which in turn abstracts the Fe(IV)-
bound OH radical to produce NOHA and ferric heme. 
Scheme 1.02:  Possible mechanism for the first cycle in NO production – NOS 





The second cycle (Scheme 1.03) requires only one electron from NADH, 
signaling a different mechanism from the first.  The one agreement for the second cycle is 
the necessary NADPH/FAD/FMN reduction of ferric heme to ferrous with binding of 
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oxygen.  Most suggested mechanisms also incorporate further reduction with H4B to the 
peroxy anion, subsequently protonated to the hydroperoxy complex.  The proton source 
in this case is purported to be the more acidic hydroxyguanidinium proton,56 rather than 
the water/arginine hydrogen-bonded network for the first cycle.57  Partly due to this 
difference in proton sources is attributed the change in heme catalysis from the first to 
second cycles. A concerted, six-membered transition state could be envisioned, in which 
a pi bond forms between the NOHA ω-nitrogen and its hydroxyl oxygen, a sigma bond 
forms between the guanidinyl carbon and the distal hydroperoxyferryl oxygen as the 
peroxo bond breaks, and the proximal hydroperoxyferryl anionic oxygen deprotonates the 
hydroxyl.  The resulting ferric hydroxide would then deprotonate the resulting tetrahedral 
intermediate, expelling nitroxyl anion to form L-citrulline.   Nitroxyl anion could then 
replace water in the experimentally-observed ferric aqua complex.57  This ligand 
exchange enables reduction of the H4B radical and results in dissociation of NO radical 
from ferric heme.53  
Scheme 1.03:  Possible mechanism for the second cycle in NO production – NOS 





1.1.2.2 Nitrate / Nitrite / NO Pathway 
Endogenous NO also derives from the nitrate-nitrite-NO pathway, in which 
nitrate and nitrite are reduced to NO.  The most abundant of these three nitrogen oxides 
in plasma (roughly 100:1:0.1 nitrate/nitrite/NO)58, nitrate was at first considered the 
physiologically inert end-product of NO chemistry, but it actually functions as a stable 
storage of the more reactive NO.  Molybdenum-based oral-commensal-bacteria nitrate 
reductases59 efficiently reduce nitrate to nitrite,60 and salivary glands extract 
approximately 25% of circulating plasma nitrate, which derives from diet and from the 
oxidation of endogenously produced NO.61  For mammals, xanthine oxidoreductase 
seems to also perform as a nitrate reductase, especially in hypoxic and low pH 
conditions.62-63   
Reduction of nitrite to NO does not depend on prokaryotic enzymes.  Nitrite 
derives from nitrate reduction or from reactions with downstream products of NO, such 
as N2O3 and peroxynitrite.  Gastric acidity does non-enzymatically reduce some of the 
nitrite to NO,64 but most nitrite is absorbed into circulation with a half-life of ten 
minutes.65  Multiple mammalian nitrite reductases convert nitrite to NO, particularly in 
hypoxic or even apoxic and/or lower than physiological pH conditions. Among these are 
the molybdenum-based xanthine oxido reductase, sulfite oxidase, and aldehyde oxidase; 
the mitochondrial amidoxime reducing components III and IV; the hemo, myo, neuro, 
and cytoglobin family, eNOS, and possibly carbonic anhydrase.66  The nitrate-nitrite-NO 
production pathway, optimal under hypo-aerobic conditions, performs complementarily 
to the NOS pathway, optimal under aerobic conditions.  In fact, the output of NO from 
nitrite in ischemic conditions rivals that of constitutive NOSs.67 
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1.1.3 Sinks for NO  
The diatom nitric oxide, with an average half-life varying from 0.1s to 6 seconds68 
(more recently estimated at 0.002 to 2 seconds),68 depending upon its environment, 
readily permeates membranes, diffusing according to its concentration gradient away 
from its point of production.  A stable radical resistant to oxidation or reduction, it reacts 
with paramagnetic partners.   Its primary partner in the bloodstream is the metalloprotein 
ferrous oxyhemoglobin in red blood cells (erythrocytes), with reaction rates on the order 
of 105 M-1s-1.  Their interaction results in heme oxidation to ferric and in oxidation of NO 
to nitrate, an apparently insignificant end to the signaling radical, except for its ability to 
be stored as NO3
- as discussed above.69  Interestingly, studies have revealed that 
hemoglobin in erythrocytes frequently carries NO in its S-nitroso form.  When 
hemoglobin adopts its oxygen-binding relaxed state, the Cysβ93 thiol tends to be 
nitrosylated,70 as shown by mass spectroscopy71 and by x-ray crystallography,72 without 
much consequence to its bioactivity.  Similar to hemoglobin’s ability to carry 
nitrosonium, the major component (> 5 µM) of S-nitrosoproteins in human plasma is 
serum albumin, with an S-nitroso Cys-34, indicating the S-nitrosation of plasma proteins 
as a significant NO sink.73 
 For the constitutive NOSs, NO’s intended reaction partner is the soluble 
Guanylate Cyclase (sGC), a ferrous heme protein that binds O2 very poorly
74 but NO 
strongly.  This binding catalyzes the conversion of guanosine triphosphate to the 
secondary messenger cyclic guanosine monophosphate (cGMP).75  NO binding to 
histidine-coordinated ferrous hemes displaces, due to strong π-backbonding between the 
metal and NO, the trans histidine, thereby activating the sGC.76-77  Other signal 
transduction targets for NO include mitochondrial cytochrome oxidase,78 cytochromes 
P450,79 vitamin B2 Cobalamin,80 nuclear factor kappa B (NF-κB),81 Ca2+-related G-
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proteins,82 apoptosis caspases and poly (ADP-ribose polymerase),83-85 partially 
oxygenated hemoglobin,86 the chelated iron pool,87 the cardiac calcium-release channel,88 
NMDA channels,89 and (at high concentrations) calcium-dependent potassium channels 
in vascular smooth muscle.90  When nitrosylating higher oxidation state metalloproteins 
[M(X)], the complex has greater M(X-1)-NO+ character, and the complex can 
stoichiometrically (not catalytically) nitrosate diamagnetic nucleophiles, such as water, 
amines, and thiols.  The reduced metal may bind NO, but with prohibitively less NO+ 
character and unable to reductively nitrosylate another nucleophile.  Nitrosothiols can 
transnitrosate other thiols, thereby acting as a storage of this nitrosonium chemistry of 
NO. 
Apart from interactions with metalloproteins, NO reacts with other radicals.  
Nitrosylation of thyil radicals provides another route to nitrosothiols and their 
nitrosonium storage capabilities.  In tissue, the main consumption is by hydroxyl and 
superoxide radicals.  HO radicals neutralize NO to nitrite.  Superoxide (O2
●-) reacts with 
NO at near diffusion-limited rates to form peroxynitrite (Scheme 1.04A).  Protonation of 
peroxynitrite (pKa ~6.6) weakens the peroxide bond and leads to disproportionation to the 
radicals nitrogen dioxide (●NO2) and hydroxyl (
●OH) in their solvent cage that recombine 
to yield nitrate or further react with NO to give nitrite and dinitrogen trioxide (N2O3, 
Scheme 1.04C).  Peroxynitrite may also react with carbon dioxide to form the 
nitrosoperoxycarbonate anion (Scheme 1.04B);91 homolytic cleavage gives NO2 and 
carbonate radicals that can rearrange in the solvent cage to nitrate and carbon dioxide.  If 
they escape the solvent cage, the two radicals can further react with NO to give N2O3 and 
nitrite and carbon dioxide, respectively.  Carbon radicals react to form organic nitroso 
compounds that tautomerize to oximes in the case of primary or secondary radicals.  
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Scheme 1.04:  Physiologically relevant reactions of NO with radicals 
A.       
B.       
C.       
A) NO and superoxide combine under near-diffusion-limited rates to form peroxynitrite, which 
decomposes after protonation (pKa ~ 6.6) to NO2 and OH radicals that can reassociate to form nitric 
acid.  B)  Peroxynitrite reacts readily with carbon dioxide to the nitrosoperoxycarbonate, which 
disproportionates to NO2 and carbonate radicals.  These can recombine and heterolyze to nitrate 
and carbon dioxide.  C)  If NO2 radical escapes the solvent cage from homolysis in (A) or (B), it can 
react with NO to form asymmetric N2O3, a nitrosating agent. 
The two unpaired electrons in oxygen entail a third-order reaction with two NO 
molecules (Scheme 1.05).  The resulting product disproportionates to two molecules of 
NO2, again with the unpaired electron primarily on the nitrogen but also more oxidizing 
than NO.  NO combines with NO2 to form N2O3 (Scheme 1.04C), and the greater 
oxidation potential of NO2 means that N2O3 has some nitrosonium character, making it a 
nitrosating agent.  Typical biological NO levels range from 10 nM to 1 µM, and at this 
dilution, for reaction with physiological levels of oxygen, NO has a half-life of nine to 
900 minutes.92  However, both NO and O2 are more soluble in hydrophobic 
environments, and so higher local concentrations in membranes and hydrophobic pockets 
enhance reaction rates about 300-fold.93   
Scheme 1.05:  Reaction of NO with oxygen to form nitrogen dioxide 
 
Another circumstance increases local concentrations of NO and O2.  As stated 
before, eNOS, which are mostly expressed in endothelial cells, produce approximately 
70% of circulating nitrite from oxidation of NO.  Diffusion of NO away from its point of 
synthesis takes it towards the proximal blood stream to be converted into nitrite by 
oxyhemoglobin in erythrocytes – or in the opposite direction, penetrating into tissues.  
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Released O2 from oxyhemoglobin similarly diffuses away from the blood stream and into 
tissues, and so the concentration gradient for NO and O2 is higher close to the 
bloodstream than average NO and O2 values, especially in hydrophobic environments, 
enabling N2O3 nitrosative chemistry. 
1.1.4 Physiology of NO 
 Nearly thirty years after its discovery as the EDRF, a myriad of 
physiological roles for NO has been elucidated.  Nitric oxide influences vasodilation;94 
glaucoma;95 proliferation and migration of vascular smooth muscle cells,96 platelet 
adhesion and aggregation;97 cell inflammation and leukocyte adhesion that can lead to 
thrombosis;98 vascular permeability;99-100 angiogenesis;101-102 fibrinolysis;103 
bronchodilation;104 β-adrenergic stimulus;105 cytokine production and mast cell 
inhibition;106 wound and muscle repair;107-108 penile erection;109 spermato/oogenesis and 
fertilization;110 colon, rectum, and sphincter relaxation;111 glomerular filtration and renin 
secretion;112-113 brain vascular tone regulation;114 thermoregulation;115 
neurotransmission;116-117 regulation of neurotransmitter uptake and reward learning;118 
sleep regulation;119 pain sensitization;120-121 hormone secretion;122-123 long-term 
potentiation and depression in synaptic plasticity;124-127 neurogenesis;128 stem cell 
differentiation;129 immune response to bacteria, parasites, and viruses;130 and tumor 
suppression.131  It is the relaxation factor produced by eNOS in endothelial cells that 
binds to sGC to activate the synthesis of cGMP, which in turn acts on protein kinases, 
gates cation channels, and regulates phosphodiesterase to cause relaxation of smooth 
muscle cells in veins and arteries.132-133  This vasorelaxation increases blood flow, lowers 
blood pressure, and decreases platelet adhesion.  cGMP also triggers mitochondrial 
biogenesis134   
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An equally major target for NO is nitrosylation (via transition metal 
intermediates) or nitrosation (via nitrosonium chemistry) of cysteine thiols in proteins.135  
This type of post-translational modification is regulated and site-directed and applies to 
nearly all protein categories, with effects such as directing proteins to subcellular 
locations; preparing proteins for degradation; and regulating interactions between 
proteins, ion-channel activity, membrane trafficking, phosphorylation, cellular redox 
stress, enzyme activities, cellular metabolism, transcription-factor activity, and 
apoptosis.136  For example, cancer cell death derives from s-nitrosylation of matrix 
metalloproteinase 9 (MMP-9) and NF-κB.137   
S-nitrosothiols, whether in proteins or deriving from low-molecular weight thiols 
such as cysteine and glutathione readily transnitrosate other thiols, performing as NO 
carriers.  In the circulatory system, when hemoglobin is in its oxygen-binding relaxed 
state, S-nitroso Cys93β resides in a hydrophobic cavity.  Hemoglobin’s tense 
conformation that releases oxygen also exposes the S-nitrosothiol to the cytoplasm.138  
Trans-nitrosation, particularly to membrane-associated proteins or to low-molecular-
weight thiols, results in the extracellular delivery of nitrosonium, according to a 
decreasing arteriovenous oxygen gradient, with subsequent vasodilation.  The mechanism 
of this vasodilation has not been established and may not proceed through the NO/sGC 
activation mechanism.139  Hydrogen sulfide may denitrosylate S-nitrosothiols via its 
disulfide, forming perthionitrite.  Homolysis releases NO and persulfide radical, initiating 
sulfide polymerization.140  Whether this sequence of reactions occurs at biological levels 
has not been determined. 
In addition, NO competes with oxygen for binding to Cytochrome C oxidase in 
mitochondria, inhibiting respiration and prolonging O2 diffusion into tissues.
141  Also, 
due to its resistance to oxidation or reduction, NO acts as a radical quencher.  It 
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transforms highly oxidative hydroxyl radicals to the much more benign nitrite anion.  The 
oxidative NO2 radical reacts with NO to form N2O3, a milder nitrosating species.  NO can 
also quench allylic and peroxy radicals in lipids to stop the propagation of lipid 
peroxidation that can disrupt cell membranes.142 
 NO levels range from constitutive NOS picomolar/nanomolar resting 
levels to inducible NOS micromolar full output concentrations.  At the lower end, 500 
pM to 5 nM steady-state NO concentrations activate sGC to augment cell proliferation 
and protection, but 100 nM concentrations are needed to activate extracellular signal-
regulated kinase (ERK).  Increasing up to 150 nM, Akt get phosphorylated, triggering the 
phosphorylation of caspase-6 and Bad, which disrupts apoptosis.143  NO inhibits non-
heme iron oxygenases at 100 to 400 nM levels, and levels above 1 µM promote 
nitrosation of proteins, thiols, zinc fingers, and DNA.144  In general terms, at lower 
concentrations, NO influences cell survival and proliferation.  Mid-level NO modulates 
metastasis, the vascular endothelial growth factor, and angiogenesis.  High NO 
concentrations tend to induce apoptosis and enact DNA nitration (nitrosative stress).145 
1.1.5 Pathology of NO 
The two extremes of NO concentration typically produce pathological results.  A 
deficiency of NO negates NO benefits and leads to hypertension; thrombosis; 
atherosclerosis; hypercholesterolemia; infarction; diabetes;146 chronic and acute 
inflammation disorders, including arthritis; stroke; hyperlipidemia; digestive tract issues, 
such as irritable bowel syndrome; chronic kidney disease;147 erectile disfunction; asthma; 
cystic fibrosis; loss of memory and learning;148 dementia;149 β-amyloid deposition in 
Alzheimer’s disease;150  Many of these hypo-nitric oxide symptoms were isolated by 
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infusing or injecting NOS inhibitors based on L-arginine derivatives, such as L-N-
monomethyl arginine (L-NMMA) or by knocking-out NOS expressing genes. 
Low NO levels can result from the uncoupling of NO synthesis in NOS, for 
instance from lack of L-arginine substrate or H4B cofactor.  This uncoupling reduces 
oxygen to superoxide through the oxy-ferrous heme complex or by flavins FAD or 
FMN.151  Various other enzymes also leak electrons to reduce oxygen when the catalytic 
system is not fully aligned, especially in the mitochondrial electron transport chain, 
whereas other enzymes such as NADPH oxidase and xanthine oxidase  primarily produce 
superoxide for immune response.  NO and superoxide combine to form peroxynitrite that, 
when protonated (pKa 6.8) can disproportionate into the much stronger oxidants 
●OH and 
●NO2, and the 30% that escape the solvent cage
152 either nitrate or oxidize unsaturated 
lipids and nitrate tyrosine, tryptophan, guanosine, and DNA.  Similarly, the peroxynitrite 
/ CO2 adduct disproportionates to 
●OCO2 and 
●NO2, and the 35% that escape the solvent 
cage153 similarly corrupt the lipid bilayer, proteins, and DNA. 
Whereas a deficiency of NO subtracts its beneficial modulatory properties, when 
concentrations reach maximum micromolar levels, NO and its metabolites themselves 
wreak pathological havoc.  At these concentrations under normoxic conditions, both NO 
oxidation to NO2 and N2O3 and NO’s reaction with superoxide anion to form 
peroxynitrite become more relevant, leading to nitrosative stress.  The most common 
indicator of nitrosative stress is the conversion of tyrosine residues to 3-NO2 tyrosine, 
stemming from radical (e.g., NO2 and OH - from disproportionation of peroxynitrous 
acid - or NO2 and CO3
- - from the nitrosoperoxycarbonate adduct of peroxynitrite and 
CO2) abstraction of a hydrogen ortho to the phenol followed by combination of the aryl 
radical with NO2.   Subjects with rheumatoid arthritis;
154 renal septic shock;155 celiac 
disease;156 cerebral ischemia;157 Alzheimer’s, Parkinson’s, Huntington’s, Lou Gehrig’s, 
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and Prion diseases158 exhibited increased levels of nitrotyrosine versus healthy ones, 
mainly due to conformational changes to the nitrotyrosine-containing protein.  The three 
radicals also abstract allylic protons from unsaturated lipids, and the lipid allylic radicals 
then form other radical adducts or initiate lipid peroxidation.159    The potent HO radical 
reacts with sugars in polysaccharides and in DNA strands, breaking the polymers.160  
Furthermore, peroxynitrite, its acid form, and nitrogen dioxide react with guanine in 
DNA to cause single strand breakage. 
Insomuch as the diffusion-limited reaction between NO and peroxynitrite, 
sometimes with the involvement of CO2, delivers NO2, CO3
-, and OH radicals, the 
diffusion limited reaction between NO and NO2 generates the nitrosonium equivalent 
N2O3 to react with diamagnetic nucleophiles, such as water, amines, and thiols.  The 
prohibitively slow (unless at high NO concentrations and in hydrophobic environments 
with oxygen) autoxidation of NO, homolysis of peroxynitrous acid, disproportionation of 
peroxynitrosocarbonate, and oxidation of nitrite all contribute to NO2 availability, and 
this neutral radical also diffuses through membranes, imparting relevance to the N2O3 
chemistry of NO.  Most damaging of this chemistry is the eventual deamination of 
primary amines through N-nitroso adducts, to the extent that the public was admonished 
to avoid nitrite-preserved meats, despite vegetables being a better source of nitrite.  
Cytosine, adenosine, and guanine DNA bases de-aminate to uracil, hypoxanthine, and 
xanthine, respectively, upon reacting with N2O3, and these point mutations (G to A 
translation and G to T transversions)161 may cause cancer.162  Enzymatic hydroxylation, 
e.g., cytochrome P450, oxidizes secondary nitrosamines to the geminal N-nitrosamine 
alcohol that heterolyzes to the carbonyl and N-hydroxy-N’-alkyldiazene fragments.  
Dehydration produces the alkyldiazonium salt, a powerful alkylating agent that has been 
observed to react indiscriminately with the gamut of available nucleophilic sites on DNA, 
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even phosphates.163  Alkylation interferes with base pairing, DNA repair, and other 
normal enzymatic processes upon DNA, also leading to mutations and eventually 
cancer.164 
Through reactive nitrogen species (RNS), excess of NO (beyond the regulatory 
mechanisms of the cell) can result in necrosis or apoptosis.   Necrosis from ATP 
depletion, which blocks apoptosis, results from pathological levels of NO that eventually 
irreversibly repress mitochondrial respiration, induce mitochondrial permeability 
transition, inhibit glycolysis, and poly-ADP ribose polymerase (PARP) activation.165  The 
impeded respiration provokes glutamate release; in glia neighboring neurons, the released 
excitatory transmitter glutamate overwhelms the sensitive neurons, resulting in their 
excitotoxicity.166  Peroxynitrite was directly implicated in multiple sclerosis in provoking 
demyelination and damage to axons,167 except when uric acid, an ONOO- scavenger, was 
administered.168  Excessive nitrotyrosination of proteins leads to Alzheiemer’s disease, 
provoking aggregation (by favoring β-sheet secondary structure) of fibrillar amyloid beta 
and paired helical filaments of  tau and triosephosphate isomerase proteins, compromised 
glucose consumption and thus cholinergic deficiency, and tubulin-network damage.20  
Similarly, Lewy-bodies α-synuclein protein aggregates in Parkinson’s disease, 
responsible for the death of 70% of Substantia Nigra dopaminergic neurons, contain 
nitrotyrosinated α-synuclein, and this nitration has been shown to induce aggregation.169    
1.1.6 NO Detection and Measurement 
 Understanding the varied roles that nitric oxide plays in the plentitude of 
biological processes highlights the need for proper methods of detection and 
quantification.  Ideally, these methods would measure and discriminate the subnanomolar 
to nanomolar concentrations of resting NO levels, up to the micromolar levels produced 
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by iNOS, with the measurement not altering or consuming the analyte.  A sensor should 
also produce a signal within the lifetime of NO, or at least within the duration of the 
change in NO concentrations brought about by an interrogation to the system.  
Furthermore, a sensor with subcellular resolution would inform on NO kinetics, from its 
origin to its diffusion and consumption.  Finally, sensors for NO’s metabolites would 
provide a full picture of the biology of NO.  To date, although many sensors and methods 
exist – a tribute to the importance of studying NO – none exhibit all the desired 
characteristics.   
One way to categorize the sensor population is according to their ability to detect 
with subcellular resolution.  Among those lacking this ability are chemiluminescent 
detection, NO electrodes, electroparamagnetic resonance (EPR) probes, and the Griess 
assay. 
1.1.6.1 Griess Assay  
Perhaps the most global and indirect measurement of NO is the Griess assay, 
which colorimetrically measures NO oxidation termini nitrite and nitrate.  Oxidation of 
NO is one of the main sinks in NO metabolism, and the sum of nitrate and nitrite 
concentrations has been considered proportional to NO production, although systems that 
incorporate ingested nitrate and nitrite cannot claim a direct proportion.  For NO-related 
hypoxia studies (e.g., ischemia-reperfusion and its treatment), however, nitrite 
quantification is highly relevant as a prominent source of NO.  The Griess diazotization 
assay comprises reacting nitrite in acid to dehydrate nitrous acid and form nitrosonium 
equivalent N2O3 in the presence of a primary amine nucleophile, such as sulfanilimide 
(Scheme 1.06).  The resulting primary nitrosamine tautomerizes and dehydrates to the 
diazonium salt, and then addition of second amine nucleophile, such as N-
 20 
naphthylethylenediamine, makes the colored diazo compound whose absorbance (with 
these reagents – 540 nm) linearly reflects nitrite concentration at the correct dilutions. 
Scheme 1.06:  Detection of NO oxidation-sink nitrite via typical Griess-assay reagents 
 
 
The Griess assay is normally applied to cell culture supernatants, serum, plasma, 
or urine.  Proteins, with nucleophilic side chains, interfere with the assay and are 
typically filtered off.  Other interferants include NADH and NADPH, anticoagulants, 
azide, ascorbic acid, and small molecular-weight thiols.  Only nitrite, not nitrate, reacts to 
form the diazonium products, but application of nitrate reductase to samples efficiently 
reduces nitrate to nitrite, enabling independent quantification of total NO oxidation 
products.  Typical limits of detection are 2.5 µM, unless the sample is first purified by 
HPLC, which resolves most interferants and concentrates the NOx analytes to their peak 
elution volume, resulting in 1 nM detection limits. 
1.1.6.2 Chemiluminescence 
For the highly sensitive (~ 10 pM)170 chemiluminescence technique, emitted NO 
gas, for example that escapes or is sparged out of a tissue sample or a cell culture, is 
directed by a stream of inert gas (or even air at low NO concentrations) to a vessel 
containing ozone.  The exothermic reaction of NO with ozone produces oxygen and 
nitrogen dioxide (Scheme 1.07), with a portion of the population of nitrogen dioxide in an 
excited state.  Relaxation to the ground state emits a broad spectrum of photons centered 
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around 1200 nm170 with a quantum yield of 0.12 to 0.18.171-172  The rate for this reaction 
is 107 M-1sec-1.173  Selectivity for NO derives from its fairly unique nIR 
chemiluminescence.  However, most commercially-available photomultiplier tubes 
(PMTs) that convert emitted photons to electrical signal do so poorly at wavelengths 
greater than 875 nm.  This limitation results in loss of most of the NO signal, so the 600 – 
875 nm signal is optimized by placing long-pass filters with a 600 nm cutoff to eliminate 
most interferences from other chemiluminescent impurities.  This assay has been 
expanded to include detection of NO released from as low as 10 nM S-nitrosothiols by 
reaction with  Cu (I) and cysteine, 10:1 hydroquinone/quinone in alkaline conditions (to 
form the semiquinone radical), or vanadium (III).  Triiodide (which also displaces the 
more weakly-bound heme-NO) measures not only NO released from S-nitrosothiols but 
also from reduction of nitrite, again at 10 nM lower limit of detection (LOD).174 
Scheme 1.07:  Chemiluminescence from the reaction of nitric oxide and ozone 
 
1.1.6.3 NO-selective Electrodes 
NO electrodes, particularly microelectrodes, provide more localized 
measurements than chemiluminescence.  Some microelectrodes have been constructed at 
7 µm in diameter,175 well below the average cell diameter of 20 µm, permitting single-
cell measurements.  Depending on the electrode material, a potential of  0.6 to 1.0 V 
(Ag/AgCl)176 oxidizes NO to NO+.  Electrodes have been fabricated from platinum, 
carbon fiber, graphene, graphite, gold, and glassy carbon, the latter exhibiting high 
inertness, good conductivity, and ease of modification.  The high potential required to 
oxidize NO also oxidizes common interferants, such as carbon dioxide, ascorbic acid, 
peroxynitrite, nitrite, hydrogen peroxide, hydrosulfide, dopamine, and acetaminophen.177  
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Coating the transducer surface with hydrophobic (often perfluorinated) polymer 
membranes; such as Nafion (also sulfonated), polystyrene, Teflon AF, chitosan or 
cellulose acetate; filters out charged or larger molecules. Conversely, the small, 
uncharged, and lipophilic NO is able to approach the junction, along with other small 
gases, including O2, CO2, and H2S.
178  In addition to functioning as NO sieves, 
membranes also serve to protect the electrode from contamination by the biological 
medium, although proteins tend to foul hydrophobic membranes more than hydrophilic 
ones due to the hydrophobic effect.179  Nafion membranes provide a compromise 
between NO-favored lipophilicity and water-ordering non-polar groups.  Membrane 
thickness also enters the equation, since the longer NO takes to diffuse to the electrode, 
the longer the response times and lower sensitivity.180  Further manipulations to improve 
selectivity and sensitivity have involved incorporating metalloporphyrins and 
metallophthalocyanines; gold, ferric oxide, or alumina nanoparticles; and single or multi-
walled carbon nanotubes.  Optimized electrodes have reached an LOD of 55 pM181 and 
can linearly detect NO from 200 pM to 4 µM.182  Typically the electrode is placed at a 
small distance above the cell or tissue, and carefully reproducing this distance enables 
comparisons between experiments.183  Incorporating the electrodes onto the surface to 
which the cells adhere eliminates distance variability from improper positioning of the 
electrode above the cell.184-185  Some complications derive from the high electrode 
potentials destabilizing the polarization of cell membranes,186-187 from causing injury to 
cells or tissue and inducing NO response (the measurement itself increasing analyte 
levels), and from hampered function and limited reusability of electrodes after exposure 
to the complex biological matrix.  More worrisome is the variability (up to six orders of 
magnitude) among electrode-based measurements in similar experiments.188-189  One 
issue was determined to be the size of the electrode; those with diameters greater than 30 
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µm consumed the local NO in the unstirred media, thus reporting that only 50 nM NO 
affected vascular smooth muscle in arterioles, whereas electrodes with diameters less 
than 15 µm reported hundreds of nanomolar NO for the same process.190  The authors 
concluded that resting NO concentrations lie in the mid 300 nM on the outer walls of 
arterioles. 
1.1.6.4 EPR 
Electron paramagnetic resonance (EPR) spectroscopy rounds out the common 
nitric oxide analysis techniques that cannot distinguish subcellular entities.  Due to 
typical spatial resolution on the order of millimeters (although micron and sub-micron 
resolution with EPR have been reported) most imaging applies to tissues, organs, limbs, 
and whole animals.   One of the main advantages of EPR is that it detects only 
paramagnetic signals, greatly simplifying complex matrices like those found in biology, 
due to the normally short lifetimes of radical species.  Like magnetic resonance imaging 
(MRI) (and often overlayed with MRI spectra), the lower energy microwaves employed 
by EPR penetrate tissue and enable in vivo imaging.  Analogous to nuclear magnetic 
resonance (NMR), the quantized electromagnetic-energy photons needed to promote an 
electron whose spin is aligned with an external magnetic field to a higher energy level in 
which the spin is aligned against the field have wavelengths in the order of millimeters, 
depending on the field strength.  Furthermore, nuclei that also align with and against the 
magnetic field affect the electron’s local magnetic field, leading to hyperfine splitting 
(e.g., doublets, triplets, multiplets). The equivalent of chemical shift in NMR, g values 
are dimensionless (proportionality constants relating the strength of the field to the 
frequency of excitation)  and describe the magnetic local environment of the electron 
relative to a free electron, with a g value of 2.0023.191 
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The EPR spectrum for short-lived and dilute NO in biological specimens is broad 
and indistinct from various endogenous signals, so paramagnetic metal-NO complexes or 
NO-adducts that produce more defined spectra and stabilize the paramagnetic species are 
preferred.  The less reactive and more selective NO radical does not form adducts with 
nitrone spin-traps, requiring the more reactive nitronyl nitroxides, such as PTIO. These 
and their iminonitroxide product from oxidizing NO to NO2 both exhibit well-defined 
and distinct spectra.  NO2 can react with another molecule of NO to form N2O3, changing 
the stoichiometry from 1:1 PTIO to NO to 1:2 PTIO(NO2) to NO (Scheme 1.08).
192  
Superoxide,193 ascorbate, thiols, and other reducing agents shorten the lifetime of both 
species by reducing them to EPR-silent diamagnetic species.  Consequently, although 
nitronyl nitroxides have been used in imaging, they have fallen out of favor. 
Scheme 1.08:  Additional reactivity of ntironyl nitroxide spin trap for NO  
 
Further reaction of nitronyl nitroxide spin trap for NO to produce NO2, whose reaction with another 
molecule of NO can distort probe to NO stoichiometry 
 
Ferrous dithiocarbamates (DTCs, Scheme 1.09A) are more robust traps for NO.  
Their lifetime in air is on the order of a day, versus the minute lifetimes of organic spin 
traps.194   The simple reaction of amine with carbon disulfide yields dithiocarbamate, 
accessing a wide variety of these ligands; such as N,N-diethyl-dithiocarbamate (DETC), 
N-methyl D-glucamine dithiocarbamate (MGD), and N(dithiocarboxyl)sarcosine 
(DTCS);  from their respective amines (Scheme 1.09B).  These dithiocarbamate traps 
detected NO in living mice that were exposed to LPS195 and in mice that had experienced 
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septic shock,196 as well in many other experiments.194, 197  In rat aortas exposed to LPS, an 
EPR system achieved an LOD of 6 pmol for NO-Fe(DETC)2, albeit at 77 Kelvin.
198   
Though widely used, Fe(DTC)2 traps interfere with the production and 
consumption of the analyte they measure.  Their dithiocarbamates’ capacity as ligands 
has been demonstrated in DETC’s reported ability to strip Cu2+ form superoxide 
dismutase (SOD), disabling the superoxide scavenger.199  DETC and other variants 
inhibit NF-κB transcription factor, thereby decreasing iNOS induction and immune 
system NO response.200  When added to a solution of isolated and purified nNOS, 
Fe(DTCS)2 and Fe(MGD)2 inhibited NO production with IC50’s of  10 and 25 µM, 
respectively.201  
Scheme 1.09:  EPR imaging of NO with dithiocarbamate spin traps 
A.      
B.   
A) Complex formed between spin trap and NO  B) From left to right:  DETC, MGD, and DTCS spin 
traps. 
Iron hemes also provide an EPR-visible detection of NO.  Ferric oxyhemoglobin 
oxidizes NO to nitrate with concomitant reduction to ferrous heme, and the aquo-
methemoglobin complex produces a g signal in the 6, not the more common 2, region.  
This complex is not stable at room temperature, so temperatures of 77 K or less are 
needed.  Not useful therefore for live imaging, aquo-methemoglobin EPR imaging can 
provide NO levels in the otherwise complicated blood or plasma matrices.202  Oxygen-
free hemoglobin binds NO with high affinity, but the four hemes, two α and two β, that 
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comprise hemoglobin complicate the spectrum.  Furthermore, the relaxed and tense states 
result in two different signals, deriving from the extent of interaction between the trans 
histidine and Fe in the nitrosyl α-hemes.  Using other techniques, basal levels of heme-
NO have been estimated at 20 nM,203 well below the ~ 200 nM LOD in EPR.192  
1.1.6.5 Fluorescence 
Fluorescence, renowned for its subnanometer spatial and submillisecond temporal 
resolution,204 enables subcellular imaging of NO activity over time.  The process of 
fluorescence starts with the absorbance of a photon of light by a molecule (fluorophore), 
which excites an electron from its ground-state orbital residency to its corresponding 
excited-state orbital (for longer-wavelength fluorophores, these are π to π* and n to π* 
transitions) of the same spin state (e.g., singlet or triplet), on a time scale of 10-15 s.  The 
quantized energy difference between these orbitals corresponds to the product of Planck’s 
constant and the frequency of the absorbed photon; often, the photon energy is specified 
by the wavelength of light (λ = c / ν).  As stated in the Frank-Condon principle, 
significant nuclear motion is not possible within ~10-15 s, and so the efficiency of 
absorbance of a photon of certain energy depends directly upon the extent of population 
density overlap (similar molecular geometries) between the ground state and the excited 
state that corresponds to that wavelength of excitation.  Quantum mechanical 
interpretation of the Franck-Condon principle states that the probability of absorbing a 
photon depends on the square of the integral overlap for the vibrational-level 
wavefunctions populated by the electron transitioning from the ground to the excited 
electronic state.   For fluorophores with distinctively different geometries in the excited 
state versus the ground state, photon absorbance is limited to the high vibrational energy 
levels in the excited state that overlap in geometry with the ground state, whereas for 
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fluorophores with highly similar ground/excited state geometries, photon absorbance may 
occur from any of the vibrational energy levels in the ground state to all the vibrational 
energy levels in the excited state.  The molar absorptivity coefficient (ε), a wavelength 
and solvent-dependent constant, empirically relates the amount (or efficiency) of photons 
absorbed to the concentration of the chromophore, according to Beer’s law. 
  A molecule contains a myriad of vibrational levels, according to the number of 
bonds and to the degrees of vibrational freedom in its bonds.  These vibrational levels 
multiply when the molecule is dissolved, due to stabilizing interactions with the solvent.  
Although quantized, these numerous levels may overlap in energy, and non-radiative 
relaxation occurs if overlap exists.  There is usually sufficient overlap in vibrational 
levels among excited states, and Kasha’s rule describes the propensity for molecules to 
first relax vibrationally (due to the relative speed of relaxation:  10-14 to 10-11 s) from 
higher-energy excited states to the lowest-energy excited state of conserved spin before 
another relaxation process can become a factor.  Flexible molecules (acyclic alkanes) 
contain a continuum of vibrational levels, to the extent that complete relaxation after 
excitation may occur via vibrational relaxation.  Rigid and constrained molecules lack 
this continuum, and so vibrational relaxation is limited to the lowest-energy excited state.   
At this time, the excited electron may emit (fluoresce, 10-9 to 10-7 s) a photon of 
light of frequency corresponding to the energy gap as it relaxes back to an accessible 
vibrational level in the ground state.  Particularly in solution, a plethora of these levels 
exist due to vibrational interactions with the solvent, and the population of emission 
energies therefore resemble a Gaussian peak.  Due to vibrational relaxation of the excited 
electron to the vibrational ground state of the excited electronic state (Kasha’s rule), the 
distribution of photons emitted are of equal or lower energy than those absorbed at 
temperatures when the Boltzmann distribution of electrons occupy the lower levels of the 
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ground electronic state.  This lower energy results in a Stokes shift – the difference 
between the excitation and emission peak maxima – that imparts notable sensitivity to 
fluorescence, as the shorter-wavelength excitation light can be filtered out from the 
longer-wavelength signal, thereby eliminating most background signal. 
If other relaxation pathways (vibrational, rotational, collisional, energy transfer) 
compete with fluorescence relaxation, the quantum yield of fluorescence – in a 
population of molecules, the ratio of photons emitted due to fluorescence versus total 
photons absorbed – decreases from 1.  The brightness of a fluorophore is typically 
defined as the product of the extinction coefficient (how much light a molecule absorbs) 
and the quantum yield (how much of that light is emitted).  Both variables are 
temperature and solvent, even microenvironment (i.e., cytosol, cell membrane, protein), 
dependent. 
Both fluorescent proteins (FPs)205-209 and organic fluorescent probes210-214 have 
provided valuable information to the field of NO detection.  While the fluorophore itself 
can be the binding or reacting moiety, typically a chelating or reactive moiety is 
connected to perturb the fluorophore’s fluorescence.  Photoinduced electron transfer 
(PET),215-218 internal charge transfer (ICT),204, 212, 219 heavy-atom quenching, and 
FRET219-221 are among favored means of modulating fluorescence.   
PET quenching of fluorescence occurs under two scenarios.  In one scenario, an 
occupied ground-state orbital exists at higher energy than the fluorophore’s ground-state 
orbital (HOMO, or S0) from which an electron is excited.  Non-bonding lone-pairs 
typically reside in these higher-energy orbitals.  Excitation of an electron from S0 leaves a 
vacancy in that orbital, and an electron of like spin from the higher-energy ground-state 
orbital occupies that vacancy.  Consequently, the excited electron can no longer 
radiatively relax to its now fully occupied S0, and fluorescence is quenched (Figure 
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1.02A).  If the quenching ground-state orbital’s energy is lowered below the 
fluorophore’s S0 by partaking in a covalent, coordinative, or ionic bond (protonation or 
chelation), its electrons cannot transfer to a higher-energy S0, eliminating PET-
quenching, and the excited electron can radiatively relax to its partially filled ground state 
orbital (Figure 1.02 B). 
Figure 1.02:  Donor PET-quenching of fluorescence 
A.        
 
B.          
HOMO/LUMOFl are the fluorophore’s molecular orbitals. 
In the second scenario, an orbital not involved in fluorescence has an accessible 
lower-energy lowest unoccupied molecular orbital (LUMO, or S1) than the fluorophore’s 
LUMO.  After the fluorophore’s electron is excited, it can relax to occupy the lower-
energy LUMO whose S0 is fully filled, once again impeding radiative relaxation (Figure 
1.03A).  If the accessible LUMO orbital is higher in energy than the fluorophore’s 
LUMO, no transfer occurs, and fluorescence proceeds accordingly (Figure 1.03B)  In 
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either scenario, electron transfer is believed to occur through hopping, tunneling, or 
superexchange between the relevant molecular orbitals.222 
Figure 1.03:  Acceptor PET-quenching of fluorescence 
A.     
 
B.       
HOMO/LUMOFl are the fluorophore’s molecular orbitals. 
1.1.6.5.1 Fluorescent Proteins 
The Nobel prize in 2008 to Shinomura, Chalfie, and Tsien recognized the 
importance of adapting and improving upon proteins that fluoresce in nature to study 
protein localization, movement, and processes in cells and organisms.  Employing this 
technology, the location of a genetically-expressed eNOS fused to green fluorescent 
protein (GFP) was monitored in response to various stimuli known to provoke changes in 
NO levels / NOS activity.223-224  Moving from NOS localization to NO concentration 
measurements, the geNOps sensors were assembled by incorporating a bacterial (to avoid 
participation in eukaryotic signaling processes), non-heme Fe(II) binding domain for NO 
 31 
that is fused near the fluorescing moiety of a green, cyan, yellow, or orange-fluorescing 
protein; and NO-binding quenches fluorescence.225  This binding is reversible, with 
return of fluorescence upon dissociation of NO.  In one study, NO production was 
correlated to Ca2+ levels by co-imaging either green or orange geNOps with Fura-2 
calcium ion indicator.226  The geNOps pKa’s range from 4.8 to 6.6; apart from the orange 
geNOps, their fluorescence intensity changes by at most 3-4% per 0.1 pH unit.225 
A second approach to direct NO measurement involves metallothioneins (MTs).  
These proteins abound in cysteines that bind zinc and copper metal ions, and interaction 
with NO results in release of the metal ions and a change in structure.  Often, a 
significant change in structure points to Förster Resonance Energy Transfer (FRET) 
based imaging.  When two different fluorophores A and B have complete overlap in the 
emission spectrum of A with the excitation spectrum of B and their dipoles are aligned 
well within the Förster radius (the distance between dipoles at which FRET efficiency is 
50%), the excitation of A solely provokes emission of B.  The amount of emission of A 
versus emission of B therefore measures the extent of spectral overlap, dipole alignment, 
and Förster proximity.  To detect NO binding to MTs, FRET pairs Cyan FP (CFP) and 
Yellow FP (YFP) were fused to the C and N termini of human type IIa MT.  Exposure to 
NO leads to a decrease in FRET efficiency; the greater the concentration of NO, the 
higher emission from CFP and lower from YFP, resulting in a ratiometric response to 
NO.227  The maximum possible response, deriving from application of 1 mM NO, was 
~40% decrease, and application of calcium ionophore 4-Br A23187 caused a ~ 20% 
decrease.  Whether perturbation by NO is reversible is not known,228 but the sensor did 
show in sheep pulmonary artery endothelial cells that metallothioneins mediate Zn2+ 
release in response to NO.229 
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A third construct responds to cGMP produced by sGC when the latter is activated 
by NO.  The FRET protein CGY230 fuses CFP and YFP to opposite termini of a truncated 
yet still active protein kinase G that has two binding sites for cGMP.  This FRET protein 
is then fused separately to each of the α and heme-containing β monomers of the sGC 
heterodimer.  The CGY fusion does not prevent formation of the α,β  heterodimer (the 
active form of sGC), and the NO-bound, CGY-fused sGC heterodimer maintains its 
activity of catalyzing cyclization of GTP to cGMP at 3000 - 6000 molecules/minute.  
This cGMP can bind at the CGY domains flanking the same NO-bound sGC 
heterodimer; flanking another sGC heterodimer, whether NO-bound or not; or fused to 
non-associated α or β monomers.  No matter the target, this binding triggers an increase 
in FRET efficiency (increased yellow emission, decreased cyan emission).  Since binding 
of NO induces hefty cGMP output that can increase FRET efficiency in various CGY-
containing constructs, this approach amplifies the signal produced by NO-binding, 
engendering the name NOA (NO Amplified).  Such amplification of signal results in a 
detection limit of 100 pM for NO.  This sensor determined the resting levels of NO in 
endothelial cells in serum-supplemented media to be 1 nM, as opposed to non-detectable 
levels in eNOS-lacking CHO cells.231  One drawback to this indirect sensing of NO 
through cGMP is that mechanisms other than NO binding to sGC exist to modulate 
cGMP levels, such as cGMP synthesis by natriuretic peptides and cGMP degradation by 
phosphodiesterases.232-233 
Similar FRET approaches have produced fluorescent proteins for both nitrate and 
nitrite.  Fusion of bacterial proteins NasT and NasS with CFP and YFP, respectively, led 
to the FRET pair as the heterodimer sNOOOpy (sensor for NO3
-/NO2
- in physiology, 
yellow fluorescence dominant due to FRET).234  Only NasS-YFP binds either NO2
- or 
NO3
-, and this binding elicits dimer dissociation, with loss of FRET, and CFP-NasT’s 
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blue fluorescence dominates.  The acellular buffer dissociation constants of NasS-YFP 
for NO3
- and NO2
- are 39.5 and 256 µM, respectively, and changes in NO3
- levels 
between 1 µM and 1 mM could be detected in seconds.  Since tissue, blood, and plasma 
nitrate levels range from 3 to 50 µM, the sensor properties seemed promising.  In HeLa 
cells, however, sNOOOPy’s sensitivity and responsivity were attenuated, even though 
cells were programmed to synthesize both monomers at equal rates. 
In summary, fluorescent proteins provide direct and indirect measurement of NO.  
With their low LODs, they have helped establish basal levels of NO in various cell types.  
Most reporting occurs via FRET imaging, giving a conformationally-based ratiometric 
response to changes in analyte levels.  These responses typically increase or decrease by 
2 to 3-fold, according to the extent of change in analyte concentration provoked by the 
applied stimulus.  To a certain degree (at most 20% of the signal), some FPs are pH 
sensitive.  For FPs that detect NO indirectly, non-NO-dependent processes that produce, 
conserve, or consume the analyte factor in the reporting by the sensor.   Not membrane 
permeable, these proteins require transfection or transduction into cells, and the relative 
rates of production of different monomers that form heterodimers may require 
programming to have similar output.  With the appropriate gene encoding, fluorescent 
protein synthesis and translocation may be directed to subcellular locations.  Along with 
analyte levels, FPs can report protein movement within the cell in response to stimuli. 
1.1.6.5.2  Fluorescent synthetic small molecules 
Non-protein, synthetic small-molecule fluorescent probes tend to be brighter and 
have greater sensitivity and dynamic range than fluorescent proteins, along with greater 
photostability.  Fluorescein, rhodamine, cyanine, bodipy, naphthalimide, and coumarin 
derivatives are frequently chosen as fluorophores.  Unfortunately, no biologically-useful 
reversible synthetic probes exist; instead, synthetic probes act as dosimeters for NO – the 
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measurement consumes the NO being measured.  Ideally, interaction with NO would be 
reversible, so that the measurement would minimally interfere with cellular processes.  
Depending on the brightness of a fluorophore, 0.5 to 50 µM amounts are normally loaded 
into cells, and intracellular concentrations may reach much higher levels if the probes are 
sequestered in the cytosol, subcellular compartments, and/or hydrophobic regions.  At 
typical low NO outputs by nNOS and eNOS, sufficiently large concentrations of a 
dosimeter could scavenge NO and quench the NO-dependent, downstream physiological 
processes.   
 Whereas fluorescent proteins require transfection or transduction to appear in 
cells, synthetic fluorophores or fluorophore precursors cannot be genetically encoded into 
production by cells.  Non-charged fluorophores passively permeate cell membranes to 
distribute into the more hydrophobic compartments of cells.  Ionically charged 
fluorophores may be masked, commonly by acetates or acetoxymethyl esters (similarly to 
pro-drugs), so that they too passively permeate membranes, and intracellular non-specific 
esterases then hydrolyze the masking groups (with acetate or acetate / formaldehyde by-
products) to reproduce the charged fluorophores that tend to locate in the cytosol.  For 
non-masked loading of charged fluorophores, techniques include electroporation, ATP-
induced permeabilization, cell-penetrating peptides, liposomes, hypoosmotic shock, and 
single-cell microinjection or patch-clamping.235 
 Synthetic fluorescent probes can also be directed to subcellular compartments.236  
Molecules with an overall delocalized positive charge tend to aggregate in mitochondria, 
attracted by the negative membrane potential (~ -180 mV)237; often 
triphenylphosphonium, pyridinium, or quinolinium moieties appended to neutral 
molecules engender mitochondrial sequestration.  Lipophilic amine (e.g., morpholine, 
N,N-dimethylethylenediamine) appendages are protonated (and therefore entrapped) in 
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lysosomes (~ pH 5). p-Toluene sulfonamide moieties direct sensors into the ER, and 
affixing L-cysteine, linked through the N or C terminus, imparts specificity to the Golgi 
apparatus.  Finally, due to the typically higher brightness of synthetic fluorophores versus 
fluorescent proteins, SNAP Tag238 and HALO Tag239 technologies have been developed.  
Cells are transduced to synthesize the protein of interest with a fused peptide that 
recognizes and covalently bonds to a specific tag – O6-benzylguanine for SNAP and 
chlorohexyl/aminoethyl glycol ether for HALO – attached to the fluorescent probe.  The 
probe can thus be directed to the subcellular compartment in which that protein resides. 
Perhaps the greatest testimonial to the favoring of fluorescent NO-imaging is the 
gamut of non-protein, synthetic fluorescent probes that have been published over the 
years.  The majority of these probes indirectly measure NO by reaction with nitrosonium 
equivalent N2O3, the product of NO autoxidation via the combination of NO2 and NO.  
Those that react directly with NO do so mainly through paramagnetic transition metals, 
often incorporating the reduction of high-valency metals by NO that also produces a 
nitrosonium equivalent. 
1.1.6.5.2.1 Small-Molecule Synthetic Probes that React Directly with NO 
1.1.6.5.2.1.1 Fluorescent Chelotropic Traps 
Certainly, to minimize experimental variables, the probe should react directly and 
selectively with NO.  The inertness of NO towards diamagnetic reagents points to 
paramagnetic probes containing either transition metals or organic spin traps.  Most 
radical spin traps fail the selectivity requirement, as they react readily with OH, NO2, O2
-, 
and other biologically relevant radicals.  However, o-quinodimethanes do react 
selectively with NO to form the corresponding nitroxides.  Although the nitroxides fail to 
sufficiently extend the radical lifetime or fluoresce significantly due to paramagnetic 
quenching, their hydroxylamine reduced product fluoresces well and with a distinct 
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spectrum from the quinodimethane.240  Indeed, when the weakly fluorescent N,N-
dimethyl-2-aminophenanthrene variant of a fluorescent nitric oxide chelotropic trap 
(FNOTC) reacts with two equivalents NO in the presence of two equivalents ascorbic 
acid, the reaction is complete within a few seconds (Scheme 1.10).  Cellular 
concentrations of ascorbic acid and glutathione reducing agents are several orders of 
magnitude more concentrated than the micromolar concentrations used for fluorescence, 
so the reduction in cells occurs quickly and without significantly affecting reducing 
levels. 
  The probe is inert to superoxide, hydrogen peroxide, and hydroxide radicals.  It 
does react with peroxynitrite, first to a fluorescent product, but further reaction with 
excess peroxynitrite turns it non-fluorescent.  Another shortcoming is its UV excitation of 
380 nm that causes significant cellular autofluorescence that can overlap with its 
emission in the blue (460 - 490 nm).  Nonetheless, an AM-loadable version of FNOTC 
applied to alveolar macrophages produced fluorescence nearly twice as bright in cells 
stimulated to iNOS high-NO production with LPS versus non-stimulated cells.241 
Scheme 1.10:  FNOCT cheletropic spin trap for NO  
 
Reaction with NO quenches the initial fluorescence of the extended conjugation system. Conversion 
to the hydroxylamine by abundant cellular reductants returns fluorescence to a less conjugated 
system.  Note:  Fluorophore colors in the structures were assigned according to a website that 
converts wavelength (in this case, emission wavelength) to RGB values:  
https://academo.org/demos/wavelength-to-colour-relationship/ For PET-quenched fluorophores, the 




1.1.6.5.2.1.2 Transition metal-based probes 
Some transition metals afford greater selectivity, mostly due to NO’s ability to π 
backbond with low-valence metals, for example, NO’s biological target – the ferrous 
heme in sGC.  In fact, the very displacement of histidine by NO when binding to sGC 
served as a model for some probes, in which NO displaces an anthracene-TEMPO radical 
that is fluorescent when bound to a sarcosinedithiocarbamate complex of Fe(II).242  
Increasing levels of NO quench fluorescence, however, a sensing tactic that counteracts 
the sensitivity of fluorescence stemming from a signal with little background.  The same 
sGC/histidine model was applied to a ferrous cyclam (to loosely mimic heme) with a 
pendant quinoline as the histidine mimic.243  The Lewis acid character of Fe(II) greatly 
enhanced and red-shifted the fluorescence of the quinoline, but binding of NO displaced 
the quinoline ligand and disrupted the fluorescence enhancement.  Although elegant, this 
probe achieved a LOD of only 1 µM, due in part to the quenching of fluorescence to 
measure NO. 
Some high-valence metals, such as Fe(III), Co(II), and Cu(II), are reduced by the 
oxidation of NO to nitrosonium, with concomitant nitrosation of a nucleophile, at times, 
in absence of a better one, the solvent.  This process has been adapted to amine-based 
ligands attached to fluorophores.  The paragmagnetic metal quenches the fluorescence of 
the fluorophore ligand when bound in proximity.  NO binding results in the metal 
oxidizing it to nitrosonium, which nitrosates the ligand amine.  Reduction of the metal 
along with N-nitrosation of the ligand reduces the affinity of the ligand for the metal.  
Furthermore, in the case of copper, Cu(I) is diamagnetic and non-quenching.  Any PET-
quenching by the amine on the ligand also terminates with N-nitrosation.  With the many 
quenching pathways eliminated, this type of probe exhibits fluorescence enhancement in 
an NO-dependent manner.  Two CuFL family provides two examples. 
 38 
CuFL1 (Scheme 1.11A) incorporates an 8-aminomethylquinaldine ligating moiety 
at the 4´-position of 7´-chlorofluorescein that, together with the 3´-phenolate binds Cu(II) 
with a dissociation constant (Kd) of 1.5 µM.
244  The aniline alone, without Cu(II) present,  
PET-quenches fluorescence to a quantum yield of 7.7%.  Cu(II) complexation drops the 
fluorescence by 18%.  N-nitrosation of the aniline as NO reduces Cu(II) to Cu(I) brings 
the quantum yield to 58%, with a ~16-fold increase in fluorescence, establishing an LOD 
of 5 nM.  Of the typical competing analytes in cells (ClO-, O2
-, H2O2, HNO, NO2
-, NO3
-, 
ONOO-), only ClO-, O2
-, and ONOO- provoked responsed of 3-fold, 2-fold, and 2-fold, 
respectively.245  In fact, autoxidation of NO failed to compete with CuFL1’s scavenging 
prowess, as an aerobic titration with NO showed no difference from an anaerobic one.  
Furthermore, CuFL1 could detect cNOS production of NO in neuroblastoma cells 
stimulated by Ca2+ influx due to estrogen application, lighting up the neuroblastoma with 
greater contrast over non-stimulated cells than a popular alternative probe (to be 
discussed below) DAF-2 DA.  CuFL1 also detected the higher NO levels brought about 
by LPS/interferon-γ stimulation of iNOS in RAW 264.7 cells.  Moreover, 80% of 
neuroblasts and 90% of macrophages survived five-day incubation with CuFL1, proving 
the probe slightly toxic to cells, and not within typical experiment time frames of less 
than 24 hours.  However, a relatively small dianion, the product of CuFL1 reaction with 
NO, FL-NO is rapidly extruded from cells by organic anion transport enzymes, causing a 
time-dependent decrease in fluorescence.   
In response to this “leakage” issue, Cu2FL2A (Scheme 1.11B) was developed, 
with two 8-aminomethyl-6-carboxymethylether-quinaldine ligands at the 4´ and 5´ 
positions.246  The tetranion is less susceptible to transport outside the cell.  Doubling the 
PET quenching ligands drops FL2A’s quantum yield lower than FL1 to 1.8%.  After 
complexation of two Cu(II) ions and exposure to NO, fluorescence enhances 27-fold.  
 39 
This larger enhancement compared to CuFL1 does not translate to lower LOD, 
established as 35 nM for Cu2FL2A.  Cu2FL2A maintained the selectivity for NO over 
competing analytes, except that it became a little more sensitive to peroxynitrite and 
hydrogen peroxide, and it binds NO2. The carboxylates require masking esters, in 
Cu2FL2E’s case – ethyl esters, to passively permeate the cell membrane, and this version 
has enabled various studies monitoring NO in cells.  86% of neuroblasts were viable after 
three days incubation with 5 µM Cu2FL2E.
247 
Scheme 1.11:  CuFL probes for NO 
A.  
B.     
A)  Reductive nitrosylation of the copper (II) complex CuFL1 eliminates both paramagnetic metal 
quenching and aminoquinoline PET quenching of the fluorescein moiety.  B) CuFL2A, R = H and 
CuFL2E, R = Et 
 An interesting variant of the CuFL approach was designed in CuRBT: Rhodamine 
B for which the lactonizable o-carboxylic acid is amidated with tris(2-
aminoethyl)amine.248  The equilibrium between fluorescent amide and non-fluorescent 
lactam forms predominantly favors the lactam at pH 7.2.  Acidification opens the lactam 
to the fluorescent rhodamine amide, but so does the incipient nitrosonium when NO binds 
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to the bis(2-aminoethyl)amine-Cu(II) complex.  Opening the lactam to the N-nitroso 
amide (Scheme 1.12) results in an impressive 700-fold fluorescence increase of 
fluorescence, although with a quantum yield of only 0.13.  The absorptivity coefficient 
also suffers at 1445 M-1cm-1, but the LOD was a respectable 1 nM.  CuRBT selects NO 
over the standard competing analytes, almost to perfection, and fluorescence fluctuated 
by less than 10% over the pH range 6.5 to 9.  Also, its 580 nm emission peak has less 
cellular autofluorescence as background. 
Scheme 1.12:  CuRBT lactam opening by NO  
 
Reductive nitrosylation opens the non-fluorescent lactam form of CuRBT to the fluorescent N-
nitroso amide form. 
 The lactam-opening approach contributed to the design of RPD, a FRET, Cu(II)-
based probe.249  N-(2-aminoethyl)piperazine connects Rhodamine B to Dansyl, with the 
piperazine connecting to Dansyl and the primary amine terminus to Rhodamine B 
(Scheme 1.13).  The piperazine and sulfonamide groups chelate Cu(II), resulting in a 
drop of Dansyl fluorescence, with almost no fluorescence from the predominant lactam 
form of Rhodamine B.  Reductive nitrosation with NO opens the lactam to the 
fluorescent Rhodamine B amide, presumably by nitrosating the amide.  Lactam-opening 
activates FRET from Dansyl to Rhodamine B with 88% efficiency and an absorptivity of 
29,000 M-1cm-1 and quantum yield of 45%.  Competitive binding experiments for Cu(II) 
versus a series of biologically-relevant metal cations showed explicit preference for 
Cu(II) over all the metals, and the FRET turn-on mechanism showed similar selectivity to 
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the CuFL series for NO over other analytes.  Cu-RPD loaded into cells and proved more 
toxic than CuFL, with nearly 80% viability at concentrations of 10 µM.  Due to Cu(II)’s 
quenching Dansyl fluorescence in Cu-RPD, the probe is not ratiometric, as diamagnetic 
Cu(I) does not quench as effectively or simple leaves the complex.  NO therefore 
produces an emission increase in both yellow and green channels. 
Scheme 1.13:  Cu-RPD FRET probe for NO 
 
Reductive nitrosation of the lactam of rhodamine 6G and dissociation of diamagnetic Cu(I) enables 
FRET from Danysl to the open form of Rhodamine 6G  
The Cu(II) reductive nitrosation probes react directly with NO and can detect low 
nanomolar to micromolar NO levels.  They show some toxicity to cells over time, 
probably from the increased levels of Cu(II) imported to the cells and deposited as Cu(I).  
They also react with NO2, although authors have not been forthcoming on the effects of 
such reaction.  Cu(II) mediates oxidation of thiols to disulfides; thiol and HNO are 
competing analytes that reduce Cu(II) that seldom appear in analyte selectivity 
experiments.  However, as nitrosation is necessary to disable PET quenching or to open 
lactams, Cu(II) reduction by other analytes does not produce fluorescence enhancement.  
It does incapacitate the sensor, removing its quantification ability, although a ratiometric 
response would correct for such incapacitation.  Despite several attempts, no ratiometric 
Cu(II) reductive nitrosation probe has been developed that can function in cells and 
detect low nanomolar to low micromolar NO concentrations. 
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1.1.6.5.2.1.3 Hantschz ester-based probes 
 In order to avoid mildly toxic and thiol non-selective copper-based probes but still 
sense NO directly, probes based on Hantschz ester aromatization by NO were developed 
(Scheme 1.14).  The mechanism has been counterintuitively described as hydrogen 
abstraction by NO to produce HNO and the aminyl radical, based on the deuterium 
kinetic isotope effect of 3 for N-H vs N-D when reacted in MeCN and under argon.250  
Another NO radical produces the N-nitrosamine, and disproportionation at the 4-position 
yields the pyridine.  When a radical stabilizing group, such as benzyl, allyl, or isopropyl, 
occupies the 4-position, it disproportionates rather than the hydrogen.  The selectivity of 
NO and not another radical species to aromatize the dihydropyridines complicates the 
proposed mechanism, as conceivably peroxy or hydroxy radicals could accomplish the 
same.  To muddy the waters further, in dichloroethane this reaction proceeded at faster 
rates with oxygen present and even made pyridine in 98% yield with only 0.2 equivalents 
of NO,251 while the proposed mechanism requires two equivalents NO and does not 
incorporate oxygen.  As discussed, NO reacts with half-equivalent of oxygen to make 
NO2, which has a larger reduction potential than NO. 
 One sensing approach for Hantschz-derived probes is based on the elimination of 
PET quenching of a fluorophore upon aromatization with NO.  Two coumarin variants, 
one connected through an ethyl linkage (DHP-1, Scheme 1.14A)252, and another directly 
connected (DHP-4, Scheme 1.14B)252, to the Hantschz ester produced LODs of 17 and 74 
nM .  Aromatization increased the quantum yield from 1 to 91% for DHP-1 and from 6 to 
63% for DHP-4.  Both proved selective for NO over competing analytes, even hydrogen 
peroxide and superoxide.   50 µM solutions of DHP applied to RAW 264.7 cells 
maintained >80% viability, and both probes responded to LPS stimulation of iNOS in 
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these cells.  Unfortunately, they also required cytotoxic and autofluorescence-enhancing 
UV excitation, and the better performer DHP-1 even emitted UV light.   
The same group therefore looked to the visible-wavelength BODIPY fluorophore, 
and attached the Hantsczh ester at the 2 position, with a triphenylphosphonium targeting 
group linked through the 8 position to give MITO-DHP (Scheme 1.14c).253  The NO-
activated pyridine quantum yield of 7.5% came short of the coumarin enhancements, and 
activation took more than ten minutes. 
Scheme 1.14:  Hantsczh ester-based NO probes 
A.    
B.    
C.  
Elimination of PET quenching by dihydropyridine after reaction with NO to form pyridine.  A) 
DHP-1, B) DHP-4, and C) MITO-DHP. 
Another sensing approach with Hantzsch esters exploits NO’s cleavage of radical-
stabilizing moieties at the 4-position in the pyridine-forming disproportionation step.  A 
very intricate design (Scheme 1.15) paired fluorescein with fluorescence-quenching 
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DABCYL.254  The pair are sufficiently proximal for FRET to occur, with ~20% of 
fluorescence quenched.  NO oxidation of dihydropyridine proceeds with the cleavage of 
the benzylic group, rather than the hydrogen, at the 4-position.  As the FRET pairs are no 
longer ligated to each other, DABCYL no longer quenches fluorescein, resulting in 
strong 525 nm fluorescence when exciting at 490 nm two minutes after NO addition.  
This probe is selective for NO over the competing analytes tested, including hydrogen 
peroxide.  At 50 µM loading concentrations, it detected 2 mM sodium-nitroprusside 
exogenously applied NO in HeLa cells and RAW 264.7 cell production of NO with LPS 
stimulation.  Its intracellular fluorescence colocalized with LyTracker Red, suggesting 
lysosome compartmentalization.  When applied in vivo to an inflamed mouse paw, the 
600 nm fluorescence (470 nm excitation) was eight times higher than that for a normal 
paw.  The authors did not address the possible competing mechanism of hydrolysis of the 
ester linking DABCYL to the Hantzsch ester, which would also break the linkage 
between the FRET pair. 
Scheme 1.15:  Cleavage of FRET pairs from Hantzsch ester reaction with NO 
 
Elimination of FRET quenching between fluorescein (green) and fluorescence quencher DABCYL 
(gray) after exposure to NO, which promotes cleavage of the benzylic bond, freeing the FTER pairs 
to separate by diffusion. 
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 1.1.6.5.2.2  Small-Molecule Fluorescent Probes that React with NO/O2 
Three categories of probes respond to the NO metabolite N2O3:  o-diaminophenyl 
to benzotriazole probes, secondary aniline nitrosation probes, and 2-aminobiphenyl to 
cinnoline probes.  The three categories rely on elimination of PET quenching, and the 
first has produced the most reported probes for NO.  In cells or in vivo, other 
nucleophiles, in particular biological thiols and amines, compete with the probes for 
N2O3, leading to very different results from those in abiotic buffers. 
1.1.6.5.2.4 o-Diaminophenyl-based probes 
N2O3 can be considered a nitrosonium (dielectrophile) donor that releases nitrite.  
o-Diaminophenyl (ODP) moieities are electron rich, with high-energy non-bonding lone 
pair orbitals that can efficiently PET quench fluorescence.  They also react readily with 
N2O3 to produce an N-nitroso adduct that is attacked by the remaining vicinal aniline.  
Elimination of water yields the benzotriazole, whose lower-energy lone-pair orbitals 
cannot participate in PET quenching.  Using anilines, rather than their higher pKa 
counterparts aliphatic amines, ensures that PET quenching is not impeded by protonation 
at physiological pH.  The ODP sensing moiety has been applied to naphthalenes (LOD 
10-30 nM),255 coumarins (LOD 24 nM),256 napthalimides (LOD 5 nM),257-258 bodipies 
(LOD 0.83 nM), 259-261 260-262 259-261 260-262 260-262 259-261 fluoresceins (LOD 3 nM),262-263 
calceins,264 rhodamines (LOD 7 nM),265 cyanines,266 Nile Red (LOD 9 nM),267-268 and 
more, at times with subcellular directing-group appendages.   
Probably the most popular of all NO probes is DAF-FM (diaminofluorescein - 
fluoro, methyl).  This ODP’s quantum yield of 0.05% increases to 81%, upon forming the 
benzotriazole (Scheme 1.16), with an LOD of 3 nM.  The 2,7-difluoro substitution drops 
the fluorophore pKa to 4.38, well below physiological pH.  The methyl group on the 
amine conjugated to the fluorophore replaces a proton that is susceptible to deprotonation 
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after formation of the triazole at pH higher than 7.  This deprotonation in the non-methyl 
triazole derivative resulted in a high-energy lone-pair orbital that could PET quench, 
albeit inefficiently, fluorescence and counteract nitrosonium signaling.   The authors do 
not mention the pKa of the probe itself; protonation of one of the vicinal diamines would 
decrease the extent of PET quenching.  (Fluorescence enhancement occurred for a 
cyanine congener as pH dropped below 6, reaching triazole intensities at pH ~3.7.)266   
DAF-FM is passively loaded across cell membranes as the lactone diacetate 
(DAF-FM DA), whereupon non-specific cellular esterases hydrolyze the acetates to 
produce the membrane-impermeable dianionic fluorescent sensing form.  Intracellular 
concentrations of DAF-FM loaded this way may approach 750 µM,269 as influx continues 
while DAF-FM DA is available, but efflux stops with hydrolysis of acetates (not 
considering “leakage”, discussed below).  The slow reactivity of DAF-FM with NO 
prevents it from wholly buffering NO and its cell-signaling processes that approach 
diffusion-controlled reaction rates.  In cell types with active organic anion transporters 
(CHO cells), DAF-FM is actively extruded (termed “leakage”) from cells.  It has detected 
the range of NO levels from cNOS stimulation by bradykinin on the low end to iNOS 
stimulation by LPS on the high end. 
Scheme 1.16:  ODP-type probe DAF-FM 
 
DAF-FM reacts with oxidized NO to form the highly fluorescent benzotriazole product. 
Most ODP probes are designed with the vicinal diamine sensing moiety linked by 
a phenyl group to the fluorophore, but three recent designs incorporate different 
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connectivity.  The first, SIRD (Scheme 1.17A, bypasses the phenyl group in linking one 
of the amines directly to the silyl rosamine (i.e., rhodamine without the lactonizable 
carboxylate) fluorophore.  This fluorophore emits in the nIR region (λex/ λem 690/710 
nm), since the less electronegative dimethylsilyl group increases the HOMO for the 
fluorophore verses the oxygen equivalent in rhodamine.  The directly-linked ODP moiety 
quenches efficiently to a quantum yield of 0.06%, and aerobic reaction with NO makes 
the triazole, with a quantum yield increase to 31%.   
Rosamines react as conjugate acceptors with thiols; the ODP group is too poor a 
leaving group for thiol displacement to be relevant, but thiols can readily replace the 
benzotriazole group.  Cysteine displacement of benzotriazole, via conversion of the 
reversible thiol-adduct kinetic product to the α-amine-adduct thermodynamic product 
(based on Anslyn group results with EVA conjugate acceptor)270, shifted the fluorescence 
wavelengths to λex/ λem 480/620 nm.  Glutathione with the more distant N-terminus did 
not react.  In fact, the N-silylrosamine-benzotriazole is quite selective as a fluorescent 
probe for cysteine versus glutathione in cells.  Apart from cysteine, SIRD maintained 
selectivity over the standard competing analytes, including peroxynitrite.  When applied 
to cells, SIRD’s positive charge directed it to mitochondria, and LPS-stimulated RAW 
264.7 cells showed both 620 (cysteine adduct) and 710 nm (benzotriazole) emission. 
A second design resembles one that we attempted and that will be discussed later.  
An asymmetric rhodamine ROPD incorporates the ODP at one of the fluorophore 
nitrogens (Scheme 1.17B).  Formation of the benzotriazole shifts the absorbance 
maximum from 546 nm to 470 nm and eliminates PET quenching, with increasing 
emission at 581 nm.  The LOD of 68 nM derives from a relatively small increase (F/Fo 
only ~6) in fluorescence upon full reaction with NO oxidation products.271  Based on our 
experience with a similar motif, the ethyl ester may serve to prevent its carboxylic acid 
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precursor from lactonizing, as the equilibrium between the non-fluorescent lactone and 
the fluorescent open forms probably favors the lactone form. 
Scheme 1.17:  SIRD and ROPD ODP-based NO probes 
A.         
B.     
A) SIRD red fluorescence detection of oxidized NO with subsequent substitution by L-cysteine  B) 
ROPD NO detection 
DALR, connects the diaminophenyl group through the amine to form a lactam on 
Rhodamine B (Scheme 1.18A).272  The equilibrium between the non-fluorescent lactam 
form and the fluorescent amide form favors the lactam until pH drops below 3, meaning 
the sensor is dark at physiologic pH.  The authors propose that the free amine of the 
vicinal diamines binds nitrosonium from N2O3, tautomerizes, and then loses water to 
form the diazonium. Then an intramolecular reaction with the lactam nitrogen opens the 
lactam to form the fluorescent benzotriazole amide.  This sensing approach differs from 
the typical elimination of PET-quenching approach typical to ODP probes, and the 2400-
fold increase in fluorescence due to NO saturation produced an LOD of 3 nM.   
DALR was selective for NO over the standard competing analytes, except for 
peroxynitrite, which produced a response very similar to that of aerobic NO.  The authors 
postulated that peroxynitrite reversibly dissociates to NO and superoxide at pH 7; 
separate applications of peroxynitrite and NO at pH 12, at which ONOO- is stable, 
produced a strong response for NO and a much reduced one for ONOO-.   
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Unfortunately, benzotriazole is a good leaving group, and after 30 minutes in 
aqueous solution, hydrolysis of the amide (λex/ λem 570/592 nm) to Rhodamine B (λex/ λem 
554/574 nm) is complete.  L-cysteine displaces benzotriazole to form the cysteine lactam 
thermodynamic product (Scheme 1.18A).  Both reactions produce a change in 
fluorescence not dependent upon NO concentrations. 
To avoid hydrolysis, the amide in DALR was converted to an aminomethyl 
connection in deOxy DAL-Si-R (Scheme 1.18B).273  The Rhodamine B fluorophore was 
also replaced with the nIR silyl rhodamine fluorophore.  Unreacted probe was dark from 
pH 4 to 10, despite the absorbance spectrum showing the spiroclactam opening below pH 
7, due to the reinforcing effect of PET quenching by ODP.  Reaction with NO under 
aerobic conditions produced a 6300-fold increase in 680 nm emission within 40 seconds, 
producing an enviable LOD of 0.12 nM.  Fluorescence of the triazole product was stable 
over the pH range of 5 to 10.  A thorough screen versus potentially competing analytes 
(including thiols) demonstrated great selectivity for NO, even in cells with exogenous 
application of the analytes. Deoxy DAL-Si-R detects basal levels of NO (and their 
attenuation with NOS inhibitor aminoguanidine), as well as LPS-stimulated micromolar 
levels of NO in RAW 264.7 cells.   In HeLa cells, it localizes primarily in lysosomes.  









Scheme 1.18:  DALR and DAL-Si-R lactam and deoxylactam ODP probes for NO 
A)    
B)   
A) DALR non-fluorescent lactam reacts with oxidized NO to the fluorescent benzotriazole amide, an 
activated amide that reacts further with cysteine or water.   B) near-IR DAL-Si-R is not susceptible 
to hydrolysis or to trans-amidation by L-cysteine 
The ODP probes have been found to exhibit some cross-reactivity.  As 
dinucleophiles, they can react well with other dielectrophiles found in cells like methyl 
glyoxal and ascorbic acid/dehydroascorbic acid (Scheme 1.19A).  In fact, a variant of 
DAMBO, a bodipy ODP published as an NO sensor,259 has been published as the methyl 
glyoxal sensor MBo (Scheme 1.19B).274  The authors for the latter publication postulated 
that, although MBo does react with N2O3, at physiological pH a portion of the non-
alkylated benzotriazole is deprotonated, quenching the fluorescence response to the NO 
metabolite (Scheme 1.19C).  The methylquinoxaline formed from reaction with 
methylglyoxal abolishes the donor PET quencher orbital, and it has no physiologically 
relevant acidic proton, so emission enhancement would arise mostly from condensation 
upon methylglyoxal, not N2O3.  Both DAMBO and MBo publications focus on 
optimizing the fluorescence reporting for the analyte (N2O3 or methylglyoxal) but ignore 
that binding to competing analytes that does not evoke fluorescence may be irreversible 
and result in consumption of probe, which would cause saturation (and therefore 
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underreporting) of probe fluorescence at high-analyte levels.  To avoid undesirable 
immine-forming condensation (such as with glyoxal and dehydroascorbic acid), Nagano 
methylated one of the vicinal amines in DAF-FM, imparting reversibility to the cross-
reactions but not to N2O3 condensation.  The methyl group also replaces the acidic 
hydrogen in benzotriazole, denying the potential for PET quenching from the 
benzotriolate.  For probes in which one of the vicinal diamines connects to the 
fluorophore directly (Scheme 1.17), not through their phenyl ring, steric constraints 
strongly minimize these methylglyoxal cyclic adducts. 
Scheme 1.19:  DAMBO and MBo examples of cross-reactivity of ODP-based NO probes 
A.     
B.   
C.    
A) Potential cross-reactivity of ODP-based probes with dielectrophiles methyl glyoxal and 
dehydroascorbic acid.  B) MBo reaction with methyl glyoxal results in a strong increase in emission.  
C)  Deprotonation of DAMBO triazole re-instates PET quenching, with 24% of triazole as the anion 
at pH 7.2. 
ODP’s also become sensitized to react directly with NO upon abstraction of an 
anilinic hydrogen by oxidizing radicals such as ●OH, ●OCO2
-, and NO2.
275  In fact, by 
mimicking physiological conditions in which superoxide is produced at equal rates to 
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NO, one study estimated only 20% of DAF (non-fluorinated, non-methylated version of 
DAF-FM) triazole fluorescence emanated from reaction with N2O3, as determined by N3
- 
(an N2O3 scavenger) competition, and the rest from NO2.
276  NO2, an intermediate to 
N2O3, forms from autoxidation of NO, homolysis of peroxynitrous acid (along with 
●OH), and homolysis of nitrosoperoxycarbonate (along with ●OCO2
-), all downstream 
products of NO biology.  If these radicals arose exclusively from these sources, then ODP 
sensitization would merely reflect the biology of NO more globally; unfortunately, other 
sources of these radicals exist.  For example superoxide dismutase makes carbonate 
radicals from bicarbonate,277 and ferrous to ferric Fenton chemistry on hydrogen peroxide 
produces hydroxyl radicals.278  As another example of cross-talk, DAF was reported to 
respond to nitroxyl, the reduced form of NO, sourced from Angeli’s salt (Na2N2O3) in 
aerobic conditions.276 
1.1.6.5.2.5 Monoamine-based probes 
Monoamine sensors for aerobic NO metabolites minimize the possibility of the 
NO sensor reacting with other dielectrophiles.  They normally have higher reaction rates 
than ODPs due to the simplicity of N-nitrosation when compared to multiple proton 
shuttling steps required to form ODP triazole.  Primary amines may form diazonium salts 
when they condense upon nitrosonium, whereas secondary amines cannot due to their 
degree of substitution.  PET-quenching secondary anilines react with N2O3 to form N-
nitrosamines, with a drop in HOMO energy that disables quenching.  In order to compete 
with vicinal-diamine nucleophilicity, the sensors were designed with an electron-donating 
group (EDG) para or ortho to the aniline.  These EDGs also help to increase HOMO 
energy to make PET quenching more effective.   
The first generation of these sensors, BNHM, incorporated a phenol as the EDG 
on a tetramethyl bodipy sensor (Scheme 1.20A).279  The secondary aniline sensing moiety 
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further served as a linker to potential cell-directing groups, such as a mitochondrial-
directing triphenylphosphonium group in BNHM-MT.  Aerobic exposure of the aniline to 
NO within twenty seconds provoked a 90-fold enhancement in 518 nm emission that 
resulted in an LOD of 4.8 nM, with the desired selectivity over standard competing 
analytes, except peroxynitrite. ONOO- promoted cleavage of the benzyl linker to a non-
responsive product (Scheme 1.20B).  Substituting the phenol in BNHM with a methoxy 
group (BNMM) lowered the LOD to 0.4 nM, but BNMM also reacted with peroxynitrite, 
resulting in an o-iminoquinone that disrupts PET quenching, with an LOD of 0.14 nM for 
peroxynitrite.  Both NO and ONOO- provoked a >800-fold fluorescence enhancement at 
518 nm.  Strangely, nitroso-BNNM and iminoquinone-BNNM both  fluoresce optimally 
only between pH 7 and 7.5; any larger fluctuations in pH caused a significant drop in 
emission.280  This sensing approach has been applied to nIR-emitting silyl rhodamine 
(LOD 14 nM), benzo[g]coumarin (LOD 37 nM), and Cy-7 (LOD 11.3 nM)281 












Scheme 1.20:  Secondary monoamine-based NO probes 
A.   
B.   
C.   
A) Cytosolic (R1 = H) and mitrochondrial (R1 = O(CH2)3PPh3) monoamine BNHM (R2 = H) and 
BNMM (R2 = Me) probes for oxidized NO.  B) Non-fluorescent consumption of BNHM by 
peroxynitrite.  C)  Consumption of BNNM by peroxynitrite produces an iminoquinone with similar 
fluorescent properties to N-Nitroso BNNM. 
 
1.1.6.5.2.6 2-aminobiphenyl-based probes 
2-aminobiphenyl (2-ABP) probes combine the selectivity of monoamines with the 
dinucleophilicity of the ODP’s for NO in aerobic conditions.  The primary aniline traps 
nitrosonium, followed by condensation from the connected aryl ring to form fluorescent 
benzo[c]cinnoline.  In this manner, NO+-binding creates the fluorophore, rather than 
modulating its fluorescence.  If the probe is fluorescent and if probe and cinnoline 
fluorescence wavelengths are well resolved, a ratiometric response to N2O3 ensues, with 
probe emission decreasing as cinnoline emission increases.  NO550, the first of these 
probes (Scheme 1.21), has negligible fluorescence but produces a 1500-fold enhancement 
of 550 nm emission (quantum yield 11%) upon complete reaction with NO to the 
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cinnoline product AZO550, with an LOD of 30 nM.
282  Reaction kinetics are comparable 
to the DAF probes, achieving ~ 80% of saturated signal at 25 seconds, with full 
saturation after 2 minutes.   
In contrast to the pH-susceptible non-N-alkylated benzotriazoles, AZO550’s 
fluorescence emission is stable from pH 5-9.  An array of competing analytes in at least 
4-fold excess could produce no signal.  A competition assay of NO550 in the presence of 
competing analytes for NO was not performed, however.  These assays have become 
more routine to elucidate side reactions of a probe with competing analytes that may  
interfere with detection (e.g., other analytes that react with the probe irreversibly to yield 
a non-fluorescent product that cannot detect NO).  When compared to ODP probe DAF-2 
DA, NO550 fluorescence remained located within PC-12 and astrocyte cells, whereas 
DAF-2 showed strong extracellular fluorescence from transporter pump extrusion that 
diminished contrast and clarity.  However, to achieve similar brightness to 1 µM DAF-
FM loading into cells, NO550 required loading concentrations of 50 - 100 µM and 5-25 
hours of scavenging N2O3.
283  Although at first glance this difference of two orders of 
magnitude seems to highlight DAF-FM as a brighter, more sensitive probe, one should 
note that when loaded as the diacetate, DAF-FM accumulates in cells to concentrations of 
750 µM.269  Loading concentrations higher than 100 µM NO550 were not attempted 
because they showed cytotoxicity.283 NO550 localized in cells in a punctate manner that 
did not overlap with lysosome-staining fluorophores, and the authors speculated the 
staining pattern might resemble that for caveolae, Golgi bodies, and cytoskeleton, where 




Scheme 1.21:  2-aminobiphenyl probe NO550 
 
NO550 traps oxidized NO and transforms it into the cinnoline fluorophore.  In the absence of the N,N-
dimethylaniline PET quencher, 5-cyano-1-methylamino naphthalene fluoresces strongly blue in 
hydrophobic solvents/regions but weakly yellow in aqueous media/cytosol.284 
The selectivity and high fluorescence enhancement of NO550 inspired the 
development of 2-ABP analogues.  The design of one analog (Scheme 1.22) ignores the 
fluorescence enhancement emanating from nitrosonium constructing the fluorophore, 
preferring to focus on the PET quenching capability of the 2-ABP moiety.  The 2-ABP 
connects through its aniline phenyl group to the meso position of tetramethyl bodipy, 
with quenching of fluorescence.285  Aerobic NO builds the cinnoline, whose HOMO is 
too low to PET quench effectively, resulting in a 5-fold fluorescence increase at 518 nm 
and an LOD of 30 nM.  Probe and azo product fluorescence are stable between pH 4.5 
and 7.5. 
Scheme 1.22:  2-ABP probes as PET quenchers 
 
Implementation of the 2-ABP moiety as a PET quencher, with fluorescence turn-on upon condensing with oxidized NO 
to the cinnoline whose HOMO is lower than 2-ABP. 
Another analog, NO-QA5 connects 2-methyl-5-aminoquinoline with N,N-
dimethylaniline (Scheme 1.23).286  Reaction with nitrite in acid yields two isomers of the 
azo product, a non-fluorescent one deriving from attack at the ortho position of the 
dimethylaniline and the fluorescent, albeit with a low quantum yield of 0.15% in aqueous 
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PBS buffer, para-attack product with well-resolved fluorescence wavelengths 
(excitation/emission maxima of 430/540 nm) from non-fluorescent NO-QA5.  The same 
reaction on NO550 did not produce the ortho-attack regioisomer, and it was not 
determined whether NO-QA5 aerobic reaction with NO yielded isomers.  The low 
background from creating a longer-wavelength fluorophore results in an LOD of 15 nM.  
Although NO-QA5 is selective for the standard competing analytes, it is sensitive to 
solvent polarity, revealing emission stemming from ICT.  Such solvatochromism means 
that fluorescence emission changes according to the probes’ local environment in the cell.  
Hydrophobic regions provoke a hypsochromic shift in emission wavelength, along with a 
strong increase in quantum yield. 
Scheme 1.23:  NO-QA5 probe and the regional isomers of its cinnoline product 
 
Weakly fluorescent ortho and para products from the reaction of NO-QA5 with nitrosonium derived 
from acidification of nitrite and possibly from the reaction of aerobic NO. 
Mito-N incorporates 6-aminonaphthalimide into the 2-ABP core structure, with 
the imide connecting a triphenylphosphonium-capped tail for directing into mitochondria 
(Scheme 1.24).287  Mito-N emits at 540 nm, but cinnoline formation extends emission to 
595 nm.  Unfortunately, reaction with N2O3 takes twenty minutes to reach 80% 
completion.  The electron-withdrawing nature of the phthalimide renders the 6-amine less 
nucleophilic, slowing down the reaction pronouncedly relative to NO550.  Excitation at 
440 nm provokes ratiometric emission at 540 nm and 595 nm, proportional to the amount 
of Mito-N versus its cinnoline product, respectively, with an LOD of 21 nM.  Although 
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mitochondrial, Mito-N produced weak response, even to exogenous NO, in RAW 264.7 
cells, not surprisingly considering its low reactivity. 
Scheme 1.24:  Mito-N, an emission-ratiometric probe with low nucleophilicity for 
aerobic NO 
 
 These analogs have informed on the 2-ABP family of NO probes, but the Yang 
group performed a more systematic study into the optimization of 2-ABP probes.  
(Portions of this document starting from Table 1 and extending through Figure 1.18 are 
adapted from 288, published by The Royal Society of Chemistry.)  Table 1 shows the 
permutations synthesized and studied.  Positions X and Y on rings A and B were varied 
due to their pronounced influence on the probes’ nucleophilicity, and ring C was 
appended to induce bathochromic shifts.  Substituents at position Z on ring C are not only 
commercially and synthetically convenient but also distant from (and less inductively and 
sterically interfering with) the N2O3 reaction site.  Z was therefore an attractive 
modification site to introduce hydrophobic, hydrophilic, cell-compartment directing, or 
tethering functionalities.   The Yang group started by evaluating the brightness and 
fluorescence properties (in 1:4 DMSO / 50 mM PBS at pH 7.4) of the probes and their 




Table 1:  Structures and optical properties of a suite of 2-ABP probes for aerobic NO. 
 
aWavelength of maximum absorbance for the most bathochromic peak in the UV-vis spectrum  bWavelength of 
maximum emission for the largest peak in the emission spectrum when excited at the most bathochromic absorbance 
maximum  cAbsorptivity coefficient/1000  dQuantum efficiency  eBrightness relative to the cinnoline product of NO550 
(9), previously reported as AZO550.  The blue values highlight the best performers in the suite.  fCinnoline brightness 
is defined as the product of its absorptivity and its quantum efficiency.  gNO550 does not fluoresce in 1:4 DMSO / pH 
7.4 phosphate buffer. 
The first set of probes studied consisted of simple variants with rings A and B 
only (no C annulation). The Y substituent was fixed as a methyl group while varying the 
X substituent on ring A.  After nitrosonium is trapped by the primary aniline, ring A 
attacks the N-nitrosamine, and the para-position substituent (X) strongly influences the 
nucleophilicity of the ring.  To X were assigned electron-donating methoxy (OMe, 1), 
hydroxy (OH, 2), and N,N-dimethylamino (NMe2, 3) groups.  By far, the hydroxyl 
variant surpassed the others in brightness due to AZO-2’s much higher quantum yield of 
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67%.   Unfortunately, its brightness depends upon the protonation state of the phenol.  
Fluorescence pH titrations on AZO-2 and AZO-3 established their pKa’s as 7.8 and 4.5, 
respectively (Figure 1.04).  These substituent variations indicated that either a methoxy or 
an amine substituent at Y are required to avoid responding to physiological pH changes. 
Figure 1.04: Fluorescence emission pH titration of AZO-2 and AZO-3 
 
The titrations were conducted with 5 µM AZO-2 (blue) and AZO-3 (red) in 2.5% aqueous DMSO. 
The influence of position Y was evaluated by changing it from methyl to cyano, 
postulating that ICT from NMe2 to CN would lead to a bathochromic shift of 
fluorescence wavelengths.  The X = NMe2 and Y = CN cinnoline variant (AZO-4) had 
excitation and emission maxima 35-40 nm longer than AZO-3; however, the quantum 
yield of AZO-4 was less than 1%, lower than AZO-3’s 2%.  
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When considering AZO-3 and AZO550’s low quantum yield, the excitation energy 
is lost to non-radiative relaxation through rotation about the ring-A aryl-NMe2 bond.
289-
290  This bond rotation decreases significantly when the N-alkyl groups are fused to the 
aryl ring, inspiring the N-methyl tetrahydroquinoline (5) and julolidine (6) variants on 
ring A, with methyl at Y on ring B.  The ring fusion in both variants resulted in a 
remarkable increase in quantum yield, from 2% and 11% for non-fused AZO-3 and 
AZO550 to 36% for doubly-fused AZO-6 and 62% for singly-fused AZO-5.  The molar 
absorptivity for AZO-5 also increased, making it the brightest within the biphenyl series - 
nearly thirty times brighter than AZO550, albeit at shorter wavelengths.  The julolidine 
variant did produce the longest fluorescence wavelengths among 1-3 and 5-6, 
corroborating the greater planarity of the dialkyl-N to aryl bond. However, a steric clash 
between ring B’s aromatic proton and the julolidine benzylic protons (Figure 1.05) 
disrupts the planarity of the entire fluorophore, possibly explaining AZO-6’s lower 
quantum yield and molar absorptivity when compared to AZO-5. 
Figure 1.05:  Disruption of planarity in AZO-6 due to A1,3 strain 
 
Probe 5 proved to be the brightest candidate, but AZO-5’s excitation and emission 
maxima (425 and 508 nm) fall short of the preferred wavelengths appropriate to the 
universal FITC filters; benzannulation (ring C) extends fluorescence wavelengths.  For 
these 1-amino-2-phenylnaphthalene-based probes, the N,N-dimethylamino, N-
methyltetrahydroquinoline, and julolidine variants at position X on ring A were 
compared.  In each of these X variants, H occupies position Y, and Z on ring C was 
derivatized with H, N-acetamide (NHAc), and CN - a total of nine variants.  Focusing on 
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brightness first, the results listed in Table 1 (probes 7-15) show that both NMe2 (at X) 
and CN (at Z) substitutions are detrimental to cinnoline brightness.  For the same Z 
substituent, the NMe2 series members have lower molar absorptivities and quantum 
yields than their corresponding N-methyl tetrahydroquinoline or julolidine congeners, 
i.e., cinnolines 7 versus 10 and 13, 8 versus 11 and 14, and 9 versus 12 and 15.  This 
trend is readily explained by the greater non-radiative relaxation rate caused by rotation 
about the N-aryl bond for NMe2 variants versus the singly fused N-methyl 
tetrahydroquinoline and doubly fused julolidine variants.  
Likewise, the Z = CN cinnoline series exhibits lower molar absorptivities than the 
corresponding Z = NHAc or H series (for the same X substituent).  One possible 
explanation is that the Franck-Condon excited state has significant quinoid character in 
the Z = CN series (due to internal charge transfer from the dialkylaniline to the nitrile), 
with less quinoid character in the ground state, such that the poor orbital overlap between 
the two states results in lower probability of photon absorption.  Within the Z = CN 
series, for the two alicyclic amine variants at X (AZO-12 and AZO-15), the ground state 
incorporates greater donation of the aligned nitrogen lone pair into the polyaromatic 
system than from the more freely rotating X = NMe2 variant (AZO550), leading to better 
orbital overlap of the ground state with the excited state, as demonstrated by their higher 
absorptivities.  For the Z = H and NHAc variants, both substituents are less electron 
withdrawing and therefore less accepting of internal charge transfer than CN, meaning 
that their ground and excited states are more similar and their absorptivities higher.291-292  
The Z = CN series also manifested lower quantum yields.  Perhaps the excited state 
relaxes through internal charge transfer to the nitrile π* orbital, with subsequent non-
radiative relaxation through the increased hydrogen-bonding of this negatively charged 
complex with buffer.  N-methyl tetrahydroquinoline variants proved brighter than their 
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A1,3-strained julolidine counterparts, as discussed for AZO-6.  Interestingly, for AZO-13 
the greater electron-withdrawing nature of the NHAc Z-substituent (acceptor) acting 
upon the dialkyl amine (donor) lone pair electrons counters the A1,3 strain to promote 
greater planarity and therefore a higher quantum yield, as compared to Z = H for AZO-
14. 
As anticipated, adding ring C to the biphenyl probes bathochromically shifts 
fluorescence wavelengths.  While benzannulation of fluorones to seminaphthofluorones 
extends wavelengths by more than 100 nm, only a 15-30 nm shift occurs for the 
cinnolines.293-295  For a π to π* excitation, extending the pi-electron system significantly 
changes the energy gap, not so much for an n to π* excitation.  Substituting CN at Z (9, 
12, 15) induces the greatest change, but this substitution prohibitively decreases 
brightness.  Variants substituted with NHAc at Z (7, 10, 13) show only slight shifts (3-7 
nm) to longer wavelengths compared to their corresponding H (8, 11, 14) substituted 
ones.  Varying X in the benzannulated series from NMe2 (7, 8, 9) to N-
methyltetrahydroquinoline (10, 11, 12) to julolidine (13, 14, 15) continues the 
aforementioned pattern in the biphenyl series of red-shifting fluorescence wavelengths 
with greater ring fusion.  Benzannulated julolidine variants therefore produce the longest-
wavelength probes; unfortunately, julolidine substitution also decreases brightness due to 
A1,3 strain, as proposed above. 
The spectroscopic data reveal probes 5, 10, 11, and 13 as the brightest in the 
group.  Importantly, as with first generation NO550 and AZO550, the absorbance spectra 
for the probes minimally overlap with the absorbance spectra of their corresponding 
cinnolines, and probe emission peaks are resolved from AZO emission peaks (Figure 
1.06). Consequently, as described below, in cells the probes can be excited independently 
from their N2O3 reaction products to compare intracellular distribution or 
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compartmentalization of probe and cinnoline product and to maintain a nearly zero 
background for detecting product (as previously reported for NO550). 
Figure 1.06:  Absorbance and fluorescence emission traces for 5, 10, 11, and 13  
 
Absorbance (dashed lines) and fluorescence emission (solid lines) traces for probes (blue) and for 
their azo products (red). 
Fluorescence titrations with NO of the probes in acellular, aerobic buffer provide 
more insight into 2-ABP probes following the same groupings for probes 1-16 above.  
Incremental aliquots of a saturated NO solution (1.9 mM)15 were added to an air-






Figure 1.07:  Fluorescence titrations of probes 3, 5-15 with NO under aerobic conditions 
 
a-1 to l-1) Fluorescence emission spectra (black traces) of titrations with NO of 50 µM probe in 1:4 
DMSO / pH 7.4 phosphate buffer at the specified excitation (λex).  Absorbance spectra (blue traces) of 
50 µM solutions of their corresponding cinnoline.  a-2 to l-2) Plots of fluorescence intensity of 
cinnolines at the specified wavelength (λem) versus added NO equivalents. 
Two equivalents of NO react with a half equivalent of oxygen to yield one equivalent of 
nitrosonium equivalent N2O3 (Scheme 1.25), which is susceptible to hydrolysis.  To 
maximize signal, probes should exhibit sufficient nucleophilicity to successfully compete 
with an excess of water.  For the first grouping (the biphenyl system with no ring C and 
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with Y as Me) the Hammett σ+ substituent constants  for position X on ring A as OMe 
(1), OH (2), and NMe2 (3) are -0.78, -0.92, and -1.7, respectively.
296  Variant 1 does not 
produce sufficient cinnoline product to be detected by fluorescence (Figure 1.08), 
whereas 2 and 3 provide ample signal, confirming that X must be sufficiently electron-
donating (σ+ < -0.78) to readily promote nucleophilic attack by ring A.   Changing the 
weakly donating methyl (σ+ = -0.311) at Y in 3 to a strongly-withdrawing cyano group, 
(σ+ = 0.659)297 in 4 (with X set as NMe2) results in no production of fluorescence; the 
cyano group decreases the nucleophilicity of the p-amine to such an extent that it cannot 
compete with water for N2O3. 
Scheme 1.25:  Stoichiometry of the oxidation of NO to the nitrosating agent asymmetric 
N2O3 
2 NO + O2 → ONOONO 
ONOONO → 2 NO2 
2 NO2 + 2 NO → 2 N2O3 
2 NO + ½ O2 → 2 N2O3 
The probes that do form cinnolines from N2O3 (2-3, 5-15) for the most part 
require less than five minutes to almost react fully.  The extent of turn-on points to probes 
10-11 and 13-14 as the most promising of the longer-wavelength variants (Figures 1.07 
and 1.08).  More than two equivalents of NO, typically four in most cases, are necessary 
to reach saturation, however.  For low starting concentrations of probe (50 µM, compared 
to 55.5 M for water), hydrolysis of N2O3 competes sufficiently as a side-reaction to 
warrant the excess NO.298  Despite requiring at least twice the theoretical amount of NO 
for full conversion, these probes surpass DAF-2, the predecessor of DAF-FM in 
reactivity.  The fluorescence intensity of a solution of 3 exposed to two equivalents of 
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NO, when calibrated to varying concentration standards of AZO-3, showed 36% 
cinnoline formation.   In comparison, 27% of DAF-2 converted to the triazole when 
exposed to 2 equivalents of NO under similar conditions.266 
Figure 1.08:  Kinetic traces of the aerobic reaction of the probes with NO  
 
Kinetics of cinnoline emission emanating from exposure to one equivalent of NO of 50 µM solutions 
of probes 1-4 and 7-15 in 1:4 DMSO / phosphate buffer at pH 7.4 under aerobic conditions.  
Respective excitation wavelengths were set to the absorbance maximum of each probe’s cinnoline 
product (AZO-1-4 and AZO-7-15). 
With the high reactivity of these probes and the creation of signal from virtually 
no background, excellent detection limits were obtained.  The LOD of 9 (NO550) was 
previously determined to be 30 nM.282  For the brighter 10, the detection limit is 2 nM, 
comparable to DAF-FM’s detection limit of 3 nM.263 
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The resolution of the probe and cinnoline emission spectra enables ratiometry 
when the probes and their cinnoline products share an excitation band (Figure 1.09).  
Ratiometry corrects for several experimental factors, including variations in intracellular 
dye concentrations, in optical path due to cell thickness, and in instrumental noise.299  
However, with this set of 2-ABP probes two factors moderate this benefit of ratiometry. 
First, the shared excitation band is in the cell-damaging near-UV range, shorter than the 
excitation for the cinnoline alone.  Second, the shorter wavelength excites the probe more 
optimally than its cinnoline product, attenuating the stronger cinnoline emission and 
increasing unreacted probe background fluorescence, thereby directly counteracting one 
of the most significant attributes of the 2-ABP system: exciting at the cinnoline 
absorbance maximum results in virtually no background contribution from the probe. 
Figure 1.09:  Probe 5 ratiometric response to NO 
 
Fluorescence emission spectra depicting the ratiometric response to NO of 5 µM probe 5 solution in 
1:4 DMSO / pH 4 phosphate buffer with excitation at 310 nm.  The inset plots the ratio of emission 
intensity of AZO-5 (515 nm) to that of probe 5 (415 nm) versus equivalents of NO. 
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In conserving the 2-aminobiphenyl core, this set of probes was expected to 
maintain the selectivity of NO550 for NO over other common biological substrates.
282  
Indeed this anticipation proved correct; as one example, Figure 1.10 demonstrates 
fluorescence emission for probe 10 in the presence of NO versus that in the presence of 
various oxidants.  Even at one hundred equivalents of peroxynitrite to probe, at most a 
five-fold increase of fluorescence was observed, as compared with a greater than 1300-
fold increase for merely one equivalent of NO. 
Figure 1.10:  Probe 10’s selective response to various physiological analytes 
 
Probe 10 response to competing analytes in 100-fold excess, as compared to its response to one 
equivalent of NO (last column).  The first column quantifies emission from 10 alone.  Note the 
break/change in the vertical axis. 
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1.2 AIMS 
Taking into consideration the probes’ spectral properties and response to NO in 
abiotic aqueous solutions, the top performers consist of probes 5, 10, 11, and 13.  To 
determine their suitability to the more complex cell environment and to compare their 
capability with the original 2-ABP probe 9 (NO550) and with the “gold standard” NO 
probe DAF-FM, we employed fluorescence microscopy.  The Anslyn lab was not 
equipped for cell culturing, nor did it have a fluorescence microscope.  Fortunately, the 
Shear lab shared their cell-culturing equipment and Zeiss Axiovert 135 microscope, as 
well as their PhD candidate (at the time) Derek Hernandez.  In his thesis,300 Derek reports 
that, in the loading of probes 5, 10, and 13 at concentrations ranging from 10 to 100 µM 
for 1.5 hours in NIH 3T3 cells, the 50 and 100 µM concentrations produced nuclear 
fluorescence, pointing to cell damage, mostly absent at lower loading concentrations.  In 
addition, after 24 hours these two highest concentrations provoked cell death in the 
population that, although not quantified, was easily discernible.  In previous experiments, 
probe 11 within an hour had produced a bright signal comparable to DAF-FM, but this 
fluorescence faded over 24 hours, indicating some undesired reaction in the cell milieu 
with AZO-11.  So concerning was this fading that no further studies were pursued with 
probe 11. 
Initial studies by Derek on probe 5 proved it similar to probes 10 and 13 in 
brightness and loading pattern.  These studies had to be conducted at the Institute for 
Cellular and Molecular Biology (ICMB) Microscopy and Imaging Facility because the 
Shear lab lacked the microscope filter sets required for probe 5’s shorter fluorescence 
wavelengths.  In transporting the adhered cells from the Shear lab in the Welch building, 
where they were cultured and loaded, to ICMB for imaging, some would detach and 
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interfere with the imaging, and their general health seemed to suffer.  As a result, we 
decided to focus on 10 and 13 only. 
To verify their response to exogenous NO, we applied separately a saturated 
aqueous solution of NO and an NO donor, S-nitroso-N-acetylpenicillamine (SNAP).  
Next, we monitored the effect of dosing cells with NOS substrate L-arginine.  Finally, 
with bacterial lipopolysaccharides (LPS), we provoked high NO production by iNOS 
enzymes in macrophage-derived RAW 264.7 cells and measured probe response to this 
endogenous production.  For quantification of fluorescence, we developed a method 
applying available analysis tools in  ImageJ software.301 
The n to π* transition typical to cinnoline probes produces low absorptivity 
coefficients due to poor Franck-Condon overlap between the ground-state and excited-
state orbitals.  Even the brightest variant AZO-5 achieves less than 25% of the brightness 
(the product of absorptivity coefficient and quantum yield) of DAF-FM triazole (13,000 
vs 59,000 respectively).  We therefore sought to incorporate the 2-ABP moiety into a 
rhodamine fluorophore more comparable in brightness to DAF’s fluorinated fluorescein 
to determine if the innate fluorophore brightness would beget a bright AZO product, as 
detailed in Scheme 1.26.  If successful, we anticipated the response to NO would be 
green-to-red, due to the extended conjugation, emission ratiometric. 
Scheme 1.26:  Proposed incorporation of 2-ABP into a rhodamine fluorophore  
 
Reaction with aerobic NO should produce a longer-wavelength cinnoline product, perhaps with 
similar brightness to the starting rhodamine. 
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Finally, we designed a diphenyl ether probe (Scheme 1.27) that would form a red-
fluorescent phenoxazine-based fluorophore if it could trap and condense upon NO under 
aerobic conditions.  Electron-donating dialkyl aniline moieties were placed at the 3, 3´ 
positions to render the 6, 6´ positions nucleophilic at physiological pH.  The alkyl groups 
terminate in water-solubilizing alcohol or carboxylate groups to prevent quenching from 
aggregate formation in aqueous media, for which phenoxazinium dyes have a propensity. 
Scheme 1.27:  Diphenyl ether probe to condense upon aerobic NO to form a 
phenoxazinium dye. 
 
 (R = CH2CH2OH or CH2CH2COOH) 
1.3  RESULTS AND DISCUSSION  
Since the samples shipped from the Yang group for probes 5, 10, 11, and 13 had 
degraded, 5 was re-purified and the remaining three re-synthesized according to Schemes 
1.28 to 1.31.  During the purification of final product, all four probes tended to oxidize 
(going from clear to yellow-colored), with 5 being the most stable to air and 11 the least, 
requiring prompt processing to vacuum-dry material and storage at -20 °C. 






Scheme 1.29:  Synthesis of probe 10 
 
 
Scheme 1.30:  Synthesis of probe 11 
 
Scheme 1.31:  Synthesis of probe 13 
 
 
We did not observe toxicity when applying these probes to cells, even after 24 
hours of incubation.  A representative toxicity assay for probe 10 (Figure 1.11) showed 
>93% of RAW 264.7 cells remained viable after two hours of exposure to probe 
concentrations ranging from 1.25 to 40 µM, as compared to >95% in controls where they 
were either exposed to DMSO only or left untreated.  (We did not attempt higher 
concentrations, since Derek Hernandez had seen cytotoxicity at 50 and 100 µM loading 
concentrations in NIH 3T3 cells.)  In the assay, viable cells have intact membranes that 
retain highly charged Calcein Blue after non-specific esterases hydrolyze the 
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acetoxymethyl ester masks that enable passive loading of this polar dye.  Propidium 
iodide cannot passively permeate intact cell membranes in viable cells; but, for dead cells 
whose membranes are compromised, propidium iodide can diffuse into the nucleus and 
intercalate into DNA, with a strong enhancement of red fluorescence.  Thus, viable cells 
fluoresce blue and dead cells red. 
Figure 1.11:  Live / Dead Assay for cells loaded with probe 10 
 
Pseudo-colored, 10X-magnification images of Calcein Blue (live cells) and Propidium Iodide (dead 
cells) in RAW 264.7 cells incubated for two hours with 1.25 (frame c), 2.5 (d), 5 (e), 10 (f), 20 (g), and 
40 µM (h) probe 10, as well as cells left untreated (a) or incubated with 0.25% DMSO only (b). 
 The popular DAF-FM probe requires strikingly different loading and imaging 
procedures.  The probe itself is negatively-charged and membrane impermeable, but 
masking it as the lactone/diacetate form DAF-FM DA enables loading.  This colorless 
and non-fluorescent form passively diffuses across cell membranes, and non-specific 
intracellular esterases hydrolyze the acetate groups, promoting the fluorescent and 
dianionic non-lactone form that cannot permeat the membrane.  However, organic anion 
transporters (OATs) efficiently pump this NO-responsive form (and its triazole product) 
out of the cell.  Whereas increased loading time would typically yield higher 
concentrations of intracellular DAF-FM, OATs counteract the trend when the rate of 
DAF-FM extrusion exceeds that of loading and esterase hydrolysis.  Therefore, loading 
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times and imaging times must be optimized and reproduced, according to cell-type and 
experiment conditions.  This high degree of variability coupled with short experiment 
times after exposing cells to DAF-FM constrain imaging of NO and limit drawing 
conclusions of NO dynamics with this probe.  In contrast, our 2-ABP probes permeate 
cell membranes readily and are poor substrates for extrusion by OATs.  
 The unreacted probes are fluorescent, although not as bright as their cinnoline 
products, and the excitation/emission profiles (Figure 1.12, excitation: dashed blue lines, 
emission:  solid blue lines) for probes 10 and 13 fit the Zeiss G 365 DAPI filter 
(Appendix C) fairly well.  Consequently, fluorescence imaging with the DAPI filter 
yields insight on probe loading and distribution.  Figure 1.12 shows DAPI-filtered 
unreacted probe 9 (NO550), 10, and 13 fluorescence in NIH 3T3 (immortalized mouse 
embryo fibroblast cell line) and RAW 264.7 (immortalized mouse leukemia-virus 
transformed tumor macrophage cell line) cells.  Fluorescence from probes 10 and 13 is 
distributed more uniformally throughout the cytosol than from 9.  Table 1 lists the probe 
form of 9 as non-fluorescent in aqueous solution, so the more punctate fluorescence for 9 
probably reflects emission from hydrophobic regions (based on the solvatochromism of 
5-cyano-1-methylamino naphthalene).284  Although nuclear fluorescence is higher than 
extracellular fluorescence for all probes, the brighter intracellular but extranuclear 







Figure 1.12:  Probe loading distribution in cells 
 
Pseudo-colored DAPI-filtered images (40x magnification) of probes 9, 10, and 13 in A) NIH 3T3 and 
B) RAW 264.7 cells 
 We used ImageJ for processing microscopy images, and we developed a protocol 
to quantify fluorescence intensity, as described in the experimental section of this 
chapter.  Regions of interest (ROI) were defined in the brightfield (not fluorescence) 
images, since these images capture the full boundaries of the cell, whereas fluorescence 
images may cut off parts of cells that are not sufficiently bright.  Figures 1.13 and 1.14 
show the process of defining the ROIs in sample images of NIH 3T3 and RAW 264.7 
cells, respectively, and the application of these ROI to the fluorescence image.  The 
morphologically less uniform NIH 3T3 cells required more background and variance 
adjustments within FIJI sofware than the simpler RAW 264.7 cells.  Figure 1.14 also lists 
sample brightness measurements (defined as area * mean intensity) for all intracellular 




Figure 1.13:  Sample processing of NIH 3T3 cell images 
 
NIH 3T3 celss at 10x magnification. a) brightfield image, b) ROI after background and variance 
filter processing, c) improved ROI upon adjusting background subtraction and variance filter 
parameters, d) optimal ROI, e) threshhold mask for cells, f) inverse mask for extracellular region, g) 
cellular mask applied to DAPI-filtered image, h) cellular mask applied to FITC-filtered image of the 
same cells 
Figure 1.14:  Sample processing of RAW 264.7 cell images 
 
RAW 264.7 cells at 10x magnification. a) brightfield image, b) image after background subtraction 
and variance filter processing, c) selection of ROI, d) threshhold mask for cells, e) cellular mask 
applied to DAPI-filtered image, f) cellular mask applied to FITC-filtered image of the same cells, 
Results:  area of cellular ROI is 138,173 pixels and of extracellular ROI 553,027 pixels.  D and F are 
abbreviations for DAPI and FITC channels, respectively.  The average intensity per pixel within a 
region is listed as the mean. 
Probes 10 and 13 responded well to exogenous NO in cells.  NIH 3T3 and RAW 
264.7 cells were pre-loaded with 10 µM solutions of 9, 10, and 13 and exposed to 1 mM 
(releases 300 µM NO) and 200 µM (releases 60 µM NO)302 SNAP solutions, respectively 
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(Figure 1.15).  The NO released from SNAP (half-life of as much as 37 hours)303 
converted probe to cinnoline under aerobic conditions, as demonstrated by the increase in 
green FITC-channel intensity, corresponding to cinnoline emission spectra.  In SNAP-
dosed cells compared to untreated cells, 13 produced the smallest signal increase 
(Fdosed/Fun-dosed) among the three probes (Figure 1.15A).  This smaller ratio primarily 
results from a higher resting-level fluorescence (Fun-dosed) for AZO-13 versus AZO-9/10.  
The longer-wavelength probe 13’s excitation and emission overlap slightly with the FITC 
filter set (Appendix C), such that some unreacted probe fluorescence bleeds into the 

















Figure 1.15:  Probe response to SNAP 
 
(A) Response of control (dotted bars) versus SNAP-dosed (solid bars) NIH-3T3 (red, dosed with 1 
mM SNAP) and RAW 264.7 (blue, dosed with 200 µM SNAP) cells pre-loaded with 10 µM probes 9, 
10, or 13.  The Fdosed/Fun-dosed ratio per probe and cell type is overlaid on the pertinent dotted/solid bar 
pairs.  (B and C) 40x magnification, pseudo-colored, FITC-filtered images of probe 9, 10, and 13-
loaded NIH-3T3 cells with no SNAP dosage (B) and with 1 mM SNAP dose (C). 
The low AZO emission, slightly above background (defined as emission in cells 
exposed only to DMSO vehicle but not to any of the three probes), for probes 9 and 10 in 
un-dosed cells may magnify error or variation in image acquisition.  Since the emission 
intensity is corrected by subtracting the average background from several images, values 
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for un-dosed cells approached zero.  Error in acquiring the images, even if it decreased 
emission by only 5%, could significantly affect Fdosed/Fun-dosed. (Case in point, if the 
background intensity is 90% of the Fun-dosed intensity, 5% error would double the ratio.)  
With a strong un-dosed signal, 5% error perturbs the ratio minimally.  (With a 
background intensity at 10% of Fun-dosed, 5% error increases the ratio by only 1.06.)  
Therefore, the Fdosed/Fun-dosed ratios for probes 9 and 10 may incoporate significant 
propagation of small error. 
A saturated NO solution applied exogenously produced similar fluorescence 
enhancement to SNAP dosage.  Cells loaded with each probe were exposed to 200 µM 
NO (NIH 3T3 cells) or 320 µM  NO (RAW 264.7 cells) by diluting a 1.9 mM saturated 
NO solution into the cell medium (Figure 1.16).  In both cell types, 10 produced the 
brightest signal and the highest ratio of Fdosed/Fun-dosed, while 9 was the dimmest and 13 













Figure 1.16:  Probe response to NO 
 
(A) Response of control (dotted bars) versus NO-dosed (solid bars) NIH-3T3 (red, dosed with 200µM 
NO) and RAW 264.7 (blue, dosed with 320 µM NO) cells pre-loaded with 10 µM probes 9, 10, or 13.  
The Fdosed/Fun-dosed ratio per probe and cell type is overlaid on the pertinent dotted/solid bar pairs.  (B 
and C) 40x magnification, pseudo-colored, FITC-filtered images of probe 9, 10, and 13-loaded RAW 
264.7 cells without any NO dosage (B) and with 320 µM NO dose (C). 
Having established that the probes could detect applied NO in a cellular 
environment, we then proceeded to verify if they could detect NO production in cells.  
Since nitric oxide synthases oxidize L-arginine to L-citrulline and NO, arginine 
supplementation would at least ensure the synthases would not lack the substrate they 
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convert to NO.  In fact, arginine supplementation was found to significantly enhance 
fibroblast proliferation in wound healing, purportedly from NO signaling by S-
nitrosylation of G-protein P21ras and by known NO activation of the ERK pathway.304  
We found that probe 13-loaded NIH-3T3 fibroblast-derived cells dosed with 2 mM L-
arginine for twenty-four hours produced a 1.7-fold increase in AZO 13 brightness over 
non-dosed cells (Figure 1.17). 
Figure 1.17:  Response of probe 13 to L-arginine 
 
NIH-3T3 cells loaded with 10 µM probe and dosed with 2 mM L-arginine (B) produced a 1.7x 
increase in brightness versus non-dosed cells (D), after 24 hours.  (A) and (C) are brightfield images, 
whereas (B) and (D) are pseudo-colored FITC-channel images. 
To achieve higher NO stimulus, we turned to RAW 264.7 cells.  These derive 
from a macrophage line, which when exposed to LPS, increase expression of inducible 
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nitric oxide synthase (iNOS), resulting in micromolar level production of NO.  We 
applied 1 μg/mL LPS to the cells overnight, followed by loading with probes 9, 10, 13, 
and DAF-FM (Figure 1.18).  DAF-FM gave the brightest images, whether stimulated or 
not (Figure 1.18, B and C).  The strong DAF-FM fluorescence in non-stimulated cells 
resulted in only a 1.8-fold increase in brightness from stimulated to non-stimulated cells 
(Figure 1.18A).  DAF-FM also leaked readily from cells, to the extent that imaging was 
optimal after only 15-20 minutes loading, with strong signal loss after that.  At the low 
extreme of brightness, probe 9 (NO550)’s stimulated signal was approximately 1/45
th that 
of DAF-FM, with a comparable 1.7-fold response to stimulus.  Importantly, probe 10 
gave the greatest (4.8-fold) response to stimulus and is brighter than NO550.  Due to weak 
fluorescence in unstimulated cells (Figure 1.18B), the increase of fluorescence ratio (turn 
on) is larger than DAF-FM.  However, stimulated cells achieve less than 20% of DAF-
FM brightness.  Probe 13 was the brightest performer among the three 2-ABP probes, 
with a 1.9-fold increase due to LPS.  In contrast to the high time-dependence of imaging 
of DAF-FM, due its extrusion by OATs from the cell, probes 9, 10, and 13 and their 
cinnoline products remain in cells over many hours, with the probes continously available 









Figure 1.18:  Response of probes to LPS 
 
(A) Response of 10 µM 9, 10, and 13 and 2 µM DAF-FM in non-stimulated (dotted bars) versus 
stimulated (with 1 µg/mL LPS, solid bars) RAW 264.7 cells.  The Fstim/Funstim ratio per probe and cell 
type is overlaid on the pertinent dotted/solid bar pairs. (B and C) 10x magnification, pseudo-colored 
FITC-filtered images of RAW 264.7 cells without any LPS added (B) and with 1 µg/mL LPS added 
(C). 
 Despite the strong time-independence of loading and imaging and despite the 
forementioned cross-reactivity of ODP probes, DAF-FM’s brightness (e.g., Figure 1.18B 
and C) still makes it the most popular probe for studies of NO in aerobic conditions.  
Rhodamines frequently exhibit similar brightness, with red-shifted fluorescence 
wavelengths that typically excite less cellular autofluorescence and provoke less 
cytotoxicity.  We sought to apply the 2-ABP selectivity and ability to create a new 
cinnoline fluorophore from oxidized NO to an intrinsically bright rhodamine derivative, 
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in hopes of harnessing this inherent brightness to create a bright, long-wavelength, 
emission ratiometric probe.  Scheme 1.32 depicts the synthesis of the asymmetric 
rhodamine we designed. 
Scheme 1.32:  Synthesis of asymmetric rhodamine 2-ABP probe. 
 
 
 Unfortunately, we saw no fluorescence in the cinnoline product from reacting the 
probe with sodium nitrite in aqueous HCl.  The LCMS chromatogram showed a 
prominent product peak with visible-wavelength absorbance maxima of 486 and 634 nm 
and whose peak of 489.2 m/z in the corresponding ESI-positive ion chromatogram agrees 
with the protonated cinnoline’s exact mass of 489.19.  In polar (aqueous) environments at 
neutral pH, the equilibrium between the fluorescent non-lactone form and the non-
fluorescent lactone form in simple rhodamine derivatives trends towards the fluorescent 
form (Figure 1.19).  Such is the case with the unreacted asymmetric rhodamine probe.  
Perhaps the extensively conjugated cinnoline product strongly favors the lactone form, 
even in an aqueous environment.  If not, an efficient PET quenching mechanism could 
also explain the lack of fluorescence.  If the cinnoline product has a higher LUMO than 
the orthogonally attached benzoic acid, the excited electron could transfer to the benzoic 
acid’s LUMO, followed by non-radiative relaxation (the benzoic acid’s HOMO is fully 
occupied) to the ground state. 
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Figure 1.19:  Equilibrium between non-fluorescent lactone and fluorescent zwitterion 
forms. 
 
 Even worse, no cinnoline product was formed after aerobic exposure of the 
asymmetric rhodamine to an aliquot of saturated NO aqueous solution.  Neither was the 
N-nitroso intermediate detected by LCMS, only the asymmetric rhodamine probe.  
Incorporating the primary amine in the rhodamine fluorophore apparently decreases the 
nucleophilicity of the amine to the extent that it does not readily react with N2O3.  Given 
these results, this design was no longer attractive, and no further work was pursued. 
 In another design, we tested the necessity of an amine to trap NO under aerobic 
conditions.  Scheme 1.33 denotes the synthesis of a 3,3´-diaminophenyl ether probe that 
we hoped would condense upon NO in aerobic conditions to form phenoxazine 
fluorescent products.  The 3-aminophenyl ether aryl ring has a strong electron-donating 
substituent in the dialkyl amine (σ+p of -1.7 for -NMe2),
305 along with a mid-level 
donating substituent in the phenyl ether (σ+p of -0.5 for -OPh).
305   Enhanced reactivity 
notwithstanding, an aqueous solution of the tetra alcohol variant exposed to an aliquot of 
saturated aqueous NO produced no reaction, and this project was terminated. 




1.4  CONCLUSIONS 
 Probes based on the 2-aminobiphenyl core structure have proven selectivity for 
NO over numerous competing analytes that are common to bioimaging in that the other 
analytes fail to produce the same fluorescent response.  The design also ingeniously 
incorporates nitrosonium to extend conjugation in the newly created cinnoline.  The n to 
π* absorption transition occurs at longer wavelengths well resolved from the 2-ABP’s 
most bathochromic absorbance peak, and cinnoline emission follows suit relative to 
probe emission.  This characteristic leads to a ratiometric response, with probe emission 
decreasing as cinnoline emission increases upon reaction with NO under aerobic 
conditions.  Alternatively, in non-ratiometric sensing, this same resolution of 
fluorescence minimizes background emission at the cinnoline wavelength, such that 
cinnoline fluorescence emanates from “darkness”, with remarkable fluorescent 
enhancement due to NO.  Unfortunately, poor orbital overlap between n and π* orbitals 
results in small absorptivity coefficients when compared to brighter probes, such as those 
based on bodipy, fluorescein, or rhodamine. 
 The main brunt of this research sought to ascertain how NO550’s progeny, the 
second generation of 2-ABP probes designed by Anslyn and Yang (Table 1), would 
perform in cellular environments.  The Yang group thoroughly investigated their 
performance in abiotic conditions, elucidating reaction kinetics, fluorescence 
wavelengths and response to NO, and brightness of probe and azo products.  They also 
verified the retention of NO550’s selectivity despite the variations upon the core structure.  
Perhaps here, the selectivity could have been tested not only as it was - in non-
competitive experiments, where the probe is exposed to a potential analyte and the 
fluorescent response compared to that for NO/O2 – but also in competitive experiments, 
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where fluorescent response to NO/O2 in the presence of a potentially competing analyte 
is compared to that for NO/O2 alone. 
 Preliminary studies by Derek Hernandez showed that probes 5, 10, 11, and 13 all 
loaded into cells and produced a fluorescent response.  Loading concentrations of 50 µM 
or higher proved toxic, with noticeable cell death at 100 µM.  FITC-channel fluorescence 
from probe 11 faded over time.  Since the extracellular fluorescence remained negligible, 
this fading pointed to further reaction to a non-fluorescent product.  The shorter 
fluorescence wavelengths for probe 5 and its azo product were not compatible with 
available filter sets in the Shear lab, provoke greater cellular auto-fluorescence, and are 
more damaging to cells.  Thus, we focused on probes 10 and 13. 
 The two probes successfully responded to both exogenous and endogenous NO in 
NIH-3T3 and RAW 264.7 cells.  For reasons not yet determined, probe 13 generated 
more FITC-channel fluorescence than either NO550 (9) or probe 10 under resting, non-
dosed/non-stimulated conditions.  Fluorescent enhancement upon dosing/stimulating 
therefore suffered in comparison to the other two probes.  Probe 13 was the most similar 
to DAF-FM in brightness in resting cells; DAF-FM also produced attenuated 
enhancement in our hands.  Although this attenuation reduces sensitivity to varying levels 
of NO, the stronger signal in resting cells establishes a value for non-dosed/non-
stimulated fluorescence easily discriminated from cellular autofluorescence, reducing 
error in calculations of fluorescence enhancement from dosing/stimulating.  In contrast, 
NO550 and probe 10 in resting cells often fluoresce barely above cellular autofluorescence 
and experimental noise – unsurprisingly as such is the design of the probes at low NO 
levels.  Higher resting brightness notwithstanding, probe 13 produced a 1.7-fold response 
to twenty-four hours of exposure to L-arginine. 
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 Probe 10 provides the best compromise between sensitivity/response and 
brightness.  When high levels of NO were applied, whether from the NO donor SNAP or 
through an aqueous NO solution, true to abiotic results, it was usually the brightest 
among probes 9 and 13 in both cell types.  However, 10 was not the brightest among the 
two other probes, and certainly not brighter than DAF-FM, in response to LPS 
stimulation of iNOS production of NO in RAW 264.7 cells.  In almost every scenario 
tested, 10 yielded the greatest enhancement after stimulus.  It also proved non-toxic to 
RAW 264.7 cells in concentrations up to 40 µM, with >93% viability rate after four hours 
exposure, comparable to >95% for untreated cells. 
 Both probes 10 and 13 are an improvement over first-generation NO550 in 
brightness, and probe 10 in response.  A direct comparison to DAF-FM is difficult due to 
cellular organic anion transporter pumps’ removing loaded probe and triazole product 
from cells, causing a troublesome and problematic time-dependence of imaging.  If 
imaged within an hour of loading (preferably 20-30 minutes), DAF-FM produces the 
brightest results, although with small stimulus-provoked signal enhancements.  In our 
hands, even ten minutes between images resulted in discernable DAF-FM triazole signal 
loss in cells.  In contrast, our probes were imaged twenty-four hours after loading, with 
no noticeable signal loss.  The attenuated fluorescence enhancement after stimulus 
derives primarily from the high non-stimulated fluorescence.  Potentially, this high 
resting fluorescence reflects DAF-FM cross-reactivity, as it is not present in NO550 and 
probe 13.  In abiotic conditions, stoichiometric reaction of 13 with NO showed greater 
conversion to cinnoline than that reported for DAF-FM to its triazole product.  Unless the 
cellular environment changes this dynamic, the stronger DAF-FM resting fluorescence 
cannot be attributed to higher reactivity with lower concentrations of NO. 
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  We also attempted a design that incorporates the 2-ABP core into a rhodamine 
fluorophore in hopes of producing a long-wavelength, emission-ratiometric set of probes 
with strong, inherent rhodamine brightness.  In aqueous solution at neutral pH, the 
cinnoline product of this asymmetric rhodamine proved non-fluorescent, however, 
probably due to favoring of the dark spirolactone form.  Worse yet, due to conjugation 
within the rhodamine fluorophore, the primary aniline was insufficiently nucleophilic to 
trap the nitrosonium moiety when exposed to an aqueous solution of NO in aerobic 
conditions. 
 Similarly disappointing was the second design  N,N-dialkyl-3-aminophenylether.  
Rather than condensing upon nitrosonium to form a phenoxazine fluorophore, this probe 
attempt also failed to react with an aqueous solution of NO.  The aryl rings lack the 
nucleophilicity of an aniline, specifically an aniline with no electron withdrawing groups 
to lower its nucleophilicity. 
1.5  FUTURE WORK 
 Both probes 10 and 13 are attractive options for bioimaging of NO in cells.  
SciFinder currently lists twenty-four vendors for NO550, and Sigma-Aldrich also sold it 
for a time.  Named NO530 (10) and NO562 (13), both probes should supplant NO550 in the 
market, due to both/either their greater response and and/or brightness and to their more 
homogeneous distribution in the cell.  Certainly, these 2-ABP probes enable more 
consistent experimentation, as they do not share the DAF series’ high time-variability of 
signal. 
At 10 µM loading concentrations, probe 13 somewhat compares to DAF-FM’s 
brightness.  Higher loading concentrations, with cytotoxicity established per cell type and 
length of experiment, could close the gap.  The stronger basal fluorescence of DAF-FM 
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and 13 versus 9 and 10 should be investigated, starting with competing L-arginine 
substrates and iNOS inhibitors, such as L-Nω-monomethyl arginine acetate (L-NMMA) 
or L-Nω-nitroarginine methyl ester (L-NAME), to determine if probe 13 fluorescence 
decreases below that for basal levels of NO production.  If the decrease reached basal 
fluorescence for probes 9 or 10 (slightly higher than cellular autofluorescence and 
instrument noise), then 13’s brightness would be attributed to higher reactivity with the 
resting NO concentrations – the most sensitive of the three.  More appropriate 
excitation/emission filters would eliminate probe bleed-through into the FITC channel 
that also increases 13’s resting brightness.   
The N-acetamide moiety in probes 10 and 13 provides an elegant synthetic handle 
to append functionalities, such as cell-compartment directing groups.  For example, 
replacing acetyl chloride with chloroacetyl chloride enables ligation of a nucleophile by 
SN2 substitution.  We performed such a synthesis on the NO562 trisaniline precursor and 
attached aminodiglycol to enhance water solubility, with qualitatively positive results by 
eye and by 1H NMR.  With the adoption of the parent probes by scientists, the 
mitochondrial triphenylphosphonium group should probably be the first group appended. 
Probe 5 should be evaluated with appropriate filters, as it is easily the brightest of 
all candidates. 
Finally, employing the 2-ABP system as a PET quencher, not as the fluorophore, 
by the Guo group is an intriguing approach that should be investigated further.  One 
could envision incorporating 2-ABP into the bright and biologically established 
fluorescein or rhodamine fluorophores (Figure 1.19), with the library of variants available 
to dial in the desired fluorescence wavelengths.  Computational studies would establish 
which variants provide better matches between the HOMO of the 2-ABP moiety and the 
HOMO of the xanthene (or other, i.e.; NR, CR2, SiR2, or PO2; derivatives), with the 
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HOMO of the former of higher energy than the latter, as well as the LUMO of the 
resulting cinnoline and the LUMO of the xanthene, with the LUMO of the former of 
higher energy than the latter. 
Figure 1.20:  Possible designs for 2-ABP probes as PET quenchers of xanthene dyes   
 
Y = O or NR´2; X = O, NR´, S, CMe2, SiMe2, PO2, etc.; R and R´ = Me, fused alicyclic, etc. 
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Chapter 2:  Sequenceable Carbamate Oligomers 
2.1 INTRODUCTION 
The tertiary and quaternary structures of biological polymers DNA/RNA and 
proteins are crucial to their performance in the organisms they inhabit.  The sequencing 
of protein and DNA biological polymers has shown how determining to these higher-
order structures are both the order and the identity of their individual components.  
Substitution and deletion studies reveal that small changes can significantly perturb the 
efficient performance of these polymers in their environments.  Such a dependence on 
constitution and order should translate to non-biological or non-natural polymers.  
Potentially, synthetic polymers could achieve the heralded selectivity and efficiency of 
biological polymers.  The allure of this possibility has birthed the field of sequence-
controlled and sequence-defined polymers.  The synthesis of these types of polymers has 
been well-established and continues to be developed.  Determining the sequence of these 
polymers, not as much. 
2.1.1 Sequence-Defined Polymers (SDPs) 
Polymers whose repeating units, or mers, are connected in identical order and 
number are considered sequence defined polymers.  This type of polymer, with a 
polydispersity index (PDI) of one, stands in contrast to most mass-produced synthetic 
polymers of higher PDIs found in plastics, synthetic textiles, vulcanized rubber, and the 
like.  The control of sequence and length of SDPs demands a more cumbersome iterative 
synthesis than the customary one-pot synthesis for most traditional polymers.  
Historically, SDPs were limited to those produced under biological controls, such as 
DNA and proteins.  With the advent of solid phase synthesis (SPS), iterative syntheses 
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have been simplified and eventually automated, conquering the fabrication of milligram 
amounts of a 167-amino-acid protein in less than seven hours, not including time for 
purification and folding.306 
2.1.1.1 Biological SDPs 
The tight control of sequence ensures reproducibility of biological polymer 
performance.  Among the most famous SDPs, the polynucleotide DNA encodes the 
genetic blueprint of its organism.  For protein synthesis, three sequential base pairs 
denote a specific amino acid (codons), and the order of the codons specifies the order of 
connection of their respective amino acids.  The DNA sequence must persist throughout 
all replications to preserve the structure of the proteins, as substituting or deleting a 
crucial amino acid or several amino acids may provoke deleterious effects.  DNA 
therefore serves as an example of SDPs functioning as data storage devices and has been 
estimated to be 104 times more space-efficient than advanced hard drives (2019).307 
Enzymes perform as enviably efficient and selective catalysts for their specific 
functions; few synthetic catalysts can compete with enzymes in reaction rates and/or 
substrate selectivity.  Their sequence, the primary structure of the protein, determines its 
secondary structure (e.g., α-helices, β-sheets, hairpins) that affect the folding and 
topology of the protein (tertiary structure). This in turn influences protein affinity for its 
binding partners; i.e., other proteins, lipids, or ions; and thus its quaternary structure.  
Selective substrate binding sites, proton or electron transfer shuttles involved in catalysis, 
and co-factor binding all depend on the amino acid sequence.  From an inverse 
perspective, point-mutation experiments exploit this sequence-dependency to elucidate 
the amino acids most crucial to protein performance. 
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2.1.1.2 Non-natural SDPs 
The four nucleotides available to DNA or RNA and the twenty amino acids that 
form proteins capacitate the great diversity found across the organisms of this planet.  
This diversity has been harnessed for purposes outside biology, for instance to design 
sensors and as catalysts.308-317  The successful implementation of these SDPs outside their 
biological applications inspired a quest to markedly expand the toolkit from the standard 
nucleotides and amino acids to non-natural ones and then to other molecules, quite 
different from nucleotides and amino acids, that can perform similar roles in iterative 
connectivity, structure determination, and catalysis. 
2.1.1.2.1 Peptidomimetics 
Expanding beyond the limited subset of biological monomers to non-natural 
repeat units with varying connectivity has resulted in a remarkable variety of SDPs.  The 
closest mimics of peptides consist of alpha-peptides with non-natural side chains, as well 
as peptoids; aza,318 aminoxy,319 and hydrazinyl320 peptides; and beta,321-323 delta, and 
gamma324 peptides (Figure 2.01).325-326   The longer beta, delta, and gamma amino acids 
avail multiple substitutions, if sterically accessible, and ring structures on the backbone of 
the same monomer, with the potential for greater complexity of the polymer versus 
natural peptides.  A myriad of examples exists for peptoids, and their secondary and 
tertiary structures have been extensively studied.327-329  One step further removed from 
peptides are carbamates (urethanes)330 and ureas.331  Ureas are typically more inert than 
amides and carbamates to hydrolysis, and their disubstituted (N,N´) variants offer two 
hydrogen-bond donors that tend to enhance secondary structure formation and stability332 
and that can act as a recognition units for anions when not participating in structure-
stabilizing hydrogen bonds.333  Carbamates offer similar stability to ureas, with two 
hydrogen-bond acceptors per occurrence. 
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Figure 2.01:  Common peptomimetic moieties in non-natural SDPs 
A.  
B.  
C.    
From left to right, A) natural α peptide backbone with non-natural sidechains R, then β, γ, and δ 
peptides; B) peptoid, aza, aminoxy, and hydrazinyl peptides; and C) ureas and carbamates.  Except 
for peptoids, R substitutions may be occupied by hydrogen. 
2.1.1.2.2 Nucleotidomimetics 
Non-natural nucleotides exemplify another preliminary step away from the 
certainty of biological SDPs.  As secondary structures for peptides motivated 
peptidomimetic studies, so did the base-pairing order and the typical resulting single 
(intra strand) or double (inter strand) helix structures for oligonucleotide mimicry.  
Whereas most fabrication of peptidomimetics is entirely synthetic, some non-natural 
nucleotides are amenable to polymerase transcription and replication.334  To maintain 
base complementarity, hydrogen bonding interactions between corresponding base pairs 
are conserved, but some non-interfering variability in structure is introduced.  These 
adaptations resulted in non-natural DNA and RNA synthesized by biological 
machinery.335-336  Interestingly, hydrogen-bonding interactions are not essential to base 
pairing by polymerases.  Mimicking the size, shape, and polarity of a natural base pair 
(such as difluorotoluene for thymine) results in modified polymerases incorporating a 
non-natural nucleotide according to a natural template.  These optimized polymerases 
tolerated one of these non-natural variants that incorporates varied side chains connected 
through a rigid alkyne, distant from the enzyme and base pair recognition site (Figure 
2.02).337  Similarly, DNA ligases can function with modified monomers and are also able 
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to ligate templated non-natural 3-mers and 5-mers, facilitating the incorporation of basic, 
acidic, aromatic, aliphatic, and hydrophobic/philic side chains into the SDP.338  
Employing RNA or single-strand DNA as a template and incorporating reactive termini 
into non-natural nucleic acid variants enables templated synthesis, discarding the 
limitations imposed by enzyme compatibility.  Commonly, reductive amination or click 
chemistry produces the ligation of complementary-sequence monomers paired to their 
template.339  Loosening the restraints even further, phosphoramidite-chemistry-enabled 
non-natural nucleotides are compatible with solid phase synthesis.  This approach 
requires no template or enzyme, but the greater flexibility in monomer design is 
counteracted by the limitations of the time-consuming process that produces 150-mer 
oligonucleotides on the average, with a maximum of ~1000,340 whereas polymerases 
have achieved 1500 monomer lengths.341 
Figure 2.02:  Non-natural base pairs Ds and Px 
 
Ds and Px structures compared to natural pairs A to T and G to C, above their space-filling models 
(deoxyribose not shown, R = Me).  The R group in Px is tolerated by a modified polymerase.   The 
aminohexanamide attachment did not interfere with replication, even when amide-coupled to 5-
carboxyfluorescein.  Thirty cycles of PCR amplification (107-fold) of DNA fragments incorporating 
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the Ds/Px base pair maintained >99.9% fidelity per cycle.  Figure reproduced with permission 
from337. 
2.1.1.2.3 Less Mimicry 
Moving further from the imitation of natural SDPs escapes their limitations but 
also produces a nearly limitless expanse of non-natural SDPs.  The manifold synthetic 
approaches fulfill the goal of synthesizing a wide variety of SDPs; however, doing so to 
create secondary, tertiary, and even quaternary structures that promote substrate 
selectivity and catalysis requires significantly more design, often by searching databases 
and employing artificial intelligence.  Aromatic oligoamides retain the amide hydrogen-
bonding stabilization of peptides and nucleic acids and tend to adopt similar structures, 
influenced also by aromatic stacking interactions (Figure 2.03A).342-344  Some designs 
have produced trihelices (parallel and antiparallel, depending on solvent polarity),345 
tetrahelices,346 and even tubular stacks.347  Bis-aminotriazine polymers contain another 
backbone rich in hydrogen-bond donors and acceptors and prone to pi-pi interactions 
(Figure 2.03B).  The decreasing reactivity of cyanuric chloride with each substitution 
imparts stepwise control of substitution, with side-chain attachment at -20 to 5 °C to the 
unsubstituted trichlorotriazine, polymer chain elongation on the monosubstituted 
dichlorotriazine at room temperature or with mild heating, and priming of the 
disubstituted monochlorotriazine for the next monomer addition with heating above 80 
°C (Scheme 2.01).  According to simulations, this polymer structure has the propensity to 
self-assemble into helices, sheets, and ribbons.347-348  A bis-aminotriazine was also 
incorporated into the backbone of a gamma-peptide with the sidechain emanating from 
the remaining position on the triazine.349  Fmoc solid-phase synthesis of triazinyl amino 
acids with hydrophilic cationic or hydrophobic aromatic residues attached as sidechains 
provided several oligomers with tunable amphipathicity. 
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Figure 2.03:  Examples of non-natural SDPs based on oligoamide and triazine backbones 
A)   
 
B)    
Scheme 2.01:  Temperature-controlled stepwise trisubstitution of cyanuric chloride  
 
2.1.1.3 Applications of SDPs 
2.1.1.3.1 Data Storage 
SDPs may function as data encoders; binders, encapsulators, and transporters; 
catalysts; and therapeutic drugs.350-353  For data storage, the number of independent 
monomers establishes the n-ary code, with reports of binary, ternary, and quaternary 
systems.354  In one example, collision-induced dissociation (CID), negative-mode 
MS/MS analysis interpreted a binary code of hydrogen vs methyl-substituted 
oligocarbamates, with an octamer serving as a byte (Figure 2.04).355  With CID, 
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fragmentation occurs only at the backbone O-alkyl carbonyl carbon bond, and the ready 
ionization of the α-terminus (carboxylic acid) provides facile negative-mode detection.  
Somewhat akin to random termination in Sanger sequencing (described later in this 
document), the ionization spectrum provides m/z ratios for fragments starting at the α-
terminus up to the point of cleavage, with similar probability of fragmentation at any of 
the linkages.  Subtraction of the largest (unfragmented) mass from the next largest 
therefore yields the molecular mass of the ω-terminal mer (terminus opposite to the 
carboxylic acid), and so on moving from the largest ω-terminal mass towards the smallest 
α-terminal fragment.  For longer oligomers, the ionizing yield decreased, but inclusion of 
a second carboxylic acid, at the ω-terminus, restored the clear detection of each fragment, 
although it added the signal set of the previously neutral but now negatively charged 
complementary fragments.356  Although the simultaneous α-to-ω fragmentation pattern 
and ω-to-α complementary fragmentation pattern provide a robust doubly confirmed 
molecular mass for each mer, the ionization spectrum doubles in number of peaks.  For 
longer oligomers, the spectrum could prove prohibitively complicated.  Moving to higher 
number systems (from binary to n-ary) also complicates the spectrum, to the extent that 
deciphering software was created.357  Not limited to language code, these SDPs may also 
function as barcodes; the same binary oligourethanes were embedded in plastic encasing 








Figure 2.04:  Tandem MS sequencing of binary-code oligourethanes 
 
Negative mode ion spectra of two different bytes of non-substituted (0) and methyl-substituted (1) 
binary-code oligocarbamates. Figure reproduced with permission from reference356. 
2.1.1.3.2 Antimicrobials 
With the increasing risk of antibiotic-resistant bacteria, SDPs provide access to 
intricately designed structures to exploit weaknesses in microbial armor.  The enriched 
anionic phosphate groups, relative to mammalian cells, at the bacterial cell membrane 
exterior electrostatically attract cationic residues, but the enriched hydrophobic lipid layer 
repels water-soluble moieties.  Fine-tuning of the cationic versus hydrophobic character 
of an SDP could simultaneously attract membrane disrupting or permeabilizing agents to 
selectively attack bacterial over mammalian cells.358-360  A set of triazine-based oligomers 
incorporated side chains of aliphatic amines or guanidines that are protonated at 
physiological pH and of hydrophobic phenyl residues.  A trimer of two aliphatic amine 
monomers and one phenyl monomer exhibited significant antimicrobrial activity.  The 
stepwise triazine synthesis obviates the need for protecting groups, so that assembly of 
the trimer is less expensive and more industrially amenable than that for peptides or 
peptidomimics.361  Furthermore, proteases ignore the triazine backbone, overcoming the 
susceptibility of antibacterial peptides to rapid degradation.   
 102 
Also resistant to proteases, oligothioetheramides, with aliphatic amine side chains 
but with varying degrees of hydrophobicity on the backbone – according to chain 
between the dithiols employed in the synthesis of the oligomer (Figure 2.05)– were toxic 
to clinically relevant pathogens with minimum inhibitory concentrations of 0.5 to 5 µM.  
This pathogen toxicity in up to 20% serum-supplemented cell medium did not extend to 
RBCs or HEK 293 cells.362  The appropriate combination of hydrophobicity and positive 
charge, as well as the conformation of the oligomers, factored into the disruption of the 
cell membrane.  The toxicity of a meta-substituted phenyl group on the backbone of an 
oligomer markedly changed versus that of a para-substituted, otherwise identical 
oligomer. 




A) Oligothioetheramide core structure with varying hydrophobicity on the backbone to fine tune the 
antiobiotic balance between positive charge and hydrophobicity.  B) The possible R groups 
incorporated into the oligomer backbone for a combinatorial library of possible antibiotics. 
2.1.1.3.3 Catalysts 
 Higher-order structure imparts the selectivity, enantioselectivity, and catalytic 
activity to enzymes.  Although a helix classifies as only secondary structure, it can 
certainly affect the approach trajectories between reagents.  Its emanating side chains 
near the binding site may reversibly react with a substrate to lower activation-energy 
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barriers.  In the case of oligoureas, the urea moiety in the backbone may also lower 
barriers through hydrogen-bonding to a substrate.   Enantiomerically pure urea hexamers 
formed from 1,2-diaminoethane monomers (Figure 2.06) – with a stereogenic methyl, 
isopropyl, or isobutyl side chain on the ethyl portion – catalyzed the enantioselective 
conjugate addition of malonates to nitroalkenes (>95% ee, complete conversion with 0.1 
mol % catalyst, 10 mol % achiral base).   The high enantiocontrol in 2.5-helix-forming 
pentamers and hexamers was lost with monomers and dimers and diminished in trimers 
and tetramers.363 
Figure 2.06:  Oligourea catalyst for the addition of malonates to nitroalkenes 
A.   
B.   
A) Structure of oligourea catalyst.  B) top:  hydrogen-bonding that foments secondary helical 
structure, bottom:  the helix that begets >95% ee for the reaction, and the molecular dipole of the 
helix.  Figure reproduced with permission from 363, https://pubs.acs.org/doi/10.1021/jacs.7b05802.  
Further permissions related to the material excerpted should be directed to the ACS. 
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2.1.1.4 Sequencing SDPs 
 At times, the sequence of a sequence-defined polymer may not be known.  To 
read SDP memory storage and barcoding, it must be decoded.  Promising SDP candidates 
selected from combinatorial libraries have a particular sequence out of all possible 
combinations of sequences equal to the number of available monomers to the nth power 
of an n-mer (for a straight-chain polymer).  To gain insight on their structure-activity 
relationships, their sequence must be elucidated.   
Crystal structures are the gold standard for reporting sequence and spatial 
organization of polymers.  The challenge lies in obtaining a crystal that can be analyzed 
for structure, and high-throughput screening systems have been developed solely for this 
purpose.364  Furthermore, the low sensitivity of the analysis requires large amounts of 
pure sample.  Lacking an acceptable crystal, the common approach is to sequence a 
polymer by clipping it to smaller oligomers or to monomers.  Due to the variation in 
oligomer connectivity, backbone, and side chains, few sequencing approaches exist, 
mostly directed towards peptides and oligonucleotides.  
2.1.1.4.1 Peptides 
 The amide bond connection in the peptide backbone is resistant to cleavage in 
physiological conditions without the aid of enzymes.  More rigorous conditions can lead 
to hydrolysis or transamidation, but with little selectivity for one connection over the 
others.  The end result is a mixture that informs on the identity and relative proportion of 
amino acids that constitute the peptide, without any information on the order in which 
they were connected. 
 2.1.1.4.1.1 Edman Sequencing 
 One method to determines the amino-acid ordering and constitution of peptides 
was reported by Edman in 1950.365-366  His iterative approach to peptide degradation 
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conserves order information.  An isothiocyanate, typically phenylisothiocyanate, reacts at 
the N-terminus to form the corresponding thiourea.  Under anhydrous acidic conditions 
(TFA, to minimize random hydrolysis of the backbone) that activate amide carbonyls to 
nucleophilic attack, the N-terminal thiourea adds to the most proximal carbonyl, 
displacing the remainder of the peptide with the formerly penultimate amino acid as the 
new N-terminus.  The resulting unstable thiazolinone cycle, with the sidechain 
corresponding to the truncated amino acid, has markedly different solubility and volatility 
from the remaining peptide.  Following its separation by extraction, the thiazolinone is 
converted to the stable cyclic thiohydantoin in aqueous acid for analysis, and then the 
cycle starts again (Scheme 2.02). 
Scheme 2.02:  Edman degradation of peptides 
 
 
Despite high yields, the iterative nature of the process without stringent purification dictates that n 
should be less than 50, with higher accuracy for 30 residues.  
Despite high yields, this sequencing works well for peptides up to fifty residues in 
length.  To sequence longer ones, including proteins, the peptides are first clipped to 
smaller pieces with endopeptidases (trypsin, pepsin) or by chemical reaction (cyanogen 
bromide) that cleave at certain amino acids.  The overlap of peptides clipped by one 
endopeptidase versus another and/or versus chemical cleavage establishes the whole 
protein sequence. 
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The Edman degradation has been automated and optimized, given the interest in 
sequencing not only proteins but also selected peptides from combinatorial libraries.  
Gas-phase and pulsed-liquid sequencing of a small protein, or of protein digests, 
individually adsorbed on a membrane have lowered required sample size to picomole 
levels.367  Either mass spectroscopy or HPLC, by comparing elution time to 
thiohydantoin standards of the twenty amino acids and their derivatives that appear in 
proteins and peptides, reveal the identity of the amino acid.  Optimization 
notwithstanding, one complete cycle takes about an hour.368  The process times multiply 
for peptides longer than fifty amino acids that require clipping with at least two 
endopeptidases and sequence overlap comparisons.  Furthermore, proteins with the N-
terminus derivatized, from post-translational modifications or from derivatizations in 
their preparation, purification, and isolation cannot undergo Edman degradation. 
 2.1.1.4.1.2 Mass Spectroscopy 
 MS analysis has in general supplanted the more cumbersome Edman sequencing, 
especially tandem MS sequencing.369-370  Typically, a single protein or even a mixture of 
proteins is treated with endopeptidases to obtain several fragments based on the 
propensity of the enzyme to break the peptide backbone at a certain amino acid 
recognition unit.  These then undergo MS/MS fragmentation (the re-fragmentation – by 
collision-induced dissociation, photodissociation, or ion-molecule reaction – of selected 
ions), which breaks both the peptide backbone and sidechains according to the weakness 
of the bonds.  Since the peptide backbone is quite simple, the three fragmentation 
possibilities are named according to the bond that is cleaved (Figure 2.07).  
Consequently, the ion spectrum, based solely on backbone fragmentation, for certain 
sequences can be predicted and assembled into a database of theoretical peptide 
fragmentation patterns.  Screening the results from tandem MS of a protein digest versus 
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the database, according to the means of digestion, produces hits for the corresponding 
peptide sequences.  If enough of these hits appear in a protein of knowns sequence, then 
with a certain confidence the digested peptides can be assigned to that protein.  Digests 
from impure mixtures may still reveal peptide sequences, since the resolution of the first 
ionization (from MS1) purifies the ion that is then subjected to further fragmentation (in 
MS2). 
Figure 2.07:  Fragmentation sites on the peptide backbone 
 
Fragmentation produces ai, bi, or ci masses in positive ionization mode (red) or xn-i, yn-i, or zn-i in 
negative ionization mode (blue). 
 Another approach, protein-ladder sequencing, captures peptide sequences, 
typically by matrix-assisted laser desorption ionization - time of flight detector (MALDI-
TOF), after incomplete N-to-C terminus degradation of the protein or its digests.371  
Several  Edman cycles of N-termini reacting with phenyl isothiocyanate poisoned with a 
small proportion of non-cyclizing phenyl isocyanate (Scheme 2.03) produce a population 
of fragments representing the sequence at each level of truncation.  The mild, matrix-
assisted ionization tends to yield ion patterns with minimal fragmentation, such that 
subjecting the Edman-treated sample to MALDI-TOF reveals a ladder pattern pertaining 
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to each intermediate in the sequencing (capped by a phenyl urea at the N-terminus), from 
the fully intact peptide to the product of the final Edman cycle.  Since each Edman cycle 
need not fully react, the reaction times for traditional Edman cycles can be shortened or 
temperatures reduced, leading to fewer side reactions that can complicate the MALDI-
TOF readout or remove post-translational modification residues.  In fact, a 
phosphorylated serine survived the multiple Edman cycles and ionization for its mass 
contribution to appear in the MALDI-TOF spectrum.  This ladder approach is also 
amenable to high-throughput processing, given that ladders for multiple samples may be 
created in their respective wells, to be then analyzed by MALDI-TOF. 
Scheme 2.03:  Isocyanate poisoning of Edman degradation 
 
The isocyanate, lacking the sulfur nucleophile, does not cyclize the terminal residue, blocking any 
further reaction and terminating the sequencing of the peptide. 






Illustration of sequencing by Edman ladders created by poisoning the standard Edman degradation 
reaction mixture with phenyl isocyanide. 
2.1.1.4.1.3 Next-generation Sequencing 
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Single-molecule sequencing enables the high-throughput simultaneous analysis of 
a matrix of samples.  Attaching protein digests by their C-terminus to a surface prepares 
the peptides for N-to-C sequencing approaches, such as Edman degradation.  Certain 
amino acid sidechains (e.g., lysine, tryptophan, cysteine, and aspartic/glutamic acid) can 
be color-coded by selectively labeling them with fluorophores.372  A peptide strand 
immobilized to a surface would then fluoresce at different wavelengths, according to the 
labeled amino acids that comprise it, with fluorescence intensity proportional to the 
number of labeled amino acids in the strand.  With each Edman cycle, detecting a loss of 
intensity of a certain fluorescence would mean that the cycle clipped the corresponding 
amino acid.  No change in intensity means that an amino acid that was not labeled was 
lost.  The strand could then be partially sequenced, with the location of fluorescently 
labeled amino acids known, but the identity of the non-fluorescent positions ambiguous.  
Nonetheless, elucidating the number and location even of only two amino acids on a 
strand of sixteen is sufficient to compare to protein databases and find matches to 75% of 
uniquely identifiable proteins.  Four labels would only increase the match finding.373 
 2.1.1.4.1.4 NMR 
 Although NMR generates not only sequence but also 3-D structure information 
for proteins,374-379 it is a complex process that does not apply to this research and will not 
be discussed. 
2.1.1.4.2 Oligonucleotides 
 DNA and RNA sequencing take advantage of the highly efficient protease 
replication of strands.  Whereas peptides are degraded when sequencing, oligonucleotide 
sequencing tracks the order of building the complementary strands.  Traditional methods 
require PCR amplification of the oligonucleotides, but next-generation methods multiplex 
single strands. 
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 2.1.1.4.2.1 Sanger Sequencing 
 Similar to ladder sequencing (Figure 2.08), this method purposefully randomly 
disrupts the replication of the full strands being sequenced, such that the various aborted 
replications comprise every intermediate in the full replication.380  A portion, typically 
1%, of each of four nucleotide triphosphate base types, has the ribose or deoxyribose 3´-
OH residue removed.  Polymerase catalyzes the phosphoesterification, with loss of 
pyrophosphate, of this 3´-OH to the 5´-triphosphate of the next nucleotide.  Without the 
3´-OH, polymerase cannot continue building the strand.  Consequently, stochastic 
incorporation of this “stop” nucleotide results in termination of synthesis at each base-
pairing of the replication.  Labeling the “stop” nucleotides prior to the replication with 
fluorescent labels, a different color for each base type, communicates the base identity of 
the last nucleotide in each fragment.  The mixture of full strand and its incomplete 
fragments is then separated by capillary array electrophoresis, and a well-resolved gel 
returns a color-coded complementary sequence, with the fastest-eluting band color 
corresponding to the base at the 3´ terminus and the least-moving one to the base at the 5´ 











Figure 2.09:  Sanger sequencing 
 
A polymerase builds a DNA strand complementary to the one being sequenced.  The cocktail of 
nucleotides is poisoned with some dideoxyribonucleotides (ddC/A/T/G) that block the next 
connection and thus terminate the strand.  Distinct fluorescent labeling of each ddBase means the 
fluorescence color of an eluting band (after capillary gel electrophoresis) reports the terminal 
nucleotide for that length of strand.  Smaller strands elute through the gel sieve first.  The sequence 
of elution corresponds to the 5´ to 3´ complementary strand. 
 Due to the increasing difficulty in resolving an incremented base with 
oligonucleotide chains of increasing length, the Sanger method is limited to 900 base 
pairs or less.  Like peptides, oligonucleotides can be fragmented by restriction 
endonucleases to overcome this limit.381  In 2003, the first human genome in the Human 
Genome Project was sequenced by the Sanger method over thirteen years and at $2.7 
billion cost.382 
2.1.1.4.2.2 Next-generation Sequencing (NGS) 
With NGS, genomes can be sequenced in a day and at much lower cost - $1000 in 
2016.383  Length limits vary from 300 to 20,000 base pairs, depending on the sequencing 
approach.  Most methods simultaneously analyze by CCD camera an array of single 
oligonucleotide strands, often overlapping fragments produced by different restriction 
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endonucleases.  Various approaches exist; most share in common the detection of a base 
complementary to the template being added to the strand by polymerase.380, 382  For 
example, the pyrophosphate released by polymerase coupling of the 3´ OH to the 5´ 
triphosphate is converted to ATP by ATP sulfurylase, with luciferase producing a 
chemiluminescent signal from ATP and luciferin.  Addition of the appropriate 
complementary base makes that location on the array light up.  Another approach 
attaches a polymerase at the bottom of each well, where it engages the template sequence, 
immersed in a solution of the four distinctly colored fluorescently labeled nucleotide 
bases.  Detection is accomplished through total internal reflection fluorescence (TIRF) of 
the bottom of the well; only fluorophores within the detection volume at the polymerase 
are detected. The fluorescence color of base pairs appropriated for ligation to the 
complementary strand registers until polymerase cleaves the fluorophore label in the 
process of ligation, and the fluorophore diffuses out of the TIRF detection range.  A 
recording of the signals from the array over time therefore captures the color sequence of 
each template as the polymerase replicates it.  20,000 base-pair lengths have been 
sequenced in this manner in less than a day. 
2.1.1.4.3 Non-natural Polymers 
The broad interest in the narrow fields of peptides and oligonucleotides has 
produced the increasingly efficient approaches to sequencing. Very few specialized 
sequencing approaches apply to the wide field of non-natural polymers.  Tandem MS is 
indiscriminate in bond-breaking, so it can be applied to all polymers.  In fact, the trends 
in backbone cleavage of peptoids were compared to those for peptides.384  Depending on 
the polymer and the MS/MS settings, the mass spectrum can range from prohibitively 
complicated to delightfully simple.  The oligocarbamates for binary data storage 
described in the applications section trended towards the latter, as do other storage 
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oligomers based on alkoxyamine amides.355, 385  For polymers that provide complicated 
fragmentation patterns, such as phosphodiesters, a re-design incorporating a much weaker 
bond, i.e. an aminoxy bond to a tertiary carbon, than those that provoked the complex 
patterns, with accordingly milder ionization methods, returns a much simpler 
fragmentation pattern.386   
Several groups have written software pertinent to their non-natural polymer 
backbones to quickly interpret tandem MS fragmentation patterns.  Oligomer Soup 
Sequencing (OLIGOSS) software generalizes the software and input requirements to all 
oligomer types, thus promoted as “a universal sequencing system for unknown 
oligomers”.387 
Last of all, in 2016 an Edman-like sequencing for peptoids was reported, 
involving DIC coupling of the N-terminus to bromoacetic acid to form the N-peptoido 
bromoacetamide (Scheme 2.04).388  Addition of silver perchlorate traps as insoluble 
silver salt the bromide expelled by intramolecular cyclization from attack by the proximal 
amide to form an oxazolinium intermediate.  Hydrolysis of this intermediate provides the 
N-sidechain-substituted morpholine-dione and releases the new N-terminus of the 
sequenced peptoid.  The sequencing occurred at room temperature in much milder 
conditions than those for Edman sequencing.  Although the yields of 70-85% per 
sequencing step fell short of Edman yields, they are amenable to molecular weight 










After amidation of the N-terminus with bromoacetic acid, addition of silver ion induces cyclization 
by removing bromide ion from the reaction.  Hydrolysis upon workup produces the sequenced 
monomer and returns an amine terminus for the next cycle. 
2.1.2 Self-immolation of polymers 
Polymer self-immolation is the reverse of polymer synthesis.  Self-immolative 
polymers (SIPs) are designed to enable the sequential degradation of the polymer under 
promoting reaction conditions and, at times, after one reaction event’s triggering the 
response.  The triggered release of monomers and the handle starting point from which 
the polymer was synthesized has found use in drug-delivery, sensing, and photo-resist 
materials.  If each monomer has an output (i.e., fluorescence turn-on or small-molecule 
drug), the event triggering the self-immolation gets amplified proportional to the 
monomers present in the polymer. 
Carbonate or carbamate junctions employed for facile ligation of monomers in 
polymer synthesis function optimally for sequential degradation.  If the release of the 
triggering molecule and monomers produces a carbonic or carbamic acid, the acid readily 
decarboxylates, with the release of CO2 as a driving force for the degradation.  For 
example, para or ortho-substituted aminobenzyl alcohol moieties convert to an 
azaquinone methide intermediate if the alcohol is transformed to a good leaving group, 
possibly via a carbonic or carbamic ester.  The ensuing carbonic or carbamic acid 
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decarboxylates, yielding another aminobenzyl ester, and the 1,6 elimination-based chain 
degradation propagates.  Disubstitution of an aniline at both para and ortho positions 
enables both the continuation of the degradation cascade (1,6 elimination) and the release 
of a side chain (1,4 elimination) to fulfill its intended application (Scheme 2.05).389-390  
Many variations of the carbonic or carbamic ester eliminations/decarboxylations self-
immolation mechanism exist.391 




A single trigger provokes a series of 1,6 and 1,4 elimination cascades through which the polymer self-
immolates while delivering amplified (proportional to the repeating units of the polymer) Response 
1’s and a Response 2. 
A second approach involves triggering a cyclization degradation cascade.  Again, 
carbamate and carbonate (and their thio derivatives)-linked polymers enable these 
cyclizations by amines, alcohols, and thiols, released by a trigger.  In one case, a released 
thiol terminus on a dimethylethylene diamine and 2-mercaptoethanol -ligated polymer 
cyclizes on the proximal carbamate to form the 2-oxathiolone and release the secondary 
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amine.392  This amine cyclizes on the proximal thiocarbamate to produce the N,N´-
dimethylimidazolidinone and releases the thiol for subsequent cyclization (Scheme 2.06).  
In this case, the cascade consists of two cyclization events per iteration. 





The triggering mechanism is designed according to the application of the SIP. 
Frequently, a triggering residue at the growth terminus of the polymer incapacitates the 
degradation cascade initiator (the aniline or the thiol in the examples above).  For sensing 
applications, the analyte provokes a change in the trigger that releases the initiator.  For 
drug-delivery, it can be the redox level of the cell or an over-expressed enzyme; for 
lithography, a photo-active residue.  When deprotonation (pH) is the activating condition, 
the acidic hydrogen is the trigger. 
In iteratively degrading the polymer, self-immolation does sequence it.  Like 
movie film, the sequencing cascade typically proceeds too quickly to capture the 
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individual frames – the product of each iteration, leaving a soup of truncated monomers 
with no order information.   
2.2 AIMS 
Tandem MS is the preferred sequencing method for non-natural SDPs, even more 
with the availability of universal fragment-predicting / database software.  Not all non-
natural SDPs produce sufficiently clean spectra to easily interpret sequence, even after 
adjusting MS ionization parameters.  For combinatorial-library applications and 
structure-activity relationship determination, correct sequences ensure better and faster 
results.  We therefore purposed to find an SDP format amenable to Edman-like 
sequencing.  If successful, it would introduce the idea of designing SDPs with their 
sequencing in mind for applications such as data storage or combinatorial libraries. 
 We chose carbamate polymers for their ease of synthesis, peptide-like hydrogen-
bonding capabilities conducive to secondary structures, and resistance to degradation by 
proteases.  Our monomers would be 2-aminoethyl alcohols, with sidechain substitution 
possible at the amine, at either carbon, or any combinations of these options (Figure 
2.10), including cyclic sidechains that incorporate the backbone.  We would synthesize 
them in N-to-O fashion by chemoselective reaction with carbonyl diimidazole (CDI), 
obviating the need for protecting groups, as the amine is more reactive than the alcohol. 
Figure 2.10:  Possible substitution on proposed oligocarbamate backbone 
 
Three possible substitutions per monomer of the polymer.  Substitution at the carbons generate 
stereocenters. 
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The sequencing approach would involve derivatizing the O-terminus to provoke 
cyclization on the proximal carbamate junction, clipping the terminal mer and releasing a 
new O-terminus.  Apart from Edman degradation of peptoids, at the time we had no 
knowledge of other Edman-like sequencing of non-natural SDPs. 
2.3 RESULTS AND DISCUSSION 
As our model for this research was the sequencing of peptides, we envisioned that 
we would eventually build libraries of our carbamate oligomers once we discovered a 
cyclization-based sequencing approach.  Many peptide libraries have been successfully 
assembled from solid phase synthesis, and so we anticipated SPS would serve for our 
libraries.  The Rink amide resin appeared to be a logical choice among the resins; the 
resin linker amine could react with the acylating agent CDI as an anchor point to the start 
of propagation of the β-amino alcohols, the reaction with 2-aminoethanol derivatives 
producing a urea less susceptible to degradation than a carbamate.  Acid cleavage of the 
oligomer from the resin would conserve the urea at the N-terminus. 
Having an idea of the resin to use prompted us to select a synthetic handle 
equivalent to the resin-linker for solution-phase chemistry studies of oligomer building 
and stepwise degradation.  In making the functional handle similar to the resin linker, we 
could screen against any reaction conditions that degrade the handle, making the eventual 
transition to SPS more robust.   Although the similarity score on the first choice of 3,5-
dimethoxyaniline certainly would not be very high, we chose it for its chromophoricity at 
244 nm and for its simplicity in the 1H NMR spectrum.  Due to its unexpected reactivity, 
we would eventually settle on the more relevant 2,4-dimethoxybenzyl amine. 
Our first approach to impart diversity on each monomer consisted of varying the 
substitution on the amine.  Rather than creating chiral centers by derivatizing the alpha or 
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beta carbons on the beta-amino alcohols, N-substitution would provide the simplest 
assembly of the oligomers.  Secondary β-amino alcohols are also conveniently accessible 
by ring-opening reaction of a primary amine with epoxide. 
With 3,5-dimethoxyaniline as the handle, we first studied the formation of the 
oligomer.  Aniline displacement of one imidazole in CDI occurred smoothly at room 
temperature in dichloromethane, without need for a base such as triethylamine, as the 
imidazole mops up the anilinium proton.  The resulting mixed urea is stable to LCMS 
conditions [MeOH (or MeCN) / H2O + 1% formic acid], as it showed quantitative 
conversion of the aniline to the urea.  LCMS monitoring of the attack on CDI in general 
revealed complete reaction within two to four hours.  Simply adding the β-aminoalcohol, 
in this case N-benzyl-2-aminoethanol, to the reaction yielded the monomer; again, the 
displaced imidazole served as a proton sponge (Scheme 2.07A).  Upon completion of 
reaction, the two equivalents of displaced imidazole were washed out with 1M HCl, so as 
to not interfere with column chromatography of the newly created urea.  (The imidazole 
tended to streak down the column.) 
Monomer in hand, we sought to extend it to a dimer, again with N-benzyl-2-
aminoethanol.  Out of curiosity we tried to purify the mixture after the first displacement 
of an imidazole from CDI by the monomer alcohol.  The reaction was loaded directly 
onto an SiO2 column, and the product degraded as it was eluted.  The imidazole 
carbamate is unstable towards the large excess of silanol groups.  A repeat of the reaction 
cleanly produced the mono-displaced carbamate by LCMS, but the second imidazole 
displacement with N-benzyl-2-aminoethanol proceeded slowly and in poor yield.  The 
LCMS (280 nm chromatogram) showed only 8% conversion by LC after stirring at room 
temperature overnight.  Suspecting that the benzyl group sterically decreases the 
nucleophilicity of the amine, we reacted the monomer with CDI, then unsubstituted 2-
 120 
aminoethanol, with much better yields.  Repeating the sequence produced the trimer with 
the first unit N-benzylated and with the remaining two unsubstituted (Scheme 2.07B). 
Scheme 2.07:  CDI-mediated synthesis of trimer carbamate from 3,5-dimethoxyaniline 
handle 
A.  
     
 
B  
      
Although not the most ostentatious of oligomers, we desired a speedy synthesis of 
a trimer to be able to study its stepwise degradation via transformation of the O-terminus 
into a nucleophilic cyclizing agent.  Sequencing of a dimer would produce the urea-based 
monomer, which we suspected would be resistant to cyclization.  With only a dimer, we 
would not be able to establish whether the sequencing step would clip the terminal 
monomer only, or if it also would degrade the remaining oligomer.   
To convert the alcohol into a better nucleophile, we envisioned esterifying it to an 
α-cyanoester, which deprotonates readily (pKa 13.1 in DMSO for ethyl cyanoacetate).  
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Baldwin’s rules favor the 7-exo-trig cyclization from attack of the enolate on the 
carbonate, which we hoped would form the 7-membered heterocyle product of 
sequencing.  With cyanoacetyl chloride we converted the alcohol into the α-cyanoester.  
The cyclization was attempted with Hünig’s base, DBU, and even NaH at room 
temperature and with heating to 70 °C, but neither the heterocycle nor the dimer was 
observed by LCMS, only the oligomer and some hydrolysis of the ester (in the reactions 
with DBU), most likely due to moisture in the reagent bottle (Scheme 2.08).  NaH 
produced a messy reaction with various products from degradation of the oligomer whose 
identity were not established.  We concluded that cyclization requires a harder 
nucleophile than the cyanoester enolate. 
Scheme 2.08:  Failed attempt at cyclization of terminal monomer 
 
    
     
The trimer was esterified with cyanoacetyl chloride, but the enolate could not effect cyclization. 
 Deprotonation of the O-terminus would produce the hard nucleophile alkoxide.  
The resulting tetrahedral intermediate from alkoxide attack could expel the remainder of 
the oligomer, clipping the terminal monomer to a cyclic oxazolidinone – thereby 
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sequencing the oligomer as we intended.  However, the basic conditions necessary for the 
terminal alkoxide to expel the truncated oligomer alkoxide would enable the latter to 
attack its proximal carbamate.   Given enough time, the oligomer would self-immolate 
completely to the urea N-terminus, destroying any sequence information. 
 Converting the O-terminus to a primary amine creates a nucleophile that does not 
require base.  Amine attack on the most proximal carbamate generates a tetrahedral 
intermediate from which the truncated oligomer O-terminus is the best leaving group.    
The amine modification should enable sequencing under neutral conditions, avoiding the 
base-promoted alkoxide self-immolation of the oligomer. 
 We followed the traditional route of alcohol transformation to an amine (Scheme 
2.09A).  The trimer was tosylated and displaced by azide; heterogeneous catalytic 
reduction yielded the amine.  The trimer amine was heated at 90 °C in either DMF or 
water, but LCMS showed no sequencing to the cyclic urea, even after overnight heating.  
Instead, the primary product was the adduct to a 3,5-dimethoxyaniline acyl species 
(Scheme 2.09B).  This reaction blocks the amine from sequencing. 
 Out of curiosity, we also investigated the same reaction with potassium carbonate 
in DMSO.  With strong bases, carbamates typically decompose via carbamate N-H 
deprotonation to the isocyanate, expelling the alkoxide.  In the case of β-aminoalcohol-
derived carbamates, deprotonation may also occur on the carbon backbone, triggering 
elimination of the carbamate leaving group, as LCMS of the reaction reported 90% 













A) Conversion of terminal alcohol to tosyl ester, then azide, and finally amine.  B) Cyclization 
attempts with the amine failed; instead, intermolecular attack on the aryl urea gave the incorrect 
product.  C)  Heating the amine with carbonate base degraded the oligomer, possibly by β-
elimination at the monomer. 
 Finally, we followed Edman’s example and reacted the trimer amine with phenyl 
and propyl isothiocyanate, hoping the thiourea would perform the sequencing cyclization 
in TFA at 50 °C without attacking the dimethoxyaniline mixed urea, as we observed for 
the trimer amine cyclization.  The mixed urea was left intact, but no Edman-like 
sequencing occurred on the proximal carbamate either (Scheme 2.10).  The N-phenyl and 
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N-propyl thioureas did not react except to oxidize or cyclize in a manner that does not  
cleave the backbone (-2H peak by LCMS). 
Scheme 2.10:  Failed Edman degradation of the amino-derivatized trimer  
 
 
The amine terminus reacted with the isothiocyanate to form the thiourea, which did not cyclize to 
sequence. 
 The intermolecular attack by the terminal amine on the mixed urea was troubling.  
Taking another look at the Rink amide resin showed the linker incorporating a dibenzylic 
amine, not an aniline.  Conceivably the aniline urea is sufficiently acidic that the 
attempted cyclization conditions deprotonated it, provoking formation of 3,5-
dimethoxyphenylisocyanate with expulsion of the remainder of the oligomer.  Another 















Mixed urea degradation to the aryl isocyanate and the truncated oligomer, followed by isocyanate 
reaction with another trimer-NH2 would form the product with a mass equivalent to that observed 
by LCMS. 
2,4-dimethoxybenzylamine was therefore chosen as the more similar handle, and 
the homodimer of 2-aminoethanol was quickly synthesized (Scheme 2.12) to derivatize at 
the terminal alcohol and evaluate sequencing strategies, with disregard to the prudence in 
synthesizing a trimer, not a dimer, discussed above. 
 Still conjecturing that a terminal amine should cyclize on the nearest carbamate, 
especially with the competing aryl urea eliminated, we converted the homodimer alcohol 
to an amine and studied the cyclization reaction (Scheme 2.12).  The polarity of the 
product was not amenable to silica, so we purified it by C18 prep LC.  Pure fractions 
containing amine as the as the formate salt (from the 0.1% formic acid additive in the 
HPLC solvents) were lyophilized.  The cyclization was attempted in polar aprotic DMF 
with aprotic Hünig’s base, as well as in a protic 1:1 MeOH/ water solution with 
phosphate base.  Base was added to deprotonate the dimer-ammonium salt.  The 
protic/phosphate base approach cyclized much more effectively than the aprotic/ Hunig’s 
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base.  Nonetheless, the reaction required stirring at 80 °C for 40 hours to reach 
completion.  Signals for both the monomer and the cyclic urea products appeared in the 
LCMS mass chromatogram, well resolved from the homodimer starting material.  The 
reaction was clean, with byproducts amounting to only 2% of the chromatogram at 280 
nm. (The absorbance maximum of the peaks was 276 nm.) 
 To shorten the long reaction times for the sequencing cycle, we turned to 
microwave heating.  Our first trial with MeOH/water/phosphate at 100 °C (250 W) for 15 
minutes consumed ~50% of the homodimer to the monomer and cyclic urea.  Happily, 
complete conversion to the two desired products occurred in 45 minutes. 





A non-substituted homodimer was synthesized using a 2,4-dimethoxybenzylamine handle to produce 
an aliphatic mixed urea.  The OH terminus was converted to an amine, followed by successful 
cyclization to the monomer and the imidazolidinone. 
 Although the transformation of the oligomer alcohol terminus to a primary amine 
was cumbersome, we were heartened by the cyclization success.  The 2-aminoethanol 
homodimer had served to establish a derivatization of the alcohol and the reaction 
conditions to promote formation of the heterocycle and monomer.  Limited to a dimer, it 
did not inform us whether the sequencing cyclization would clip only the terminal 
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monomer, expelling the remaining oligomer with an alcohol terminus as desired.  Neither 
did the homodimer, composed of the simplest β-aminoalcohol, reveal side-chain 
compatibility with the derivatization and cyclization reactions.  At least a trimer, if not 
longer, comprising more complex and diverse monomers, was necessary to better vet the 
promising yet nascent design. 
With the dimethoxyaniline handle, N-benzyl-2-aminoethanol successfully 
produced the monomer, but propagation to the homodimer suffered from low yields in a 
lethargic reaction.  Suspecting that steric or electron-withdrawing substituents would 
adversely lessen the nucleophilicity of the secondary amines, possibly enough to reduce 
the chemoselectivity of amine over alcohol for the attack on CDI, we abandoned this 
category of monomers.  Monosubstituting sidechains would then be located either alpha 
to the amine or to the alcohol, their point of connectivity to the backbone a stereocenter.  
Since steric or elecetron-withdrawing substituents could still influence the nucleophilicity 
of the adjacent amine or alcohol, it seemed prudent to connect the side chains alpha to the 
more nucleophilic amine rather than further dampen the alcohol’s nucleophilicity.  In 
addition, reduction of stereoisomerically pure amino acids makes this type of monomer 
readily accessible, with some reduced amino acids commercially available.  These 
include L-phenylalaninol (F), L-alaninol (A), L-leucinol (L), L-methioninol (M), and L-
tryptophanol (W). 
The reduced amino acids were nicely compatible with CDI-based stepwise 
oligomer synthesis (Scheme 2.13).  With carbon-based side chains, the FAL trimer 
synthesis was rudimentary.   Care was needed to extend the oligomer to FALM; the 
methioninol sulfide tends to oxidize, but reacting under argon atmosphere and 
minimizing exposure to air curtailed sulfoxide formation.  The pentamer FALMW was 
readily obtained with these precautions. 
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Scheme 2.13:  Synthesis of FAL-OH trimer and FALMW-OH pentamer 
 
 
We subjected the FAL trimer to our sequencing procedure.  The terminal alcohol 
was converted to an amine, this time by Mitsunobu reaction with phthalimide, followed 
by aminolysis with methylamine.  FAL-NH2 was purified by reverse-phase 
chromatography as the ammonium salt.  To our dismay, the 1-hour microwave reaction in 
MeOH/H2O/PO4
3-/100 °C conditions degraded the oligomer down to the F-OH monomer, 
with both leucinol-based imidazolidinone and alaninol-based oxazolidinone present 
(Scheme 2.14).  Subjecting the FAL-NH3
+ to the same degradation conditions without 
base resulted in no reaction.  Reductive aminations are typically conducted at pH 4, a 
compromise between activating the carbonyl at low pH and maintaining a neutral amine 
at higher pH.  FAL-NH3
+ was dissolved in MeOH/ H2O with NaOAc, and the pH was 








Scheme 2.14:  Synthesis of FAL-NH2 and its full self-immolation under sequencing 
conditions 
A.  
       
 
 
B.   
     
A) Conversion of FAL-OH to FAL-NH2  B) Unexpected degradation of FAL-NH3+ trimer to F-OH 
monomer and A and L-based oxazolidinones 
As a control experiment, we also subjected the FAL-OH trimer directly to the 
MeOH/water/phosphate microwave cyclization conditions.  Surprisingly, even without 
the amine terminus, this reaction still produced only F-OH monomer and the A and L-
based oxazolidinones.  We repeated the reaction with FALMW-OH, and even the 
pentamer degraded completely to the F-OH monomer (Scheme 2.15A).  Flabbergasted, 
we applied the same conditions to FAL-OH, except without base.  For the first time, we 
were able to see the FA-OH dimer expected from a stepwise sequencing, although the F-
OH was also present (Scheme 2.15B).  After one hour reaction, 88% FAL-OH remained, 
with 10% dimer and 2% monomer (percentage of chromatogram peak area divided by 
total peak area at 280 nm, near the absorbance maximum of 276 nm for the oligomers, 
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presumably due to the 2,4-dimethoxybenzylamine handle).  Five hours produced 46% 
dimer and 21% monomer.  We were observing sequencing by sluggish self-immolation! 
Scheme 2.15:  Self-immolation of FALMW-OH under sequencing conditions 
A.       
      
 
B.   
  
A) FALMW-OH also degrades completely to F-OH and the corresponding oxazolidinones with PO43- 
base at 100 °C. B) Without base, FAL-OH degrades partially, and thereby sequences, to FA-OH and 
F-OH and the corresponding oxazolidinones. 
We had abandoned conventional heating in favor of microwave to shorten 
reaction times.  At 100 °C and without base, the FAL-OH degradation had not completed 
in five hours.  With base at the same temperature, it fully degraded in one hour.  We 
applied a compromise of 50 °C with PO43- base for one hour, and it yielded the three 
species FAL/FA/F in a proportion of 32/47/21 percent.  That every species was well 
represented was promising, and so we applied the same conditions to FALMW-OH.  
Possibly due to lower solubility, the reaction proceeded more slowly for the pentamer, 
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reaching only 62/25/8/4/1 percent of FALMW/FALM/FAL/FA/F.  Further optimization 
of temperature and reaction time yielded 90 °C for one hour to nearly degrade the 
pentamer fully to the monomer.  In sampling the reaction at every six minutes, we 
observed the waxing and then waning of the intermediates as the self-immolization 
progressed (Figure 2.11). 
Figure 2.11:  Waterfall plot of the self-immolation of FALMW-OH pentamer.   
 
LCMS chromatograms (280 nm) showing the time-dependent, stepwise self-immolation of FALMW-
OH.  The table lists chromatogram peak integrations as percentage of the total area per run.  
Compounds were assigned to peaks according to their m/z. 
Additional experiments revealed more details about the mechanism of the 
degradation.  Polycarbamates tend to degrade via proton transfer from the carbamate 
amine that produces an isocyanide and expels the alkoxide or by α or β elimination.393  
These pathways would not provide sequence information, so we sought to define their 
contribution to the degradation.  A FAG-OMe trimer was synthesized from FA-OH with 
CDI and 2-methoxyethylamine.  It did not degrade in the sequencing mixture after one 
hour reaction at 70 °C, but 7% F-OH monomer did appear after one hour at 90 °C 
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(Scheme 2.16).  The low conversion to monomer points to an alternative degradation 
pathway that proceeds more slowly than the sequencing cyclization pathway. 
Scheme 2.16:  Degradation conditions applied to control trimer FAG-OMe 
 
The methoxy-capped trimer degraded minimally to F under conditions that fully converted FAL-OH 
to F, pointing to the necessity of the OH terminus for self-immolation by cyclization. 
Monohydrogen potassium phosphate has a pKa of 12.3 in water, whereas carbonic 
acid’s is 6.4.  Degradation of FAL-OH proceeded much more slowly without base, 
leading us to suspect that the alcohol must be deprotonated to attack the proximal 
carbamate efficiently.  We again submitted FAL-OH to reaction at 100 °C, but this time 
with KHCO3 rather than K3PO4.  Within 15 minutes, the FAL/FA/F percentages were 
23/48/28, much faster than without base.  FAL-OH degradation at 100 °C with K3PO4 
yields 97% F-OH in only three minutes.  The degradation is a pH-dependent process. 
We propose the following mechanism (Scheme 2.17).  Base deprotonates the 
terminal alcohol of an n-mer oligomer to the alkoxide, which is sufficiently reactive to 
cyclize on the proximal carbamate via a tetrahedral intermediate.  Cyclization expels the 
alkoxide of the remainder of the oligomer (n-1 mer), which deprotonates the conjugate 
acid of the base, as proton transfers occur at much faster rates than attacks on carbamate 
carbons.  The free base once again deprotonates the n-1 mer terminal alcohol, and 
cyclization releases the n-2 mer alkoxide that then gets protonated.  The cycle continues 
until the monomer alkoxide, which cannot efficiently cyclize on the urea connection to 









R is a non-reactive handle/linker. 
Resolution of intermediates’ peaks by HPLC, coupled with low-resolution mass 
spectroscopy of the peaks, enables determination of the sequence.  The peak with the 
lowest molecular mass corresponds to the handle-derivatized monomer.  Subtracting this 
mass from the second lowest mass reveals the mass of the second monomer, and so on 
until the parent peak is reached.  This ladder sequencing process is quite analogous to 
sequencing by tandem MS.  LC separation resembles mass-ion separation by MS1, and 
the self-immolation reaction parallels backbone fragmentation by MS2. 
2.3 CONCLUSIONS AND FUTURE WORK   
We started this research looking for an Edman-type sequencing of N-substituted 
carbamate oligomers, wherein the terminal alcohol would be transformed into a 
nucleophilic residue that could cyclize on the proximal carbamate and sequence the 
terminal mer.  In the end we found that self-immolation of carbamates substituted alpha 
to the carbamate nitrogen could be kinetically slowed enough by controlling temperature 
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and pH to observe the sequence-dependent waxing and waning of intermediates by 
LCMS.  If the identity of all the monomers that could be incorporated in the oligomer are 
known (as they would in a combinatorial library or in chemical encoding), then the 
resolution of intermediates enables facile calculation of sequence by subtracting an 
intermediate’s m/z value from the next largest intermediate’s m/z values.  If the 
ionization can be adjusted to ionize only parent peaks, the chromatography would not be 
necessary, as the self- immolation produces ladder masses. 
Further work in our group has synthesized a carbamate heptamer by SPS, labeled 
the N-terminus with the NBD fluorophore, and sequenced it by slow immolation (Figure 
2.12).  This study serves as proof-of-concept for building combinatorial libraries and 
sequencing hits. 
Figure 2.12:  Ladder MS interpretation of self-immolated heptamer 
 
Subtracting the second-highest m/z from the highest gives the m/z of the terminal mer.  Subtracting 
the third-highest from the second-highest gives the m/z of the penultimate mer, and so on.  Reprinted 
with permission from 205. Copyright 2020 American Chemical Society 
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The self-immolation has already been optimized with respect to base, solvent, and 
heat by another research group.394  They found that sodium hydroxide in ethanol/water 
mixtures induces slow immolation at room temperature. 
If Edman-type sequencing were still desired, the next step would be to look for 
conditions that would force the terminal amine to cyclize without further base-promoted, 
uncontrolled cyclizations that degrade the polymer.  An oxophilic Lewis acid might 
catalyze this conversion of a carbamate into an imidazolidinone.  In an avenue pursued 
but then abandoned, the terminal alcohol on the 3,5-dimethoxyaniline handle trimer was 
oxidized to the aldehyde with DMP.  Reaction with hydroxylamine produced the oxime 
that seemed to cyclize to release dimer, not monomer, by LCMS.  Also, Mitsunobu 
reaction with monoBoc hydrazine or N-Boc hydroxylamine would incorporate 
supernucleophiles that might cyclize more efficiently than the amine. 
The concept of slowing self-immolation to observable intermediates could be 
applied to other polymers.  Under forcing conditions or with the help of a catalyst, 
transamidation by the N-terminus of a peptide upon the amide residue two mers away 
would form a six-membered cyclic bisamide with sidechains corresponding to the 
ultimate and penultimate mers, freeing the N-terminus of the antepenultimate mer to 
undergo its own cyclization.  Under dilute conditions, the high effective molarity of an 
intramolecular reaction should dominate over intermolecular transamidations.  At certain 
intervals, the reaction would be sampled to determine the dimer rungs of the ladder. 
We sought to present to the scientific community the idea of designing a polymer 
with its sequencing in mind.  Instead, our oligomers sequenced themselves by kinetically 
lethargic self-immolation.  In so doing, they may have presented to us a sequencing 
approach with ties to Edman ladders and Sanger sequencing.  Future designs may involve 
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finding how a polymer degrades, if a self-immolative pathway is available, and how to 





APPENDIX A:  GENERAL INFORMATION 
Chemicals and reagents were purchased from commercial sources available on 
UT Market.  TLCs, prep TLCs, and SiO2 were sourced from Sorbtech.  NMR spectra 
were acquired with 400 and 500 MHz instruments in the UT NMR facility.  Prep LC 
purification was performed on Shimadzu binary gradient instrument equipped with a 
diode array detector with a C18 21.5 mm x 125 mm column.  LCMS spectra were 
acquired by an Agilent 1200 Series HPLC / 6130 single quadrupole mass spectrometer. 
APPENDIX B: EXPERIMENTAL DETAILS AND SPECTRA FOR CHAPTER 1 COMPOUNDS 
8-bromo-2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinoline (3-bromojulolidine) 
 
2.18 mL (0.02 mol) 3-bromoaniline, 7.9 mL 1-bromo-3-chloropropane (0.04 mol, 4 eq), 
and 4 mL DMF were refluxed at 170°C under N2 for four days, by which point the 
reaction had solidified.  The solid was diluted in DCM and purified by SiO2 column 
chromatography, eluting with 2% EtOAc in hexanes to give 3.56 g (70.6% yield) 1H 
NMR (400 MHz, Chloroform-d) δ 6.93 – 6.82 (d, J = 8.1 Hz, 1H), 6.68 (d, J = 8.1 Hz, 
1H), 3.15 (dq, J = 14.4, 8.8, 7.1 Hz, 4H), 2.76 (dt, J = 23.2, 6.6 Hz, 4H), 2.13-1.95 (m, 








1.008 g (4 mmol) 3-bromojulolidine, 1.22 g (4.8 mmol, 1.2 eq) bis(pinacolato)diboron, 
and 147 mg (1.5 mmol, 3 eq) KOAc in 3 mL DMSO were sparged for 10 minutes with 
N2 to remove O2 from the system. 30 mg (0.04 mmol, 0.01 eq) PdCl2dppf were quickly 
added, and the system was sparged with N2 for another five minutes.  The mixture was 
heated under N2 balloon at 120 °C for 1 hr.  After cooling to RT, the reaction was diluted 
with EtOAc, and all solids were filtered off.  The organics were washed 2x with brine, 
dried over Na2SO4, filtered, and stripped of solvents under reduced pressure.  SiO2 
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column purification (1% EtOAc in hexanes) provided 681 mg (57% yield).  1H NMR 
(500 MHz, CDCl3) δ 6.94 (d, J = 7.4 Hz, 1H), 6.70 (d, J = 7.4 Hz, 1H), 3.03 (t, J = 5.7 
Hz, 2H), 3.01 (t, J = 5.6 Hz, 2 H), 2.96 (t, J = 6.6 Hz, 2H), 2.67 (t, J = 6.6 Hz, 2H), 1.92 – 
1.82 (m, 4H), 1.22 (s, 12H). 13C NMR (126 MHz, CDCl3) δ 143.12, 128.56, 126.34, 
125.18, 124.02, 83.14, 50.65, 50.17, 28.31, 27.39, 24.94, 22.42, 22.16.  HRMS (ESI +):  







2.1 g (10 mmol) 7-bromoquinoline, 1.26 g (20 mmol, 2 eq) NaCNBH3, and 330 mg (11 
mmol, 1.1 eq) paraformaldehyde in 50 mL AcOH were stirred at RT for 4 hrs.  The 
reaction was poured over ice, and the pH was adjusted to neutral with 7 g NaOH.  The 
aqueous mixture was thrice extracted with DCM, and the combined organics were 
washed with brine, dried over Na2SO4, filtered, and stripped of solvents under reduced 
pressure.  SiO2 column chromatography (3% EtOAc in hexanes) provided 1.7 g (75% 
yield).  1H NMR (500 MHz, CDCl3) δ 6.791 (dt, J = 7.8, 1.1 Hz, 1H), 6.700 (dd, J = 7.8, 
1.9 Hz, 1H), 6.676 (d, J = 1.9 Hz, 1H), 3.235 (t, J = 5.5 Hz, 2H), 2.876 (s, 3H), 2.698 (t, J 
= 6.8 Hz, 2H), 2.013 – 1.899 (m, 2H).  13C NMR (126 MHz, CDCl3) δ 147.81, 129.92, 
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121.59, 120.70, 118.55, 113.32, 50.96, 39.00, 27.47, 22.18.  HRMS (ESI+):  226.0226 







330 mg (1.46 mmol) N-methyl-7-bromo-1,2,3,4-tetrahydroquinoline, 408 mg (1.65 
mmol, 1.1 eq) bis(pinacolato)diboron, and 507 mg (5.16 mmol, 3.5 eq) KOAc in 5 mL 
DMSO were sparged for 15 minutes with N2 to remove O2 from the system. 32 mg (0.044 
mmol, 0.03 eq) PdCl2dppf were quickly added, and the system was sparged with N2 for 
another ten minutes.  The mixture was heated under N2 balloon at 120 °C for 2 hrs.  After 
cooling to RT, the reaction was diluted with EtOAc, and all solids were filtered off.  The 
organics were washed 2x with brine, dried over Na2SO4, filtered, and stripped of solvents 
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under reduced pressure.  SiO2 column purification (1% EtOAc in hexanes) provided 200 
mg (50% yield). 
1H NMR (500 MHz, Chloroform-d) δ 7.07 (dd, J = 7.3, 1.1 Hz, 1H), 7.03 (s, 1H), 6.96 
(d, J = 7.3 Hz, 1H), 3.20 (t, J = 5.7 Hz, 2H), 2.93 (s, 3H), 2.77 (t, J = 6.5 Hz, 2H), 2.00 – 
1.93 (m, 2H), 1.33 (s, 12H), 1.27 (d, J = 2.6 Hz, 9H), 1.24 (s, 4H).  13C NMR (126 MHz, 
CDCl3) δ 146.42, 128.46, 126.66, 123.20, 117.00, 83.57, 51.47, 39.38, 28.20, 24.93, 







1.1 g (5.0 mmol) 1,5-dinitronaphthalene was dispersed in a solution consisting of 1.86 g 
(7.11 mmol) ammonium chloride in 10 mL water plus 0.31 mL (4.6 mmol) saturated 
(28%) aqueous ammonia.  The mixture was heated to 70 °C, and 4.0 g (16.7 mmol, 3.3 
eq) were added in six portions over 1.5 hrs. to ensure the temperature remained at 70 °C.  
Red solid forms after addition of the second portion.  LCMS shows trace amounts of 
starting material and of over-reduction to the diamine.  The reaction was poured over ice, 





To 1 g 5-nitronaphthalen-1-amine (5.3 mmol) in 50 mL MeCN were added 35 mg SiO2, 
followed by 1 g (5.62 mmol, 1.06 eq) N-bromosuccinimide.  The reaction was stirred at 
RT for 7 hrs.  Solvents were removed under reduced pressure.  SiO2 column 
chromatography (2:1 hexanes/ethyl acetate) to remove dibromo and succinimide 
impurities provided 1.37 g (69% yield).  1H NMR (400 MHz, DMSO-d6) δ 8.635 (d, J = 
8.6 Hz, 1H), 8.212 (dd, J = 7.5, 0.9 Hz, 1H), 7.707 (d, J = 9.2 Hz, 1H), 7.643 – 7.558 (dd, 







186 mg (0.696 mmol) 2-bromo-5-nitronaphthalen-1-amine, 190 mg (0.696 mmol, 1 eq), 
and 340 mg cesium carbonate in 3 mL toluene were sparged with N2 for 10 min. to 
remove O2.  80 mg (0.0696 mmol, 0.1 eq) Pd(PPh3)4 were added quickly and the mixture 
was sparged with N2 for another 10 min before refluxing at 120 °C under N2 for 16 hrs.  
After cooling to RT, the reaction was diluted in EtOAc and washed with brine.  The 
organics were dried over Na2SO4, filtered, and stripped of solvents under reduced 
pressure.  SiO2 column purification (3:1 hexanes/EtOAc) provided 130 mg (56% yield).  
1H NMR (400 MHz, DMSO-d6) δ 8.598 (dt, J = 8.6 Hz, 1.0 Hz, 1H), 8.175 (dd, J = 7.6, 
1.0 Hz, 1H), 7.557 (dd, J = 8.6, 7.6 Hz, 1H), 7.537 (dd, J = 8.6 Hz, 0.9 Hz, 1H), 7.437 (d, 
J = 8.8 Hz, 1H), 7.022 (d, J = 7.4, 1.0 Hz,1H), 6.626 (dd, J = 7.3, 1.7 Hz, 1H), 6.610 (d, J 
= 1.7 Hz, 1H), 5.702 (s, 2H), 3.242 (t, J = 5.7 Hz, 2H), 2.856 (s, 3H), 2.752 (t, J = 6.4 Hz, 





130 mg of the nitro compound were dissolved in 15 mL MeOH (with heating), and 22 mg 
10% Pd/C were added after reaching RT.  The suspension was sparged with hydrogen for 
15 minutes and then stirred at RT overnight under H2 balloon.  Solids were filtered off, 









118 mg (0.389 mmol) diamine and 65 µL (0.467 mmol, 1.2 eq) in 5 mL DCM were 
cooled in an ice bath for 10 min.  28 µL AcCl were added dropwise via syringe over 20 
min.  The ice bath was removed, and the reaction stirred while warming to RT.  Residual 
diamine and diacetamide impurities in the crude mixture were removed by SiO2 column 
chromatography (2:1 hexanes/EtOAc) to give 80 mg (60% yield) mono acetamide 
product.  1H NMR (500 MHz, Methanol-d4) δ 7.916 (d, J = 8.5 Hz, 1H), 7.549 (d, J = 7.3 
Hz, 1H), 7.415 (d, J = 8.6 Hz, 1H), 7.413 (dd, J = 8.6, 7.1 Hz, 1H), 7.277 (d, J = 8.5 Hz, 
1H), 6.998 (d, J = 7.5 Hz, 1H), 6.662 (d, J = 1.6 Hz, 1H), 6.649 (dd, J = 7.5, 1.6 Hz, 1H), 
3.220 (t, J = 5.6 Hz, 2H), 2.853 (s, 3H), 2.775 (t, J = 6.5 Hz, 2H), 2.257 (s, 3H), 1.983 (p, 
J = 6.4 Hz, 2H).  1H NMR (400 MHz, DMSO-d6) δ 9.796 (s, 1H), 7.994 (d, J = 8.4 Hz, 
1H), 7.634 (d, J = 7.4 Hz, 1H), 7.398 (d, J = 8.3 Hz, 1H), 7.388 (t, J = 8.2 Hz, 1H), 7.234 
(d, J = 8.6 Hz, 1H), 7.008 (d, J = 7.5 Hz, 1H), 6.634 (dd, J = 7.4, 1.5 Hz, 1H), 6.622 (d, 
1H), 5.316 (s, 2H), 3.226 (t, J = 5.6 Hz, 2H), 2.853 (s, 3H), 2.743 (t, J = 6.4 Hz, 2H), 
2.183 (s, 3H), 1.927 (p, J = 6.1 Hz, 2H).  13C NMR (126 MHz, MeOD) δ 172.76, 148.48, 
140.62, 139.90, 134.23, 130.24, 130.12, 129.94, 126.07, 125.25, 124.80, 123.77, 123.36, 
121.58, 118.38, 113.11, 113.09, 52.36, 39.48, 28.62, 23.61, 23.25.  13C NMR (101 MHz, 
dmso) δ 168.83, 146.88, 140.21, 138.55, 133.61, 129.01, 128.36, 127.99, 123.76, 123.68, 
121.29, 121.08, 120.95, 119.89, 116.49, 111.43, 110.94, 50.62, 38.75, 27.10, 23.46, 












1.8 g (12.57 mmol) naphthylamine in 40 mL DCM was cooled to -78 °C in a dry ice/IPA 
bath for 10 min.  2.2 g (12.36 mmol, 1 eq) NBS were added in ten portions every five 
minutes.  Thirty minutes after the final addition, the reaction was stripped of solvents 
under reduced pressure.  SiO2 column chromatography (2.5% EtOAc in hexanes) to 
remove starting material, dibromo and para-bromo impurities produced 2.0 g (57% 
yield).  The para product is produced primarily by reacting in DMF at 0 °C.  The 
dibromo product is produced in MeCN or MeCN/DCM, even at -78 °C, with very little 
monobromo product, and unreacted naphthylamine.  The para product oxidizes readily 
on TLC under UV light, as does naphthylamine.  The desired product oxidizes more 
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slowly, presumably due to the inductive effect of the bromide on the amine.  The 
dibromo product shows very little oxidation.  1H NMR (500 MHz, DMSO-d6) δ 8.221 
(dd, J = 7.3, 2.3 Hz, 1H), 7.770 (dd, J = 6.25, 2.5 Hz, 1H), 7.532 – 7.441 (m, 2H), 7.443 
(d, J = 8.6 Hz, 1H), 7.070 (d, J = 8.7 Hz, 1H), 5.897 (s, 2H).  13C NMR (126 MHz, 
DMSO) δ 141.22, 133.06, 129.78, 128.02, 126.08, 125.00, 123.10, 122.60, 116.98, 







1H NMR (400 MHz, Methanol-d4) δ 7.990 (d, J = 8.3 Hz, 1H), 7.939 (d, J = 7.7 Hz, 1H), 
7.702 (d, J = 8.4 Hz, 1H), 7.669 - 7.533 (m, 2H), 7.227 (d, J = 8.4 Hz, 1H), 7.044 (d, J = 
7.6 Hz, 1H), 6.678 (d, J = 7.6 Hz, 1H), 3.454 – 3.327 (m, 2H), 3.326 – 3.198 (m, 2H), 
2.919 (t, J = 6.8 Hz, 2H), 2.587 – 2.367 (m, 2H), 2.108 (p, J = 6.1 Hz, 2H), 1.960 (p, J =  






152.1 mg (0.570 mmol) of the bromide, 198.8 mg (0.664 mmol, 1.17 eq), and 557 mg 
(1.710 mmol, 3 eq) cesium carbonate in 10 mL toluene were sparged with N2 for 20 min. 
to remove O2.  66 mg (0.057 mmol, 0.1 eq) Pd(PPh3)4 were added quickly and the 
mixture was sparged with N2 for another 10 min before refluxing at 120 °C under N2 for 
16 hrs.  After cooling to RT, the reaction was diluted in EtOAc and washed with brine.  
The organics were dried over Na2SO4, filtered, and stripped of solvents under reduced 
pressure.  SiO2 column purification (10% EtOAc in DCM) provided 100 mg slightly 
impure product.  Prep TLC (1000 mm SiO2 F60) purification with 2:1 hexanes/EtOAc 
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provided 97 mg (47% yield).  1H NMR (400 MHz, Chloroform-d) δ 8.165 (dt, J = 8.6, 
1.1 Hz, 1H), 8.139 (dd, J = 7.6, 1.1 Hz, 1H), 7.917 (dd, J = 8.8, 1.0 Hz, 1H), 7.500 (dd, J 
= 8.5, 7.6 Hz, 1H), 7.380 (d, J = 8.8 Hz, 1H), 6.971 (d, J = 6.8 Hz, 1H), 6.602 (bs, 1H), 
4.235 (bs, 2H), 3,394 – 3.086 (m, 4H), 2.884 (t, J = 6.7 Hz, 2H), 2.484 (t, J = 6.8 Hz, 





100 mg (0.278 mmol) were dispersed in 10 mL MeOH, and 20 mg 10% Pd/C were 
added.  The suspension was sparged with H2 for 15 min and then stirred at RT for 36 hrs.    
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The reaction was then filtered, and the filtrate was stripped of solvents at reduced 






41 mg (0.124 mmol) diamine and 65 µL (0.467 mmol, 1.2 eq) triethylamine in 3 
mL DCM were cooled in an ice bath for 10 min.  9 µL AcCl were added dropwise via 
syringe over 10 min.  The ice bath was removed, and the reaction stirred while warming 
to RT.  SiO2 column chromatography (1-2% MeOH in Et2O) gave 21 mg (45% yield) 
product after removing solvents at less than 30 °C under reduced pressure.  1H NMR (400 
MHz, DMSO-d6) δ 9.759 (s, 1H), 7.953 (d, J = 8.6 Hz, 1H), 7.603 (d, J = 7.4 Hz, 1H), 
7.362 (t, J = 8.6 Hz, 1H), 7.352 (d, J = 7.3 Hz), 7.044 (d, J = 8.6 Hz, 1H), 6.819 (d, J = 
7.5 Hz, 1H), 6.319 (d, J = 7.5 Hz, 1H), 4.963 (s, 2H), 3.147 (dt, J = 5.6, 2.1 Hz, 2H), 
3.093 (dt, J = 5.3, 3.3 Hz, 2H), 2.737 (t, J = 6.5 Hz, 2H), 2.441 – 2.241 (m, 2H), 2.164 (s, 
3H), 1.995 – 1.846 (m, J = 6.7 Hz, 2H), 1.769 (p, J = 6.3 Hz, 2H).  13C NMR (101 MHz, 
dmso) δ 169.21, 143.61, 140.67, 137.01, 134.02, 128.61, 128.51, 127.29, 123.96, 123.89, 
121.73, 120.97, 120.65, 120.29, 117.54, 110.98, 50.07, 49.67, 27.84, 25.31, 23.90, 22.09, 







Probe 6’s tendency to oxidize is much lower than that of 10, 11, and 13.  The sample 
from the Yang lab was fairly intact and could be purified by SiO2 chromatography; no 
synthesis was required.  Probe 6 is soluble in hexanes. 
1H NMR (500 MHz, Methanol-d4) δ 6.955 (d, J = 7.5 Hz, 1H), 6.895 (dd, J = 8.0, 2.4 Hz, 
1H), 6.870 (d, J = 2.4 Hz, 1H), 6.718 (d, J = 8.0 Hz, 1H), 6.587 (d, J = 1.8 Hz, 1H), 6.565 
(dd, J = 7.5, 1.8 Hz, 1H), 3.222 (t, J = 5.7 Hz, 2H), 2.866 (s, 3H), 2.767 (t, J = 6.4 Hz, 
2H), 2.226 (s, 3H), 1.992 (p, J = 6.5, 5.1 Hz, 2H), 1.284 (s, 1H).  13C NMR (126 MHz, 
MeOD) δ 148.32, 142.16, 139.79, 131.49, 130.83, 130.01, 129.41, 128.95, 123.21, 








139 mg (1 mmol) m-nitrophenol and 40 mg NaOH were dissolved in MeOH to produce 
an orange solution.  Solvents were removed at reduced pressure to give an orange solid, 
which was combined with 202 mg (1 mmol) 3-bromo-nitrobenzene and dissolved in 0.5 
mL dry DMF.  The mixture was sparged with N2 for 5 min., and then 5 mg (0.08 mmol, 
0.08 eq) copper powder were added.  After sparging for another 10 min, the reaction was 
heated to 140 °C under N2 balloon for six hours.  The reaction was diluted with EtOAc 
and washed twice with 1 M aqueous citric acid and once with brine.  The organics were 
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dried over Na2SO4, filtered free of solids, and stripped of solvents under reduced 
pressure.  The resulting solid was triturated with MeOH to give 200 mg (77% yield). 
1H NMR (500 MHz, DMSO-d6) δ 8.062 (m, J = 8.2, 2.6 Hz, 2H), 7.860 (t, J = 2.4 Hz, 
2H), 7.725 (t, J = 8.2 Hz, 2H), 7.595 (dd, J = 8.2, 2.7 Hz, 2H).  13C NMR (126 MHz, 




20 mg 10% Pd/C  was added to a solution of 45 mg (0.25 mmol) dinitro 
compound in 5 mL DCM.  The mixture was sparged with H2 for 15 min and then stirred 
at RT overnight.  It was next filtered through celite and stripped free of solvents under 
reduced pressure to give 34 mg (98% yield) crude.  1H NMR (400 MHz, Methylene 
Chloride-d2) δ 7.064 (t, J = 8.0 Hz, 1H), 6.399 (ddd, J = 8.0, 2.2, 1.0 Hz, 2H), 6.349 (ddd, 





50 mg (0.25 mmol, crude) diamine, 141  µL (2 mmol, 8.0 eq) 2-bromoethanol, 100 mg 
(1.0 mmol, 4 eq) calcium carbonate, and 4 mg (0.025 mmol, 0.1 eq) KI in 1 mL water 
were refluxed under N2 at 110 °C overnight.  After cooling to RT, the reaction was 
diluted with brine and extracted with EtOAc.  The organics were washed with brine, and 
the combined aqueous layers (pink) were extracted with 20% methanol in DCM.  The 
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organics were comibined, dried over Na2SO4, and stripped of solvents under reduced 
pressure.  SiO2 column chromatography (0-8% MeOH in EtOAc) gives 40 mg (42% 
yield).  1H NMR (500 MHz, DMSO-d6) δ 7.064 (t, J = 8.2 Hz, 2H), 6.413 (dd, J = 8.5, 
2.5 Hz, 2H), 6.331 (d, J = 2.4 Hz, 2H), 6.096 (dd, J = 8.0, 2.1 Hz, 2H), 4.748 (t, J = 5.7 
Hz, 4H), 3.511 (q, J = 6.0 Hz, 8H), 3.387 (d, J = 2.6 Hz, 8H).  13C NMR (126 MHz, 
DMSO) δ 157.94, 149.55, 129.93, 106.47, 104.80, 101.86, 58.07, 53.31.  HRMS (ESI+):  




34 mg (0.170 mmol) diamine, 150 µL (1.36 mmol, 8 eq) ethyl bromoacetate , 178 µL 
(1.02 mmol, 6 eq) N,N-diisopropylethylamine in 2 mL MeCN were stirred at 80 °C 
overnight.  The reaction was diluted in EtOAc, washed twice with brine, dried over 
Na2SO4, and stripped of solvents under reduced pressure.  The crude product was loaded 
onto two 1mm prep TLC SiO2 plates in DCM, eluted with hexanes/EtOAc, and extracted 
from the plates with EtOAc to give mg (% yield) after filtering and stripping solvents to 
dryness.  1H NMR (400 MHz, Chloroform-d) δ 7.107 (t, J = 8.2 Hz, 2H), 6.358 (ddd, J = 
8.1, 2.1, 0.80 Hz, 2H), 6.319 (ddd, J = 8.2, 2.6, 0.80 Hz, 2H), 6.285 (t, J = 2.4 Hz, 2H), 
4.185 (q, J = 7.1, 8H), 4.092 (s, 8H), 1.377 – 1.121 (t, J = 7.2 Hz, 12H).  HRMS (ESI+):  








275 mg (2.0 mmol) N,N-dimethyl-3-aminophenol and 296 mg (2.0 mmol, 1 eq) phthalic 
anhydride were suspended in 10 mL toluene and refluxed at 100 °C overnight.  After 
cooling, the crude mixture was purified free of tetramethyl rhodamine by SiO2 




337 mg (1.18 mmol) ketone, 222 mg (1.18 mmol, 1 eq) 3-amino-4-bromophenol, 
and 100 mg (0.734 mmol) zinc chloride were melted at 180 °C and stirred until the 
mixture solidified (40 minutes).  The solid was triturated with 0.5 M aq. HCl, filtered, 
and air-dried overnight.  1H NMR (500 MHz, Methanol-d4) δ 8.258 (d, J = 7.7 Hz, 1H), 
7.778 (t, J = 7.4 Hz, 2H), 7.729 (t, J = 7.6 Hz, 2H), 7.329 (d, J = 7.4 Hz, 1H), 7.188 (s, 
1H), 7.061 (d, J = 9.6 Hz, 1H), 7.006 (dd, J = 9.6, 2.4 Hz, 1H), 6.883 (s, 1H), 6.865 (d, J 
= 2.4 Hz, 1H), 3.219 (s, 6H).  13C NMR (126 MHz, MeOD) δ 167.98, 161.67, 159.69, 
159.36, 157.76, 156.74, 134.69, 134.40, 134.04, 132.65, 132.56, 132.19, 131.78, 131.43, 







22 mg (0.050 mmol) bromide, 11 mg (0.067, 1.3 eq) boronate, and 54 mg (0.51 
mmol, 10 eq) in 1 mL EtOH, 300 µL benzene, and 300 µL water were sparged with 
argon for 10 min.  4 mg (0.0035 mmol, 0.07 eq) Pd(PPh3)4 were quickly added, and the 
mixture was sparged with argon for another 5 min prior to stirring overnight at 95 °C 
under argon.  The solvents evaporated off by the next morning.  The solid was sonicated 
in EtOH, and the suspension was diluted with DCM and washed with pH 4 (adjusted with 
HCl) brine.  The aqueous layer was extracted repeatedly with DCM until colorless.  The 
combined organics were dried over Na2SO4, filtered, and stripped free of solvents at 
reduced pressure.  The crude mixture was purified by prep HPLC (C18 column, 
MeOH/water binary gradient with 0.1% formic acid added) to remove major de-
brominated rhodamine and other minor impurities.  Combined pure fractions were 
stripped of solvents to 10 mL volume under reduced pressure, and the remaining solvents 
were removed by lyophilization to 16 mg (61 % yield).  1H NMR (500 MHz, DMSO-d6) 
δ 7.927 (d, J = 7.6 Hz, 1H), 7.769 (t, J = 7.5 Hz, 1H), 7.665 (t, J = 7.5 Hz, 1H), 7.288 (d, 
J = 7.6 Hz, 1H), 7.144 (t, J = 7.9 Hz, 1H), 6.640 (s, 1 H), 6.632 (dd, J = 8.875, 2.8 Hz, 1 
H), 6.538 (d, J = 1.9 1.6 Hz, 1H), 6.515 – 6.441 (m, 3H), 6.397 (d, J = 7.4 Hz, 1H), 6.184 
(s, 1H), 5.295 (s, 2H), 2.941 (s, 6H), 2.830 (s, 6H).  13C NMR (126 MHz, DMSO) δ 
168.82, 152.33, 152.22, 151.94, 151.50, 150.51, 147.70, 138.71, 135.36, 129.91, 129.47, 
128.66, 128.32, 126.68, 124.41, 124.08, 123.86, 116.16, 112.07, 111.26, 108.95, 106.80, 
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106.05, 100.12, 98.20, 84.67, 48.61.  HRMS (ESI+):  478.2130 (M+H), Calculated 
C30H28N3O3 478.2131. 
APPENDIX C:  CELL EXPERIMENTS, MATERIALS, EQUIPMENT, AND IMAGING 
Cell Cultures 
NIH 3T3 and RAW 264.7 cells (ATCC) were cultured in high-glucose 
Dulbecco’s Modified Eagle Medium (DMEM) or Leibovitz’s L-15 Medium (L-15) with 
10% BCS (NIH 3T3) or 10% FBS (RAW 264.7) added. For the bicarbonate-buffered 
DMEM medium, the cells were incubated in a humidified environment at 37 °C under 
5% CO2/air, whereas for the phosphate-buffered L-15 medium, no CO2 was added. Cells 
were passaged at least three times prior to any imaging experiments. For fluorescence 
microscopy, cells were plated onto Lab-Tek II Chambered #1.5 German Coverglass 
sterile 8-well plates in DMEM or L-15 medium supplemented with 1% serum. 
Passaging Cells 
DMEM + 10% BCS medium was removed from 70-90% confluent NIH 3T3 cells 
in T25 culture flasks, and 0.05% trypsin-EDTA solution with phenol red was promptly 
added. The cells were incubated at 37 °C under 5% CO2 for one minute so they would 
detach, and then the cell suspension was transferred to a 15 mL centrifuge tube. The 
culture flask was rinsed with 3 mL DPBS,and the cells were centrifuged to a pellet. The 
supernatant was discarded, and the cells were suspended in 1 mL DMEM + 10% BCS. 
80-100 μL of this suspension was added to a new culture flask containing 4 mL DMEM + 
10% BCS, and the cells were incubated at 37 °C under 5% CO2 to complete the passage. 
DMEM + 10% FBS was removed from 70-90% confluent RAW 264.7 cells, and 
1 mL DPBS was added. The cells were detachedwith a cell scraper, and the cell 
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suspension was transferred to a 15 mL centrifuge tube. The culture flask was rinsed with 
3 mL DPBS, and the cell suspension was centrifuged. The cell pellet was suspended in 1 
mL DMEM + 10% FBS, and an 80-100 μL aliquot of this suspension was added to 4 mL 
DMEM + 10% FBS in a new culture flask. The cells were incubated at 37 °C under 5% 
CO2 to complete the passage. 
Cell plating 
Each well of a Nunc Lab-Tek II Chambered Coverglass 8-well plate was charged 
with 500 μL DMEM + 1% BCS (NIH 3T3) or FBS (RAW 264.7). The centrifuged cell 
pellet obtained as described in the section above was suspended in 1 mL DMEM + 1% 
serum.  A 10-20 μL aliquot of this suspension was added to each well, and the cells were 
incubated at 37 °C under 5% CO2. 
SNAP stimulus experiments 
NIH 3T3 cells were plated into a Nunc 8-well plate in high-glucose DMEM + 1% 
BCS and incubated overnight at 37 °C under 5% CO2/air. The DMEM was then replaced 
with Hepes Hanks Buffered Saline Solution (HHBSS) + 1% BCS, and the cells were 
incubated at 37°C for twenty minutes. 2 mM probe solutions of NO550 (9), NO530 (10), 
or NO562 (13) in DMSO were diluted in HHBSS + 1% BCS to give a 15 μM probe 
concentration, with 0.75% DMSO. The medium in a pair of wells was replaced with 15 
μM probe loading solution – three probes, six wells total. To the no-probe pair of wells 
was added the same volume of DMSO without probe to give 0.75% DMSO. The cells 
were incubated in this loading solution for two hours at 37 °C. The loading solution was 
then replaced with HHBSS + 1% BCS. A 200 mM S-Nitroso N-acetyl D,L-penicillamine 
(SNAP) solution in DMSO was diluted into the medium of four wells (stimulated), 
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containing the three different probes and no probe, to give 1 mM SNAP, 1.23% DMSO. 
The same volume of DMSO was diluted into the medium of the remaining wells (non-
stimulated) to give 1.23% DMSO. The cells were incubated for four hours at 37 °C. 
Brightfield and DAPI and FITC-filtered fluorescence images were acquired through 10x 
and 40x objectives. 
RAW 264.7 cells were plated into a Nunc 8-well plate high-glucose DMEM + 1% 
FBS and incubated overnight at 37 °C under 5% CO2/air. The DMEM was then replaced 
with Krebs-Ringer buffer (KRB) + 1% FBS. 2 mM probe solutions of 9, 10, or 13 in 
DMSO were diluted in KRB + 1% FBS to a final concentration of 10 μM, 0.5% DMSO, 
and the medium over cells was replaced with this 10 μM loading solution, two wells per 
probe, six wells total. A 25 mM SNAP solution in DMSO was diluted into the loading 
solution of three wells (stimulated), each containing a different probe, to give 200 μM 
SNAP, 1.3% DMSO. The three remaining wells (nonstimulated) were treated with the 
same volume of DMSO but without SNAP, to give 1.3% DMSO. The cells were 
incubated for four hours at 37 °C. The medium in all wells was replaced with KRB + 1% 
FBS. Brightfield and DAPI and FITC-filtered fluorescence images were acquired through 
10x objective. 
NO Solution Stimulus 
To the wells containing NIH 3T3 cells - loaded with probes 9, 10, or 13 or with 
no probe at all - that had not been subjected to 1 mM SNAP (above) was added 1.9 mM 
aqueous NO solution to a final concentration of 250 μM. The cells were incubated at 37 
°C for 10 minutes, and then brightfield and DAPI and FITC-filtered fluorescence images 
of the four wells were acquired through 10x and 40x objectives. 
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RAW 264.7 cells were plated into a Nunc 8-well plate high-glucose DMEM + 1% 
FBS and incubated overnight at 37 °C under 5% CO2/air. The DMEM was then replaced 
with DPBS + 1% FBS. 2 mM probe solutions of 9, 10, or 13 in DMSO were diluted in 
DPBS + 1% FBS to a final concentration of 10 μM, 0.5% DMSO, and the medium over 
cells was replaced with this 10 μM loading solution, two wells per probe, six wells total. 
Two wells were left without probe, but DMSO was added to the medium to 0.5%. The 
cells were incubated at 37 °C for 9 hours, and then the 10 μM loading solutions were 
replaced with DPBS + 1% FBS. A 1.8 mM aqueous NO solution was diluted into the 
medium in three wells (stimulated), each containing a different probe, and one no-probe 
well (also stimulated), to a final concentration of 300 μM NO. Nothing was added to the 
remaining four wells (non-stimulated). The cells were incubated for ten minutes at 37 °C, 
and then brightfield and DAPI and FITC-filtered fluorescence images of all wells were 
acquired through 10x and 40x objectives. 
L-Arginine Stimulus 
NIH 3T3 cells were plated into a Nunc 8-well plate in high-glucose DMEM + 1% 
BCS and incubated overnight at 37 °C under 5% CO2/air.  A 2 mM probe 13 in DMSO 
was diluted in DMEM + 1% BCS to give 10 μM probe concentration, with 0.5% DMSO. 
The medium in two wells was replaced with 500 μL 10 μM probe loading solution.  The 
cells were incubated in this loading solution for one hour at 37 °C.   4 μL of a 100 mM L-
arginine solution were added to one of the wells (2 mM L-arginine diluted 
concentration); 4 μL water were added to the other well.  The cells were incubated for 
twenty-four hours at 37 °C. The medium in both wells was replaced with Krebs-Ringers 
solution + 1% BCS for imaging.  Brightfield and DAPI and FITC-filtered fluorescence 




Lipopolysaccharides from Escherichia coli: 026:B6 (L2654), 055:B5 (L6529), 
0111:B4 (L4391) and purified by phenol extraction (L2630), and 0127:B8 (L4516) and 
from Salmonella enterica: serotype enteritidis (L7770), serotype Minnesota (L4641), and 
serotype typhimurium (L6143) were purchased from Sigma (catalog numbers in 
parentheses). 1 mg of each LPS variant was dissolved in 1 mL water sterilized by 0.2 μm 
filtration. To seven wells (stimulated) of an 8-well plate that had been plated with RAW 
264.7 cells in DMEM + 1% FBS was added an appropriate aliquot of a different LPS 
variant so as to achieve a final concentration of 1 μg/mL LPS. No LPS was added to one 
well (non-stimulated). The cells were incubated for 90 minutes at 37 °C, 5% CO2. A 1 
mM solution of DAF-FM diacetate in DMSO was diluted to 2 μM in DMEM + 1% FBS, 
and the medium in all wells was replaced with this 2 μM solution. After incubation at 37 
°C, 5% CO2 for 30 minutes, the medium was replaced with KRB, and the cells were 
incubated for 5 minutes further at room temperature. They were then imaged through the 
FITC filter set. Cells stimulated with variant Escherichia coli 011:B4 (L4391) produced 
the greatest increase in DAF-FM brightness over the nonstimulated cells, although the 
same variant purified by phenol extraction (L2630) also produced a greater increase than 
the remaining variants. 
Cell exposure to LPS 
RAW 264.7 cells were plated into a Nunc 8-well plate in high-glucose DMEM + 
1% FBS and incubated overnight at 37 °C under 5% CO2/air. To four (stimulated) of the 
eight wells was added 1 mg/mL LPS in 0.2 μm filtered water to a final concentration of 1 
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μg/mL. Nothing was added to the remaining four wells (non-stimulated). The cells were 
incubated at 37 °C, 5% CO2 for 15 hours. The medium in all wells was replaced with L-
15 + 1% FBS, and 1 mg/mL LPS solution was diluted to 1 μg/mL in the four stimulated 
wells. The cells were incubated at 37 °C for another six hours. A 2 mM solution of 
probes 9, 10, and 13 in DMSO was first diluted to 150 μM, 7% DMSO in L-15 + 1% 
FBS in order to avoid high localized concentrations of DMSO over the cells. Each 150 
μM probe solution was further diluted to 15 μM, 0.7% DMSO into two wells, stimulated 
and non-stimulated, for a total of six wells, and the cells were incubated at 37 °C for 2.5 
hours. A 1 mM DAF-FM diacetate solution in DMSO was diluted to 10 μM in L-15 + 1% 
FBS and then diluted further to 1 μM in the two remaining, one stimulated and one non-
stimulated, wells. After 25 minutes at room temperature, the DAF-FM diacetate loading 
medium was replaced with L-15 + 1% FBS. The cells were left for another ten minutes at 
room temperature for non-specific esterases to finish hydrolyzing the two acetate 
functionalities. (This extra hydrolysis time must be counterbalanced with the propensity 
of the hydrolyzed form of DAF-FM to leak or get pumped out of cells.) Brightfield and 
DAPI and FITC-filtered fluorescence images were acquired for all wells (starting with 
the two containing the leakage-prone DAF-FM) through a 10x objective. 
Calcein Blue/Propidium Iodide Cell Viability Assay 
The membrane-permeable acetoxymethyl ester derivative of Calcein Blue is non-
fluorescent until non-specific esterases in viable cells hydrolyze the esters to produce the 
membrane-impermeable blue fluorophore that remains in the cytosol of cells with intact 
membranes. Propidium iodide becomes red fluorescent when it intercalates into DNA. 
The membrane-impermeable propidium iodide cannot intercalate into the DNA of viable 
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cells with intact membranes. Therefore, blue fluorescent cells are deemed viable, whereas 
red fluorescent are not. 
The DMEM + 1% FBS medium over RAW 264.7 cells was replaced with L-15 + 
1% FBS; 4% DMSO in L-15 + 1% FBS; or 1.25, 2.5, 5, 10, 20, or 40 μM 10 (diluted 
from 2 mM probe 10 in DMSO) in L-15 + 1% FBS. Cells were incubated at 37 °C for 
two hours. A 2 mM Calcein Blue (AM) solution in DMSO was diluted to 50 μM in 
DPBS. A 1.5 mM propidium iodide solution in 0.2 μm-filtered water was diluted to 50 
μM in the 50 μM Calcein Blue (AM) solution. The medium in all wells was replaced with 
DPBS, and then the 50 μM Calcein Blue (AM), 50 μM propidium iodide solution was 
diluted ten-fold into each well. Cells were incubated at 37 °C for 30 minutes prior to 
imaging. Brightfield and DAPI, FITC, and TRITC-filtered fluorescence images were 
acquired for all wells. 
Image Processing 
Images were saved as TIFFs. All images were processed with FIJI software, 
version 2.0.0-rc-65/1.52a.3 Brightfield images were processed with the Subtract 
Background command, typically with a rolling ball radius of 10 pixels and with 
smoothing disabled, followed by further processing with a variance filter set at a radius of 
2-5 pixels. A threshold was applied to the background-subtracted and variance-filtered 
images to reduce them to 8-bit images from which a selection could be created. This 
selection was converted to a region of interest and served as a mask for areas occupied by 
cells. The rolling ball radius values in the Subtract Background command and the radius 
values in the variance filter were adjusted to achieve the best fit of the region of interest 
to the cells in the image. Each brightfield image-derived mask was applied to the 
corresponding FITC and DAPI channel images to obtain the mean pixel intensity within 
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the mask, which was treated as intracellular signal. An inverse of the selection produced a 
mask of the region not occupied by cells, and this mask was applied to the FITC and 
DAPI channel images to measure extracellular signal. An image 960 x 720 pixels in size 
contains 691,200 pixels. Processing Figure 12e and 12f gave a mean intensity value of 
1316 for FITC and 705 for DAPI over 138,173 pixels for the intracellular signal. The 
inverse of the selection produced a mean of 636 for FITC and 604 for DAPI over 553,027 
pixels for the extracellular signal. The intracellular and extracellular pixels totaled to 
691,200 pixels. 
These signals were corrected by subtracting the mean intracellular signal from 
cells not loaded with probe from those loaded with probe for experiments with SNAP, 
NO solution, and LPS stimuli in NIH 3T3 and RAW 264.7 cells. For LPS stimuli 
experiments in cells, images of cells not loaded with probes were not collected, so the 
lowest extracellular mean signal, no matter which probe was loaded into cells, in a certain 
experiment was subtracted from the mean intracellular signals for all loaded probes. 
Furthermore, if at any point the intracellular signal from cells not loaded with 
probe was greater than that for cells loaded with probe, the lowest extracellular mean 




Zeiss DAPI, FITC, and TRITC Filters 
 
Percent transmittance versus wavelength graphs for DAPI (top), FITC (middle), and TRITC 
(bottom) filters.2  Excitation filter (blue), beam splitter (gray), and emission filter (red) parameters 
(listed in this order) for each set: DAPI (G 365, FT 395, LP 420), FITC (BP 450-490, FT 510, LP 515), 
and TRITC (545/25, FT 570, BP 605/70).  From  
(A) Carl Zeiss Microscopy, L. Filter Set 02. 
https://www.microshop.zeiss.com/images/fat/chart.gif.php?l=en&a=v&ft=446431-0011-
000&fa=000000-4242- 879&fe=447741-8001-000;  
(B) Carl Zeiss Microscopy, L. Filter Set 09. 
https://www.microshop.zeiss.com/images/fat/chart.gif.php?l=en&a=v&ft=446431-0011-
000&fa=000000-4242- 879&fe=447741-8001-000;  








To a solution of 198 mg 84% CDI (16% imidazole, as determined by 1H NMR, 1 mmol, 
1 eq) in 5 mL DCM was added via syringe a solution of 153 mg (1 mmol) 3,5-
dimethoxyaniline in 1 mL DCM at a rate of 100 µL every two minutes.  The reaction 
stirred at room temperature for four hours, and then 140 µL (1 mmol, 1 eq) N-benzyl-2-
aminoethanol, and the reaction stirred at room temperature overnight.  The reaction 
mixture was diluted with DCM, washed twice with 0.1 M HCl, and once with brine.   The 
combined aqueous layers were back-extracted with DCM.  The combined organics were 
dried over Na2SO4, filtered free of solids, and stripped free of solvents under reduced 
pressure.  SiO2 column chromatography (1:1 hexanes/EtOAc) yielded 267 mg (81%).  1H 
NMR (400 MHz, DMSO-d6) δ 8.647 (s, 1H), 7.371 – 7.283 (m, 2H), 7.283 – 7.193 (m, 
3H), 6.705 (d, J = 2.3 Hz, 2H), 6.086 (t, J = 2.3 Hz, 1H), 5.263 (t, J = 4.8 Hz, 1H), 4.569 
(s, 2H), 3.672 (s, 5H), 3.535 (q, J = 5.3 Hz, 2H), 3.379 – 3.299 (m, 1H).  13C NMR (126 
MHz, DMSO) δ 160.40, 155.65, 142.32, 138.86, 128.43, 127.31, 126.93, 97.36, 93.88, 










33 mg (0.1 mmol) of the mixed urea and 16 mg (0.1 mmol, 1.0 eq) CDI in 1 mL CDCl3 
were agitated on a mechanical shaker for one hour.  6 µL (0.1 mmol, 1 eq) 2-
aminoethanol were added, and the reaction was shaken at room temperature for four 
days.  The reaction mixture was diluted with DCM, washed twice with 0.1 M HCl, and 
once with brine.   The combined aqueous layers were back-extracted with DCM.  The 
combined organics were dried over Na2SO4, filtered free of solids, and stripped free of 
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solvents under reduced pressure.  SiO2 column chromatography (2:3 hexanes/EtOAc) 
yielded 39 mg (95%).  1H NMR (400 MHz, Chloroform-d) δ 7.898 (s, 1H), 7.571 (d, J = 
1.0 Hz, 2H), 7.450 – 7.164 (m, 5H), 7.011 (d, J = 1.0 Hz, 4H), 6.831 – 6.660 (m, 2H), 
6.585 (dd, J = 12.4, 2.2 Hz, 1H), 6.141 (q, J = 2.6 Hz, 1H), 5.894 (s, 1H), 4.563 (d, J = 
7.0 Hz, 2H), 4.025 (t, J = 6.6 Hz, 2H), 3.695 (s, 4H), 3.670 (s, 1H), 3.664 – 3.585 (m, 
2H), 3.514 (t, J = 6.5 Hz, 2H), 3.287 (q, J = 5.3 Hz, 2H).  LCMS:  418 (M+H), 440 





79 mg (0.91 mmol) dimer and 171 mg (1.05 mmol, 1.15 eq) in 10 mL DCM was stirred 
for four hours.  Then 153 µL (2.53 mmol, 2.8 eq) 2-aminoethanol were added, and the 
reaction stirred overnight at room temperature.  The reaction mixture was diluted with 
DCM, washed twice with 0.1 M HCl, and once with brine.   The combined aqueous 
layers were back-extracted with DCM.  The combined organics were dried over Na2SO4, 
filtered free of solids, and stripped free of solvents under reduced pressure.  SiO2 column 
chromatography (1:2 hexanes/EtOAc) yielded 430 mg (94%).  LCMS 505 (M+H), 527 







A solution of 25 mg (0.05 mmol) and 6 mg (0.05 mmol, 1.0 eq) DMAP in 0.5 mL DCM 
was cooled in an ice/brine bath for 10 minutes, and then 6 mg (0.05 mmol, 1.0 eq) 
cyanoacetyl chloride in 0.5 mL DCM were added.  After 15 minutes stirring, the ice bath 
was removed, and the reaction stirred for two hours warming to room temperature.  The 
reaction mixture was diluted with DCM, washed twice with 0.1 M HCl, and once with 
brine.   The combined aqueous layers were back-extracted with DCM.  The combined 
organics were dried over Na2SO4, filtered free of solids, and stripped free of solvents 
under reduced pressure.  SiO2 column chromatography (1:1 hexanes/EtOAc) yielded 11.4 





A solution of 50 mg (0.1 mmol) trimer-OH and 32 µL (0.23 mmol, 2.3 eq) in 1 mL DCM 
was cooled in an ice/brine bath for 10 minutes before 30 mg (0.16 mmol, 1.6 eq) tosyl 
chloride in 0.5 mL DCM were added.  The ice-bath was removed after 15 minutes, and 
the reaction warmed to room temperature while stirring.  After four hours, the reaction 
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mixture was diluted with DCM, washed twice with 0.1 M HCl, and once with brine.   The 
combined aqueous layers were back-extracted with DCM.  The combined organics were 
dried over Na2SO4, filtered free of solids, and stripped free of solvents under reduced 
pressure.  SiO2 column chromatography (1:2 hexanes/EtOAc) yielded 50 mg (77%).  






A solution of 50 mg (0.076 mmol) trimer-OTs and 10 mg (0.152 mmol, 2 eq) in 1 mL 
DMF was heated at 50 °C for four hours.  After cooling to RT, it was poured into sodium 
bicarbonate, filtered, and rinsed with dI water.  The solid was air-dried overnight to give 
41 mg, 100% crude.  LCMS (APCI +/-):  530 (M+H), 552 (M+Na), 564 (M+Cl) 





A dispersion of 40 mg (0.076 mmol) trimer-N3 and 10 mg 5% Pd/C in 1 mL 1,2-
dichloroethane was sparged with H2 for 10 minutes and then stirred at RT for 2 hours.  
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The reaction mixture was filtered through hardened filter paper, and the filtrate was 
stripped of solvents under reduced temperature.  SiO2 column chromatography (2% 
MeOH in DCM + 5% Et3N) yielded 32 mg still impure amine.  This amine was sonicated 
in toluene and filtered to give 16 mg of ~89% pure product.  LCMS (APCI +/-):  504 





4 mg trimer-NH2 (0.008 mmol) in 100 µL DMF were stirred at 90 °C overnight.  LCMS 





4 mg trimer-NH2 (0.008 mmol) and 4 mg (0.029, 3.7 eq) K2CO3 in 100 µL DMSO were 









Two separate reactions:  4 mg trimer-NH2 (0.008 mmol), 0.95 µL (0.008 mmol, 1.0 eq) 
phenyl isothiocyanate or 0.82 µL (0.008 mmol, 1.0 eq) propyl isothiocyanate, 1.12 µL 
triethylamine (0.008 mmol, 1.0 eq), in 200 µL DCM were stirred at room temperature 
overnight.  Two more equivalents of either PhITC or PrITC were added the next day to 
effect complete conversion of the amine to the thiourea after four hours stirring.  The 
reaction mixture was diluted with DCM, washed once with 0.1 M HCl, and twice with 
brine.   The combined aqueous layers were back-extracted with DCM.  The combined 
organics were dried over Na2SO4, filtered free of solids, and stripped free of solvents 
under reduced pressure.  SiO2 prep TLC (1:2 hexanes/EtOAc) yielded 2 mg Ph and 2 mg 
Pr variants (40 % Ph, 42% Pr).  LCMS (APCI +/-):  639 (M+H), 661 (M+Na).  HRMS 
ESI+:  639.2597 (M+H) Calculated C31H39N6O7S 639.2595 for Ph variant.  605 (M+H), 









Edman degradation with phenyl or propyl thioureas. 
 
 
2 mg (0.003 mmol) of the thiourea was dissolved in 300 µL TFA and heated at 50 °C 
overnight.  No peak with a mass equivalent to the sequenced product dimer-OH was 
observed. The main conversion was to a product 2 m/z less than the thiourea molecular 





150 µL (1 mmol) 2,4-dimethoxybenzylamine and 186 mg (1.15 mmol, 1.15 eq) CDI in 1 
mL 1,2-dichloroethane was stirred at room temperature for two hours.  78 µL (1.3 mmol, 
1.3 eq) 2-aminoethanol were added, and the reaction stirred overnight.  The mixture was 
poured into 1M HCl and thrice extracted with EtOAc.  The combined organics were 
washed with 1M HCl, then brine, dried over Na2SO4, filtered, and stripped of solvents to 
dryness under reduced pressure.  SiO2 column chromatography (3:1 EtOAc / hexanes) 
gave 185 mg (73% yield).  1H NMR (500 MHz, DMSO-d6) δ 7.065 (d, J = 8.3 Hz, 1H), 
6.526 (d, J = 2.4 Hz, 1H), 6.460 (dd, J = 8.3, 2.4 Hz, 1H), 6.155 (t, J = 5.9 Hz, 1H), 6.000 
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(t, J = 5.7 Hz, 1H), 4.670 (t, J = 5.1 Hz, 1H), 4.078 (d, J = 5.8 Hz, 2H), 3.776 (s, 3H), 
3.733 (s, 3H), 3.370 (t, J = 5.5 Hz, 2H), 3.143 – 2.994 (m, 2H).  13C NMR (126 MHz, 
DMSO) δ 159.59, 158.26, 157.72, 128.78, 120.46, 104.18, 98.19, 60.91, 55.33, 55.18, 
42.15, 37.89.  LCMS (ESI/APCI +/-) 255 (M+H), 277 (M+Na), 531 (2M+Na) 253(M-1), 







220 mg (0.865 mmol) and 162 mg (0.995 mmol, 1.15eq) CDI in 3 mL 1,2-dichlorethane 
were stirred at RT for 3 hours.  61 µL 2-aminoethanol were added, and the reaction 
stirred overnight.  The mixture was poured into 1M HCl and thrice extracted with EtOAc.  
The combined organics were washed with 1M HCl, then brine, dried over Na2SO4, 
filtered, and stripped of solvents to dryness under reduced pressure.  SiO2 column 
chromatography (2% MeOH in EtOAc) gave 175 mg (59% yield).  1H NMR (500 MHz, 
DMSO-d6) δ 7.059 (d, J = 8.3 Hz, 1H), 7.021 (t, J = 5.2 Hz, 1H), 6.525 (d, J = 1.9 Hz, 
1H), 6.460 (dd, J = 8.2, 2.0 Hz, 1H), 6.146 (t, J = 5.6 Hz, 1H), 6.022 (t, J = 5.3 Hz, 1H), 
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4.618 (t, J = 5.5 Hz, 1H), 4.075 (d, J = 5.7 Hz, 2H), 3.903 (t, J = 5.6 Hz, 2H), 3.776 (s, 
3H), 3.733 (s, 3H), 3.384 (d, J = 5.9 Hz, 2H), 3.192 (s, 2H), 3.036 (q, J = 6.1 Hz, 2H). 
13C NMR (126 MHz, DMSO) δ 159.61, 157.96, 157.72, 156.29, 128.83, 120.35, 104.20, 
98.20, 63.42, 59.96, 55.35, 55.19, 43.04, 38.90, 37.90.  HRMS ESI+:  342.1663 (M+H) 










682 mg (2 mmol) dimer-OH and 12 mg (0.1 mmol, 0.05 eq) DMAP were dissolved in 4 
mL pyridine and cooled in an ice/brine bath for 10 minutes.  572 mg (3 mmol, 1.5 eq) 
tosyl chloride were added in four portions every five minutes.  The ice bath was removed 
20 minutes after the last addition, and the reaction stirred overnight at RT.  230 mg (4.2 
mmol, 2.1 eq total) tosyl chloride were added in two portions at RT, and the reaction 
stirred for another night.  The reaction was diluted with DCM and washed twice with 1:1 
citric acid/brine.  The emulsion that formed on the second wash was filtered, and the 
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organic layer was dried over Na2SO4, filtered, and stripped of solvents under reduced 
pressure.  SiO2 column chromatography (1:3 hexanes/EtOAc) gave 525 mg (53% yield).  
LCMS (ESI/APCI +/-): 496 (M+H), 518 (M+2H), 530 (M+Cl).  HRMS ESI+:  496.1749 




200 mg (0.59 mmol) dimer-OTs and 76 mg (1.172 mmol, 2 eq) sodium azide were 
reacted in 4 mL DMF at 50 °C for four hours.  After cooling, the reaction was poured into 
sodium bicarbonate solution, filtered, and rinsed with dI water.  The filtered solid was 
air-dried overnight to give 235 mg (110%, crude).  LCMS (ESI/APCI +/-):  389 (M+Na), 





235 mg (0.59 mmol) dimer-N3 and 30 mg 5% Pd/C in 10 mL DCM were sparged with H2 
for 10 min and then stirred for 2 hours.  The reaction mixture was filtered through 
hardened filter paper, and the filtrate was stripped free of solvents under reduced 
pressure.  Reverse-phase chromatography purification yielded 155 mg (48%) as the 
formate salt.  1H NMR (500 MHz, DMSO-d6) δ 8.415 (s, 1H), 7.417 (s, 1H), 7.061 (d, J 
= 8.3 Hz, 1H), 6.517 (d, J = 2.4 Hz, 1H), 6.455 (dd, J = 8.3, 2.4 Hz, 1H), 6.403 (t, J = 5.8 
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Hz, 1H), 6.306 (t, J = 5.7 Hz, 1H), 5.764 (s, 3H), 4.069 (d, J = 5.6 Hz, 2H), 3.912 (t, J = 
5.7 Hz, 2H), 3.769 (s, 3H), 3.729 (s, 3H), 3.192 (dd, J = 11.7, 5.9 Hz, 4H), 2.794 (s, 2H).  
13C NMR (126 MHz, DMSO) δ 159.54, 158.13, 157.65, 156.35, 128.71, 120.42, 104.19, 
98.15, 63.72, 55.34, 55.19, 38.72, 37.79.  LCMS (ESI/APCI +/-):  341 (M+H), 363 
(M+Na), 681 (2M+H), 703 (2M+Na), 375 (M+Cl), 385 (M+formate).  HRMS ESI+: 




Dimer-NH2 cyclization sequencing 
 
0.3 mg (0.09 mmol) of the formate salt of the dimer-NH2 and 5 mg potassium phosphate 
in 200 µL H2O and 200 µL MeOH in an LCMS vial was stirred at RT overnight.  Since 
there was no reaction by LCMS, the reaction was stirred at 40 °C for 3 hours, then at 60 
°C overnight.  With about 15% conversion to the monomer, the reaction was then stirred 
at 80 °C overnight, with 78% conversion.  Another 24 hours at 80 °C were necessary to 
drive the reaction to 96% completion. 
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0.3 mg (0.09 mmol) of the formate salt of the dimer-NH2 and 50 µL Hünig’s base in 300 
µL DMF were stirred at 50 °C for 1 hour.  Since there was no reaction by LCMS, the 
reaction was stirred at 50 °C overnight.  There was little conversion to the monomer-OH, 
only to a mixture of other unrecognizable products.  The reaction was abandoned to the 
more favorable results with potassium phosphate/methanol/water. 
 
F-OH:  (S)-1-(2,4-dimethoxybenzyl)-3-(1-hydroxy-3-phenylpropan-2-yl)urea 
 
2.8 mL (18.65 mmol) 2,4-dimethoxybenzyl amime and 3.32 g (20.52 mmol, 1.1 eq) 
carbonyldiimidazole (CDI) in 50 mL anhydrous DMF were stirred at RT for three hours.  
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2.82 g (18.65, 1 eq) L-phenylalaninol were added, and the reaction stirred overnight at 
RT.  The mixture was poured into 1M HCl and thrice extracted with EtOAc.  The 
combined organics were washed with 1M HCl, then brine, dried over Na2SO4, filtered, 
and stripped of solvents to dryness under reduced pressure.  SiO2 column 
chromatography (3:1 EtOAc / DCM) gave 3.94 g (61% yield) F as a white solid.  1H 
NMR (500 MHz, DMSO-d6) δ 7.32 – 7.23 (m, 2H), 7.23 – 7.14 (m, 3H), 6.98 (d, J = 8.3 
Hz, 1H), 6.52 (d, J = 2.4 Hz, 1H), 6.44 (dd, J = 8.3, 2.4 Hz, 1H), 6.09 (t, J = 5.9 Hz, 1H), 
5.89 (d, J = 8.3 Hz, 1H), 4.80 (dd, J = 5.5, 4.8 Hz, 1H), 4.04 (d, J = 5.9 Hz, 2H), 3.76 (s, 
3H), 3.75 (m, 4H), 3.32 (dt, J = 10.6, 4.8 Hz, 1H), 3.24 (dt, J = 10.6, 5.5 Hz, 1H), 2.79 
(dd, J = 13.5, 6.3 Hz, 1H), 2.60 (dd, J = 13.5, 7.5 Hz, 1H). 13C NMR (126 MHz, DMSO-
d6) δ 159.52, 157.68, 157.64, 139.39, 129.25, 128.63, 128.12, 125.87, 120.44, 104.15, 
98.12, 62.72, 55.33, 55.20, 52.63, 37.74, 37.36.  HRMS +ESI [M + K+]: 383.1374, 









3.94 g (11.44 mmol) F and 1.95 g (12.01 mmol, 1.05 eq) CDI in 50 mL anhydrous DMF 
were stirred at RT for three hours.  0.945 g (12.584, 1.1 eq) L-alaninol were added, and 
the reaction stirred overnight at RT.  The mixture was poured into 1M HCl and thrice 
extracted with EtOAc.  The combined organics were washed with 1M HCl, then brine, 
dried over Na2SO4, filtered, and stripped of solvents to dryness under reduced pressure.  
SiO2 column chromatography (2:1 EtOAc / hexanes, to 100% EtOAc ) gave 2.86 g (56% 
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yield) FA as a white solid. 1H NMR (500 MHz, DMSO-d6) δ 7.29 (t, J = 7.4 Hz, 2H), 
7.19 - 7.22 (m, 3H), 6.98 (d, J = 8.3 Hz, 1H), 6.94 (d, J = 8.1 Hz, 1H), 6.53 (d, J = 2.4 
Hz, 1H), 6.45 (dd, J = 8.3, 2.4 Hz, 1H), 6.10 (t, J = 5.9 Hz, 1H), 5.97 (d, J = 8.1 Hz, 1H), 
4.66 (t, J = 5.7 Hz, 1H), 4.05 (d, J = 5.9 Hz, 2H), 4.01 – 3.90 (m, 1H), 3.89 – 3.79 (m, 
2H), 3.77 (s, 3H), 3.74 (s, 3H), 3.59 – 3.42 (m, J = 6.6 Hz, 1H), 3.34 (dt, J = 10.6, 5.5 Hz, 
1H), 3.22 (dt, J = 10.6, 5.9 Hz, 1H), 2.77 (dd, J = 13.5, 6.0 Hz, 1H), 2.68 (dd, J = 13.5, 
7.5 Hz, 1H), 1.02 (d, J = 6.6 Hz, 3H). 13C NMR (126 MHz, DMSO-d6) δ 159.99, 158.09, 
157.87, 156.09, 138.92, 129.63, 129.12, 128.69, 126.57, 120.76, 104.59, 98.57, 65.56, 
64.98, 55.77, 55.62, 50.46, 48.89, 38.20, 37.97, 17.78. HRMS +ESI [M+H]: 446.2285, 








1.4 g (3.14 mmol) FA and 0.94 g (5.80 mmol, 1.85 eq) CDI in 20 mL anhydrous DMF 
were stirred at RT for three hours.  1.1 g (9.39 mmol, 3.0 eq) L-leucinol were added, and 
the reaction stirred overnight at RT.  The mixture was poured into 1M HCl and thrice 
extracted with EtOAc.  The combined organics were washed with 1M HCl, then brine, 
dried over Na2SO4, filtered, and stripped of solvents to dryness under reduced pressure.  
SiO2 column chromatography (5:1 EtOAc / hexanes) gave 1.120 g (61% yield) FAL as a 
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white solid. 1H NMR (500 MHz, DMSO-d6) δ 7.28 (t, J = 7.4 Hz, 2H), 7.24 – 7.10 (m, 
4H), 6.97 (d, J = 8.3 Hz, 1H), 6.82 (d, J = 8.9 Hz, 1H), 6.52 (d, J = 2.4 Hz, 1H), 6.44 (dd, 
J = 8.3, 2.4 Hz, 1H), 6.09 (t, J = 5.9 Hz, 1H), 5.96 (d, J = 8.1 Hz, 1H), 4.59 (t, J = 5.5 Hz, 
1H), 4.05 (d, J = 5.9 Hz, 2H), 4.01 – 3.94 (m, 2H), 3.87 – 3.78 (m, 4H), 3.76 (s, 3H), 3.73 
(s, 3H), 3.72 – 3.62 (m, 1H), 3.47 (dq, J = 10.6, 5.6 Hz, 1H), 3.30 (dt, J = 10.6, 5.5 Hz, 
1H), 3.20 (dt, J = 10.6, 6.2 Hz, 1H), 2.76 (dd, J = 13.6, 6.1 Hz, 1H), 2.68 (dd, J = 13.6, 
7.5 Hz, 1H), 1.73 – 1.44 (m, 1H), 1.33 – 1.13 (m, 2H), 1.03 (d, J = 6.5 Hz, 3H), 0.83 (dd, 
J = 9.4, 6.6 Hz, 6H). 13C NMR (126 MHz, DMSO-d6) δ 159.56, 157.66, 157.43, 155.96, 
155.64, 138.44, 129.21, 128.71, 128.26, 126.15, 120.32, 104.16, 98.14, 66.13, 65.29, 
64.09, 55.35, 55.20, 50.87, 50.02, 45.93, 37.77, 37.62, 24.22, 23.44, 21.80, 17.40. HRMS 





FAL-phthalimide:  (S)-2-(3-(2,4-dimethoxybenzyl)ureido)-3-phenylpropyl ((S)-1-((((S)-
1-(1,3-dioxoisoindolin-2-yl)-4-methylpentan-2-yl)carbamoyl)oxy)propan-2-yl)carbamate 
 
100 mg (0.169 mmol) FAL-OH, 58 mg (0.22 mmol, 1.3 eq) PPh3, 43 µL (0.22 mol, 1.3 
eq) DIAD, and 32 mg (0.22 mol, 1.3 eq) phthalimide were stirred in 4 mL THF at room 
temperature overnight.  LCMS showed FAL-OH was still present.  PPh3, DIAD, and 
phthalimide quantities were doubled, and the reaction stirred overnight.  Only 62% had 
converted to FAL-phthalimide, and so another 1.3 eq phthalimide were added.  After 
stirring one more night, the reaction reached 89% product with 11% FAL-OH.  The 
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reaction was filtered free of solids, poured into water, and extracted twice with DCM.  
The organics were washed twice with brine, dried over Na2SO4, filtered of solids, and 
stripped of solvents under reduced pressure.  SiO2 chromatography (slow gradient 3:1 
Hexanes/EtOAc to 100% EtOAc to 2% MeOH in EtOAc) to remove excess reagents and 
triphenylphosphonium oxide gave 103 mg (85% yield) product.  LCMS (ESI / APCI +/-):  





To 50 mg (0.0697 mmol) in 0.5 mL ethanol were added 10 µL (0.0837 mmol, 1.15 eq) 
8M methylamine in ethanol, and the reaction was stirred at room temperature overnight. 
18% of the phthalimide remained. Two µL more methylamine solution were added, and 
the reaction stirred another night.  Formic acid was added to pH 3, and the reaction was 
stripped of ethanol and methyl amine solvents at reduced pressure.  Reverse-phase 
purification produced 9 mg (22% yield) of the amine as the ammonium formate salt.  
Pure fractions were lyophilized free of water overnight.  LCMS (ESI/APCI +/-):  588 








265 mg (0.450 mmol) FAL and 265 mg (1.638 mmol, 3.64 eq) CDI in 4 mL anhydrous 
DMF were stirred at RT for three hours.  444 mg (3.28 mmol, 7.3 eq) L-methioninol were 
added, and the reaction stirred overnight at RT.  The mixture was poured into 1M HCl 
and thrice extracted with EtOAc.  The combined organics were washed with 1M HCl, 
then brine, dried over Na2SO4, filtered, and stripped of solvents to dryness under reduced 
pressure.  SiO2 column chromatography to remove sulfoxide (oxidized FALM) (4:1 
EtOAc / hexanes to 100% EtOAc) gave 125 mg (37% yield) FALM.  1H NMR (500 
MHz, DMSO-d6) δ 7.29 (t, J = 7.4 Hz, 2H), 7.24-7.12 (m, 4H), 7.01 (d, J = 8.8 Hz, 1H), 
6.98 (d, J = 8.2, 1H), 6.86 (d, J = 8.6 Hz, 1H), 6.53 (d, J = 2.4 Hz, 1H), 6.44 (dd, J = 8.2, 
2.4 Hz, 1H), 6.08 (t, J = 5.9 Hz, 1H), 5.95 (d, J = 8.1 Hz, 1H), 4.64 (t, J = 5.7 Hz, 1H), 
4.05 (d, J = 5.9 Hz, 2H), 4.0 – 3.93 (m, 1H), 3.90 – 3.78 (m, 5H), 3.77 (s, 4H), 3.74 (s, 
3H), 3.72 – 3.63 (m, 2H), 3.50 (tq, J = 9.5, 5.2 Hz, 1H), 3.40 – 3.35 (m, 1H), 3.25 (dt, J = 
11.4, 6.4 Hz, 1H), 2.77 (dd, J = 13.8, 6.2 Hz, 1H), 2.69 (dd, J = 13.7, 7.5 Hz, 1H), 2.46 
(dd, J = 9.4, 5.0 Hz, 1H), 2.40 (dq, J = 13.1, 7.1 Hz, 1H), 2.02 (s, 3H), 1.78 (td, J = 9.2, 
4.6 Hz, 1H), 1.57 (dqt, J = 14.5, 9.6, 5.6, 4.7 Hz, 2H), 1.28 (ddt, J = 17.2, 12.2, 6.0 Hz, 
1H), 1.19 (q, J = 7.3, 6.3 Hz, 2H), 1.05 (d, J = 6.9 Hz, 3H), 0.84 (dd, J = 11.3, 6.6 Hz, 
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6H). 13C NMR (126 MHz, DMSO-d6) δ 159.55, 157.40, 155.93, 155.88, 155.61, 138.40, 
129.16, 128.70, 128.22, 126.11, 120.31, 104.18, 98.14, 66.23, 63.26, 59.77, 55.32, 55.17, 
51.99, 50.01, 48.16, 45.90, 37.75, 37.60, 30.60, 29.99, 24.06, 23.20, 21.68, 20.76, 17.39, 











95 mg (0.127 mmol) FALM and 31 mg (0.190 mmol, 1.5 eq) CDI in 4 mL anhydrous 
DMF under argon balloon (to prevent sulfide oxidation to sulfoxide) were stirred at RT 
for three hours.  53 mg (0.280 mmol, 2.2 eq) L-tryptophanol were added, and the reaction 
stirred overnight at RT.  The mixture was poured into 1M HCl and thrice extracted with 
EtOAc.  The combined organics were washed with 1M HCl, then brine, dried over 
Na2SO4, filtered, and stripped of solvents to dryness under reduced pressure.  SiO2 
column chromatography (4:1 EtOAc / hexanes to 100% EtOAc) gave 85 mg (69% yield) 
FALMW.  1H NMR (500 MHz, DMSO-d6) δ 10.76 (d, J = 2.5 Hz, 1H), 7.58 (d, J = 7.9 
Hz, 1H), 7.32 (d, J = 8.1 Hz, 1H), 7.28 (t, J = 7.5 Hz, 2H), 7.24 – 7.13 (m, 4H), 7.09 (d, J 
= 2.3 Hz, 1H), 7.05 (t, J = 7.5 Hz, 2H), 7.02 (s, 1H), 6.99 – 6.94 (m, 2H), 6.92 (d, J = 8.4 
Hz, 1H), 6.52 (d, J = 2.4 Hz, 1H), 6.44 (dd, J = 8.3, 2.4 Hz, 1H), 6.08 (t, J = 5.9 Hz, 1H), 
5.95 (d, J = 8.2 Hz, 1H), 4.65 (t, J = 5.7 Hz, 1H), 4.05 (d, J = 5.8 Hz, 2H), 4.00 – 3.94 
(m, 1H), 3.94 – 3.86 (m, 2H), 3.86 – 3.78 (m, 6H), 3.76 (s, 3H), 3.73 (s, 3H), 3.73 – 3.61 
(m, 4H), 3.28 – 3.20 (m, 1H), 2.89 (dd, J = 14.6, 6.6 Hz, 1H), 2.82 -2.71 (m, 2H), 2.68 
(dd, J = 13.7, 7.5 Hz, 1H), 2.45 (dd, J = 8.9, 5.1 Hz, 1H), 2.42 – 2.29 (m, 1H), 2.01 (s, 
3H), 1.76 – 1.64 (m, 1H), 1.64 – 1.48 (m, 2H), 1.27 (dq, J = 16.9, 9.2, 7.1 Hz, 1H), 1.22 – 
1.11 (m, 1H), 1.11 – 0.96 (m, 4H), 0.87 – 0.76 (m, 6H). 13C NMR (126 MHz, DMSO-d6) 
δ 159.56, 157.66, 157.43, 155.90, 155.80, 155.62, 138.40, 136.18, 129.17, 128.71, 
128.23, 127.51, 126.12, 123.16, 120.81, 120.31, 118.42, 118.18, 111.42, 111.31, 104.20, 
98.15, 66.25, 65.97, 65.29, 65.03, 62.72, 55.34, 55.18, 53.79, 50.03, 49.33, 48.16, 45.92, 
45.71, 37.76, 37.60, 30.71, 29.64, 26.73, 24.05, 23.21, 21.68, 17.40, 14.64. HRMS +ESI 
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